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Abstract
This thesis investigates structural and dynamic properties of drug recognition
mechanisms to duplex and quadruplex DNA using primarily high field NMR
techniques and molecular dynamics simulations.
The mechanism of co-operative binding of Hoechst 33258 to the DNA minor
groove of duplexes that contain two binding sites such as d(CTTTTGCAAAAG)2,
d(GAAAAGCTTTC)2 and d(CTTTTGGCCAAAAG)2 has been studied. NMR and
other titration techniques have evidenced co-operative binding and no detection of an
intermediate I: 1 complex. High-resolution NMR structure determination showed no
evidence of direct contact between Hoechst 33258 molecules or DNA structure
deformation that would facilitate co-operativity, Molecular dynamics simulations
based on NMR data, allowed us to calculate thermodynamic quantities of the two
binding events, and lead us to conclude that ligand binding can induce changes in
DNA conformational flexibility in sites of the structure distant from the binding site
and result in more favourable second ligand binding. The results highlight the
general importance of flexibility in determining the properties of ligand-DNA
interactions.
The relative importance of ligand isohelicity and phasing in DNA minor
groove has been investigated by studying the structure and dynamics of the I: 1
complex of Hoechst IO-d(GCAAATTTGC)2. The results suggest that DNA
sequence-dependent structure and flexibility have significant role for the strong
binding of Hoechst 10 to the duplex.
The formation, stability, structure and dynamics of the d(TTAGGGT)4
quadruplex structure, which contains the human telomeric repeat TTAGGG, have
been studied. Characteristic features of the quadruplex structure were determined
and this information was used for understanding drug-quadruplex interactions. The
complex of the fluorinated polycyclic methylacridinium cation RHPS4, lead
compound for telomerase inhibition, with the d(TTAGGGT)4 quadruplex structure
has been investigated. RHPS4 forms a stable G-quadruplex complex by end-
stacking externally to the a-tetrads of the Apa and Gp'T steps. This study presents
detailed properties of the complex and provides further information for lead
optimisation studies.
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1. Co-operative interactions in DNA recognition
1.1 Introduction
Co-operative binding of ligands to nucleic acids is possible when multiple
ligands can bind to the same nucleic acid molecule. Co-operativity is a
thermodynamic effect that reflects the influence of one bound ligand on the binding
affinity of the second ligand. Co-operative interactions arise when the changes in
free energy from the binding of two or more ligands to the same nucleic acid are
mutually dependent. Table 1.1 shows the ligand configurations and associated free
energy states for co-operative ligand binding to two linked binding sites on a DNA
molecule.
In the literature co-operativity is defined in two modes: positive or negative,
reflecting the influence on the binding affinity of the second ligand which is
enhanced or diminished according to the interaction of the first ligand. Negative co-
operativity is usually related to statistical effects that result from the overlap of
potential ligand binding sites, while positive co-operativity is induced by real
changes to the intrinsic binding parameters. Co-operativity can arise from
ligand-ligand interactions when ligands are bound to adjacent sites on DNA. It can
also occur through short-range conformational changes that are induced in the DNA
molecule on ligand binding. There are also examples for some DNA binding
proteins that are bound to specific sites well separated along the length of the DNA
molecule. The origins of co-operativity in such systems have generally become
evident after structure elucidation.
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Table 1.1 General configuration and associated free energy states for ligand binding to a
two-sites DNA system. Binding sites are stated by L if liganded, co-operative interactions
are stated with B. The total free Gibbs energy of each configuration (.1G.) relative to the
unliganded reference state is given from the sum of the contributions from six energy
changes (column 3). .1G" .1G2 are the intrinsic free energy changes for binding to the
individual sites, .1G'2 is the free energy of co-operative interaction between liganded sites,
defined as the difference in free energy to fill the sites simultaneously and free energy to fill
them individually. In the case that the two binding sites are identical.1G,=.1G2.
Two binding sites (general case)
Species Binding configuration Free energy contributions Total free energy
Site 1 Site 2
1 reference state .1Gl1
2 L .1G, .1G'2
3 L .1G2 .1G'3
4 L B L .1G, + .1G2+ .1G'2 .1G'4
It is particularly interesting to understand how co-operativity operates in
ligand-DNA complexes and what are the factors that contribute to the overall
favourable co-operative binding interactions that result in higher sequence specificity
as well as greater sensitivity to changes in ligand concentration. This chapter
reviews structural investigations of specific DNA complexes with proteins and drug
molecules where co-operative binding is observed. The origins of co-operative
interactions are discussed, together with sequence-dependent structural features, and
the role of the structural flexibility of these DNA complexes is emphasised.
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1.2 Co-operativity in protein-DNA interactions
The initiation of transcription is a primary control point for the regulation of
gene expression in all organisms. The regulation of transcription initiation is
mediated through specific interactions between complex regulatory assemblies. The
latter can be proteins that interact with one another and with arrays of DNA sites that
are often separated by considerable distances (1). A common feature of these
regulatory assemblies is the co-operative binding of the regulatory proteins to DNA.
Co-operative interactions of proteins with DNA have been recognised to playa key
role in controlling the transcription regulation by enhancing binding selectivity and
also increasing sensitivity for protein concentration (2). Thus understanding the
nature of co-operative interactions between protein-DNA complexes is a crucial step
in understanding the molecular mechanism of gene regulation.
Homeodomain proteins have become one of the most studied eukaryotic
DNA-binding proteins because of their key role in development and gene regulation
(3-5). The homeodomain is a compact 60 residue DNA-binding domain that
consists of three a helices folded around a hydrophobic core and a flexible N-
terminal arm that becomes ordered only upon binding to DNA. The most interesting
characteristic feature of many homeodomains is that they do not function in the cells
as monomers, but instead bind DNA co-operatively with other homeodomain
proteins, such that the affinity of the second protein for DNA is higher in the
presence of the binding of the first protein (6).
One of the most studied examples of co-operative DNA-binding
homeodomain proteins is the "Paired" class. The co-operative DNA binding of the
"Paired" class is based entirely on the conserved 60 amino acid homeodomain, unlike
other cases of co-operative DNA binding of homeoprotein dimers that do need
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protein-protein interactions extrinsic to the homeodomain (7). The high-resolution
crystal structure of the "Paired" class, co-operative homeodomain dimer on the DNA
sequence 5'- TAATCTGA TTA-3', composed of two inverted TAAT motifs, has
been determined at 2.0 A resolution (figure 1.1) revealing the structural basis for the
observed co-operative binding (8).
This study shows that the two-paired homeodomains do interact when bound
to the DNA site through hydrophobic contacts, water mediated hydrogen bonds and
electrostatic interactions. However, conformational changes in the DNA structure
are essential for the homeodomains to come in position to interact. The deformation
of the DNA structure that allows them to interact is mainly a bend (21°) at the centre
of the palindrome site, primarily due to positive roll and tilt at the base steps from 5
to 7. Most importantly, the conformational change in the DNA that implies the co-
operative interaction is a consequence of the single homeodomain binding to one half
site and not a result of the dimerisation. This is strongly supported by the fact that
the binding of a monomer or other homeodomain protein, brings about a similar
conformational change in the DNA (9).
To summarise, there is strong evidence that co-operative binding is mediated
by DNA conformational changes. However, it is not obvious how the binding of the
first homeodomain promotes changes in DNA conformation, making the second
binding site more favourable for the second homeodomain while maintaing the
essential contacts between the DNA and the first homeodomain. In addition, how are
these changes transferred from the one binding site to the other? The question that
arises is what role do DNA structure and flexibility play in mediating co-operative
binding of proteins at adjacent sites.
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Figure 1.1 View rotated by about 900 along the DNA axis, showing the complex of a head-
to-head arrangement of the paired homeodomains on the palindromic DNA site. The arrows
indicate the 210 bend in the DNA (8).
It is well known that RNA-protein interactions play a central role in the
regulation of gene expression. In eukaryotes there are proteins that bind to rnRNA,
to control their processing and export to the cytoplasm and also their translation into
a protein. A well-studied example of such a protein is U IA protein, which regulates
its own translation by binding to an RNA element called the polydenylation
inhibition element, PIE. Two UIA molecules bind co-operatively to the PIE region.
The resulting trimolecular complex interacts with the enzyme responsible for the
formation of the poly (A) tail, poly(A) polymerase, and inhibits its activity (9). Co-
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operative binding is necessary for the regulation of polydenylation as loss of the co-
operative binding when the spacing between the two binding sites ofUIA proteins is
increased results in cancellation of the inhibition.
Figure 1.2 shows the structure of the trimolecular complex of two UIA
proteins and the RNA element PIE (9). The dimer interface is formed by the
interactions of each helix C between the two UIA proteins. The authors suggested in
this case that co-operativity in protein binding is mediated by direct protein-protein
interactions and not by protein-induced structural changes in the RNA element. This
is in agreement with the RNA-protein interface being minimally affected by the
protein-protein interactions in the trimolecular complex. The trimolecular UIA-PIE
complex is the largest protein-RNA complex solved. The quality of the structure is
clear with many of the intermolecular interactions in the protein-RNA interface and
intramolecular interactions observed.
The structure of the bimolecular complex has been previously resolved and
the differences with the trimolecular complex have been extracted. Characteristic
NOE interactions between the hydrophobic residues of helix C and the remainder of
the RNA-binding domain showed that the location of the helix C remained
constrained by the requirement to maintain necessary interactions with the RNA,
however helix C becomes longer and more rigid in the trimolecular structure. The
structure explains that the observed co-operativity is a result of the optimal spacing
of the two bulges. A change in the RNA structure would alter the spacing and
thereby twist the two UIA monomers with respect to each other, pushing them either
too close or too far apart. Formation of the trimolecular complex is favourable and
offers a larger surface area of interaction with the poly(A) polymerase.
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UIA
PIE RNA
Figure 1.2 Structure of the trimolecular complex of two UIA proteins and PIE RNA. The
dimer interface is formed by protein-protein interactions of the helix C from each UIA
protein.
1.3 Co-operativity in drug-DNA interactions
Co-operative binding to DNA has been reported in a number of studies of
natural or synthetic drug molecules that recognize specific DNA sequences.
Although the factors that are responsible for co-operative binding have not been fully
understood and in each case different factors may be responsible, it is likely that the
phenomena associated with co-operative binding are important for the therapeutic
activity of these substances. Moreover, co-operative binding appears between drug
molecules that bind to DNA with different modes of interaction such as intercalation
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(11), by inserting a planar aromatic chromophore between adjacent DNA base pairs,
or groove binding by fitting into the DNA minor groove (12). In each case, DNA
structure and flexibility should have a role in mediating co-operative binding of drug
molecules, in other words DNA should allow the information from the first drug
binding to be transferred through its sequence to the following site making the
second binding more favourable.
1.3.1 Co-operative binding in DNA intercalation
The DNA intercalators (11) have a planar aromatic ring system that inserts
between the DNA base pairs, figure 1.3. Intercalation involves separation of the
DNA base pairs, distortion of the backbone conformation, and finally, unwinding of
the duplex. The formation of the complexes with DNA is primarily stabilised by
stacking interactions between the base pairs and the aromatic ring systems of the
intercalator. Some intercalators have bulky groups at either end of the aromatic
system that interact with the grooves of the DNA and offer extra binding stability.
There are two types of intercalators: mono-intercalators, which have one aromatic
system, and bis-intercalators, which have two aromatic systems attached with a
linker.
One of the most demonstrated examples of co-operative binding in DNA
intercalation has been reported for the antibiotic echinomycin, figure 1.3.
Echinomycin is an antitumour antibiotic possessing a cyclic octadepsipeptide that
binds tightly to DNA by the mechanism of bis-intercalation (13) and inhibits DNA-
directed RNA synthesis (14). Various footprinting (15), NMR (16) and
crystallographic (17) studies have demonstrated that echinomycin binds
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preferentially to sites containing CpG steps in DNA. However, a weaker binding to
CpA steps has also been established (18).
Figure 1.4 is a schematic representation of the echinomycin complex with the
duplex d(ACGTTATACGTh, showing the intercalation of the quinoxaline rings at
the ApC steps and the peptide binding in the minor groove (19). Its sequence
selectivity is mediated by the formation of three hydrogen bonds between the alanine
residues of the ligand and the N3 and 2-amino groups of the guanosine nuc1eotides in
the recognition site. An unexpected feature of the echinomycin-oligonucleotide
complexes from crystallographic studies (17) was the observation of Hoogsteen base
pairing at the AT base pairs flanking the intercalation sites. Hoogsteen base pairing
has been proposed to bring the sugar phosphate backbones 2A closer together than
found for Watson-Crick pairs, allowing better Van der Waals contacts around the
echinomycin molecule. However, Hoogsteen base pairing has not been observed in
long DNA sequences and several NMR studies (16,19,20) confirmed that Hoogsteen
base pairing depends both on the sequence and temperature.
Co-operative binding of echinomycin to specific sites of DNA has been
studied by NMR spectroscopy and qualitative footprinting studies and the results
from both studies agree to a high degree. Qualitative footprinting (21) showed a high
degree of co-operativity in the binding of the echinomycin to certain closely spaced
ACGT and TCGA sites. These results fully agree with the NMR studies of
echinomycin binding to the sequences ACGTACGT (19) and ACGTATACGT (20)
where echinomycin molecules bind co-operatively to each CpG step. Moreover,
another NMR study showed that no co-operativity is observed between echinomycin
molecules bound to TCGATCGA (19), where each molecule binds independently at
each CpG step. Footprinting studies also detected co-operative interaction to the
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sequence TCGAACGT (21). There is strong evidence that co-operative binding of
echinomycin to DNA is sequence-dependent, and also that the distance between
binding sites plays a role.
nogalamycin echinomycin
acridine m-amsacrine
Figure 1.3 CharacteristicDNA intercalators.
5'- A~ T
3'-Tb-JA
A T A~ T-3'
T'o-e1A-5'T A
Figure 1.4 Schematic representation of the echinomycin complex with the duplex
d(ACGTT AT ACGT)z (20).
Looking at both the NMR and footprinting data, it is unlikely that co-
operativity originates from direct interaction between bound echinomycin molecules.
The most likely origin of co-operativity, considering that it is sequence-dependent, is
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drug-induced DNA conformational changes that are propagated from one binding
site to the other. An interesting observation from an early NMR study of
echinomycin with d(ACGTACGT)2 (19) was that the central TA base steps are
Hoogsteen paired. In contrast, the complex of echinomycin with
d(ACGTATACGT)2 (20) revealed that no Hoogsteen base pairs are formed in any
central AT base pairs, showing that the extra ApT step prevents the formation of
stable Hoogsteen base pairs immediately adjacent to the binding site. These NMR
studies evidenced two major structural changes in the DNA duplex when two
echinomycin molecules bind. The DNA duplex in the
d(ACGTATACGTh-echinomycin complex is underwound at the central ApT step
when compared with the free duplex. The presence of a cross peak between the
A5H8 and T6H6 indicates an unwinding of the duplex by approximately 20 degrees.
In addition, the internal AT base pairs are less stable in the bound DNA duplex than
in the ligand-free duplex. The role of the destabilisation of base pairs in mediating
co-operative interactions is not clear.
Footprinting results (22,23) have shown that the hyperactivity of AT-rich
regions adjacent to echinomycin binding sites to DNA cleavage reagents, is
propagated a significant distance from the binding sites. The unwinding of the
duplex beyond the binding sites in AT-rich regions was proposed to increase the
minor groove width, thus rendering the DNA more susceptible to DNA cleavage
reagents.
On the basis of these observations, it is evident that bis-intercalation of
echinomycin around a CpG step induces significant structural changes in the DNA
helix. The unwinding of the duplex and accompanying changes in minor groove
width may be slightly different between the two binding sites. Therefore these
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structural changes upon the first binding of echinomycin may propagate differently
to the second binding site and so may be differently perceived by the second
echinomycin molecule, making the second interaction more favourable.
1.3.2 Co-operative binding in the DNA minor groove
Minor groove binders (11,12) interact with the DNA minor groove through
non-covalent binding that causes small changes in DNA structure (figure 1.5). Many
of them have planar and aromatic moieties that offer a complementary curvature to
the bending surface of the narrow minor groove, enabling close Van der Waals
contacts and hydrophobic interactions. Minor groove binders also have the potential
for hydrogen bonding with the donors and acceptors on the floor of the groove. A
characteristic of minor groove binders is a positively charged group that enables
them to form electrostatic interactions with the negative phosphates and the negative
potential of the AT tracts.
Naturally occurring oligopeptide distamycin A (figure 1.5) has been shown
from numerous studies to bind to the minor groove of DNA in a co-operative mode.
Distamycin A is potent antibacterial, antiviral, and antineoplastic agent whose
pharmacological activity has been correlated to its ability to block DNA template
function (25). Distamycin A forms non-covalent complexes with the DNA minor
groove and exhibits considerable preference for AT-rich sequences.
Crystallographic and NMR studies of 1: 1 distamycin A-DNA complexes have
shown that a minimal binding site consists of four AT base pairs, and that binding at
asymmetrical sites is directional with the N-terminal formyl group pointing towards
the 5' end of the AT-rich strand, figure 1.6 (11). The orientation of the first two
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rings of the drug is parallel, while the third ring is inclined to conform to the rotation
of the helix.
netropsin
lexitropsin
Figure 1.S Characteristic minor groove binders.
I 0
/~~ ~N-C~-
~ ~ yO
°J-NH HN~+
H NH2
distamycin
NH2
The earlier studies (25-27) of complexes of distamycin A with binding sites
consisting of four AT base pairs proposed that close Van der Waals contacts between
adenine and drug H3 protons and potential three center hydrogen bonding between
drug amide and adenine N3 and thymine 02 atoms on the floor of the minor groove,
are common stabilizing factors. While hydrophobic interactions, hydrogen bonding
and electrostatic interactions are proposed as general stabilizing factors, stacking
interactions between DNA sugar 01 'atoms and the three N-methylpyrrole rings are
also thought to contribute significantly to complex stability (27).
NMR studies (12) have also established an interesting 2: 1 binding motif of
two distamycin molecules that bind simultaneously, side by side in an anti-parallel
orientation, at binding sites of at least five base pairs, figure 1.6 (28). In these 2:1
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complexes, distamycin molecules preserve their recognition elements of minor grove
binders and are stacked side by side in the minor groove with the positively charged
end groups pointing in opposite directions. The formyl group of each ligand lies at
the 5' end of the adjacent strand. The binding of the second ligand in the 2: 1 motif
must widen the minor groove by approximately 3.5 A relative to the 1:1 complex.
The 2: 1 binding motif can be highly co-operative and this depends strongly on the
base sequence of the binding site, figure 1.7.
5'- A A A T T
02 02
3'-
02
T
N3
A
Figure 1.6 The antiparallel side-by-side motif composed of two distamycin molecules.
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Figure 1.7 Structure of the 2: 1 distamycin-d(CATATATG)2 complex (29).
Molecular modelling studies based on NMR data of the 2: 1 complex with the
non-complementary duplex d(CGCAAA TTGGC).d(GCCAA TTTGCG) suggested
that distamycin A molecules are staggered with respect to one another so that drug
pyrrole rings of one antibiotic stack with the amide linkages of the another (30).
Hydrogen bonds from the distamycin amide NHs to adenine N3 and thymine 02 are
present again as stabilizing factors, however, three-centre hydrogen bonds with the
DNA acceptors on different strands are not included in the 2: 1 motif. The drug
molecules are pushed to the sides of the groove rather than lying in the central region
as observed in the 1: 1 complex. In the 2: 1 complex, the minor groove widens in
order to accommodate two drug molecules side by side and this relies on the
adequate flexibility of the phosphate backbone of the duplex, figure 1.7.
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NMR titration of distamycin A within the complementary duplex
d(CGCAAA TTTGCG)2 revealed additional kinetic features of the 2: 1 interaction
(31). At low drug:DNA ratios (0.5 equiv), both the one-drug and the symmetric two-
drug binding motif were observed, while at higher ratios (2 equiv) the two drug
complex was the primary species in solution. The off rate for the drug from the 2: 1
motif was found to be slow on the NMR time scale. NOE data from the drug pyrrole
H3 to DNA deoxyribose HI' and adenine H2 protons together with observed line
width changes of DNA protons as a function of temperature were consistent with a
model, in which two drugs bind highly co-operatively in the minor groove, with each
drug sliding between S'-AATT-3' and S'-ATTT-3' binding sites at a rate that is fast
on the NMR time scale.
This dynamic equilibrium of the two drug molecules with the two possible
binding sites on each strand is a consequence of one more A- T base pair added to
the sequence, as the interaction of distamycin with the previously mentioned binding
site 5' -AAATT-3' (30) resulted in one 'static' 2: 1 complex. The proposed dynamic
model, which is fully consistent with all the intermolecular NOE data, is illustrated
schematically in figure 1.8.
NMR titration studies of distamycin A with the wider minor groove of an
alternating site S'-ATATAT-3' within the d(CGCATATATGCG)2 duplex (32) gave
also a symmetrical 2: 1 complex, however the two-drug binding is more co-operative
than the binding to the 5'-AAATTT-3' (31) site described above. This observation
has been interpreted as weaker binding in the 1:1 mode as a consequence of poorer
complementarity of the drug with the wider ATATAT minor groove.
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Figure 1.8 Schematic representation of the dynamic model for the 2: 1
distamycin-d(CGCAAATTTGCG)2 complex (31).
Distamycin A binding was also examined with
d.(CGCIIICCGGC).d(GCCIICCCGCG) (32) where I represents inosine(2-desamino-
guanosine). An I-C base pair has minor groove functional groups equivalent to an
A-T pair however, the groove width is similar to typical G-C rich regions (6-7 A)
rather than the narrower groove observed in AT-rich regions (3-4 A). The
electrostatic potential of I-C pairs is probably closer to that of G-C than A- T.
Titration of distamycin to a 5' -IIICC site showed no evidence of an intermediate I: 1
complex, but only for the 2: 1 even at very low drug concentrations, indicating a very
high degree of co-operativity for the drug binding.
Comparing these titration results with the AAA TTT minor groove results,
these data strongly suggest that the IIICC minor groove is wider and can readily be
filled with two ligands, each one making close contacts with each side of the groove.
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However, one drug would make contact with only one side, lowering the binding
affinity. Later NMR studies of distamycin analogues indicated only the presence of
highly co-operative binding with sequences containing 5'-AAGTT-3' (33), 5'-
TACGTA-3' (34) or 5'-TAACAA-3' (35) binding sites. These distamycin analogues
contain imidazole nitrogens that can recognize a guanine amino group by hydrogen
bonding.
The introduction of a GC base pair into an AT sequence of DNA widens the
minor groove locally and results in distamycin binding preferentially in the 2:1
mode. These results emphasize that the binding behaviour of distamycin reflects the
local variation in DNA groove, specifically the minor groove width geometry and
flexibility. Distamycin forms tight complexes with DNA only if it can provide close
Van der Waals contacts and hydrogen bonding, and also if the DNA minor groove
can expand to accommodate two distamycin molecules. In addition, it seems
energetically unfavourable to narrow a wide minor groove to increase the binding
affinity of the 1:1 complex. Therefore, it was suggested that the loss of shape
complementarity and contact surface between ligand and groove is more important
that the depth of the groove (12). Clearly the co-oprative 2: 1 binding of distamycin
depends on the sequence-dependent variations in minor groove structure and
flexibility.
1.4 Conclusions
This chapter defines the term co-operativity and discusses mainly structural
studies of ligands that show co-operative interactions when bound to DNA. We saw
that co-operativity can operate when the ligand intercalates between base pairs or
binds within the minor or major groove of the DNA molecule. Enhancement of the
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binding interaction in co-operative systems is usually a consequence of favourable
ligand-ligand interactions. We are interested to investigate co-operativity in a
system where there is a communication between binding sites without the sites being
in close proximity, preventing direct ligand-ligand interactions. Echinomycin is a
very good example of co-operativity where binding sites are well separated. The
intercalation reaction involves distortion and unwinding of the DNA helix, which can
allow for preorganisation of the second binding site when the first echinomycin
molecule binds. However, when the ligand interacts with the minor groove it is
unlikely that this causes similar distortion in the DNA structure as that induced by
intercalators, so the origins of the co-operativity are not obvious. In the next two
chapters the efforts of understanding co-operativity in the DNA minor groove, when
binding sites are well separated, are described. First, our efforts are concentrated on
establishing co-operativity and understanding its origins in our system. Then
sequence dependent effects of the DNA as well as increase of the distance between
sites are considered in order to obtain insights into the factors important in
information transfer between binding sites that leads to co-operativity.
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2. Structural investigations on DNA recognition
by Hoechst 33258
2.1 Introduction
Studies of the interactions of small drug molecules with DNA have been
carried out for several decades in the hope of learning the recognition code that
governs the targeting of specific DNA sequences in order to control gene expression
(1-3). There are a number of natural antibiotics and synthetic molecules that bind to
DNA in different modes and act as inhibitors of DNA transcription and replication
processes (4). Their mechanism of action usually involves the inhibition of
topoisomerases I and II. This prevents DNA religation and stabilisation of the
protein-DNA complex during the processes of replication, resulting in protein-
induced DNA strand breaks. A number of these drug molecules have been proven
clinically useful as anti-tumour, anti-viral or anti-microbial agents (5-9) although
their exact mode of action has not been defined completely. Understanding the
molecular basis of action of such molecules will permit the rational design of new
improved therapeutic agents with enhanced or more selective activity.
Ligands with low molecular weight, e.g. drug molecules that interact non-
covalently with the DNA have been used as model compounds for DNA binding
proteins, in order to make the analysis of these systems relatively simple. Drug
molecules represent good model systems both in their way of interacting with the
DNA, as the same forces are responsible for protein-DNA interaction, and by
exhibiting similar binding site size. Thus drug-DNA complexes may serve as good
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models to investigate the molecular basis of DNA binding and increase our
knowledge about the mechanism of recognition involved in gene expression.
Hoechst 33258, figure 2.1, abbreviated to H33258, is a synthetic compound
containing two linked benzimidazole rings with phenol and N-methylpiperazine rings
attached at either end of the structure, giving the molecule a crescent shape. H33258
is the best known and studied of the bis-benzimidazole family of minor groove
binders and it has been used widely as a fluorescent cytological DNA stain (10,11).
It possesses anthelmintic properties (12) and shows some activity against L210 and
P388 leukemias (13). Recently, phase II clinical trials were carried out for the
treatment of pancreatic cancer, but efforts were abandoned due to high toxicity (14).
A number of H33258 analogues have been designed and synthesised usually by
substituting the phenol and piperazine rings with other moieties. Some analogues
have shown increased DNA specificity and significant cytotoxicity against several
human cancer cell lines (15-16).
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Figure 2.1 Hoechst 33258 scheme with atoms, torsion angles and residues labelled. Arrows
indicate hydrogen-bonding potential.
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DNA footprinting and spectroscopic studies have shown that H33258 exhibits
a distinct selectivity for AT-rich DNA sequences with a binding site of 4-5 bases
(17,18). Although H33258 requires at least 4 consecutive AT bases for strong
binding, additional studies with repeating synthetic DNA polymers and natural DNA
showed that H33258 has a weaker binding mode which is reduced in the presence of
high salt and has no apparent base specificity (19). Linear dichroism studies show
minor groove binding with poly(dA-dT)'poJy(dA-dT), poly(dA)'poly(dT) and DNA
from calf thymous and partially intercalating binding with
poly(dG-dC)'poly(dG-dC), poly(dA-dG)'poJy(dT-dC) and poly(dG)(dC) (20).
Association constants K, for binding of H33258 with AT-rich self-complementary
duplexes determined using fluorescence titrations lie in the range of 2-5 x 108
(duplex Mr' (21). A detailed calorimetric and fluorescence study with the
oligonucleotide d(CGCAAATTTGCG)2 has concluded that H33258 DNA
recognition is an entropy-driven process and that Van der Waals contacts along with
hydrogen-bonding interactions play only a fine tuning role in the binding site (22).
A number of NMR (23-27) and X-ray crystallographic (28-33) studies of
H33258 complexes with AT-containing oligonucleotides have been reported and, in
part, shed light on the molecular basis for DNA minor groove recognition. These
studies position the drug in the minor groove with the benzimidazole groups
following the groove curvature. Each nitrogen atom forms hydrogen bonds in a
bifurcated manner to a pair of hydrogen-bond donors of adjacent AT base pairs
found on the floor of the groove. While both NMR and X-ray studies agree that the
two almost planar aromatic benzimidazoles and phenol rings are accommodated
firmly within the narrow AT-tract, there is some controversy about the degree of GC
tolerance of the bulky positively charged piperazine ring. Specifically, there are
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some crystal structures (29,30) where the piperazine ring is bound at the wider GC
minor groove close to the end of the AT-tract, while most of the structures suggest
that binding preferentially occurs within the central region of the AT groove. This
structural heterogeneity may arise from the way crystals are grown as well as the
temperature at which data were collected, or may be due to X-ray crystal structures
being a series of snap shots of a dynamic complex.
Hoechst 33258 possesses the common recognition properties found for minor
groove binders such as complementary shape with the floor of the minor groove,
hydrogen bonding with the acceptors on the floor of the groove and cationic charge
for electrostatic interactions with negative phosphates and negative potential of AT-
tracts. The NMR study (27) of H33258 with an extended AT-tract in the sequence
d(GCAAAATTTTCG)2 identified one binding site and no evidence of movement
(sliding) along the length of the AT-tract. H33258 was bound at the central AATT
site, where the groove is narrower and restricts the mobility of the drug. This study
suggests that sequence specificity may be dominated by the ability to select binding
sites on the basis of groove width, allowing optimum Van der Waals
complementarity and hydrophobic surface burial, rather than specific hydrogen-
bonding interactions with the groove floor. Similar conclusions have been drawn
from the crystallographic study ofa meta-hydroxy Hoechst analogue (34).
The vast majority of the structural data on Hoechst 33258 and its analogues
bound to DNA have reported complexes containing a single binding site of 4-6 A- T
base pairs within self-complementary AATT, ATAT and AAATIT binding sites
(23-33). The limitations imposed by these sequences are two fold: (i) the limited
size of these binding sites has complicated the analysis of sequence-dependent A-
tract recognition by restricting the number of high affinity binding sites available in
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one sequence; (ii) the orientational preference of the bound ligand has been obscured
by choosing A-tracts containing self-complementary (AnTn) binding sites where the
drug can bind in one of two symmetry related orientations. It is known that Tn or An
tracts (n~4) are not uniform; recent studies of the localisation of ammonium ions in
the minor groove of various A-tracts show sequence-dependent effects which
correlate with groove narrowing towards the 3'-end of An tracts (n>4) (35), making
symmetrical AnTn tracts narrowest at the centre of the sequence. The sensitivity of
ligand binding to the direction of groove narrowing in isolated An and Tn tracts,
together with the effects of A-tract junctions on binding orientation, has not been
addressed.
To examine the effects of sequence-dependent structural features on groove
recognition and ligand orientation we describe a high resolution NMR study of
H33258 binding to the dodecamer duplex d(CTITTGCAAAAG)2 containing two
TITT tracts. Previously, titration studies and subsequent low-resolution structural
analysis revealed that two bound drug molecules are accommodated in symmetry-
related orientations such that the overall dyad symmetry of the duplex is retained in
solution (23). Binding at the two sites was found to be highly co-operative with only
the 2: 1 complex detected in equilibrium with the free duplex. Capillary
electrophoresis studies have demonstrated a similar co-operative behaviour with
other AT-rich sequences (36). Furthermore, the two TITT sites are separated by an
intervening GC pair, which isolates the two ligands, figure 2.2. Thus, a direct-
contact mechanism cannot explain the observed co-operativity. This contrasts with
the anti-parallel side-by-side dimer motif of distamycin (figure 1.7) where there is a
highly complementary fit within a widened minor groove with a favourable 7t-
stacking interaction between the two drug molecules (37, 38).
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Figure 2.2 Left, side by side, head to tail co-operative binding of distamycin molecules in
the 2: I complex, right, co-operative head to head binding of H33258 molecules in the minor
groove of the 2: 1 complex with d(CTTTTGCAAAAG)2'
We investigate the molecular basis of co-operative processes in ligand-DNA
interactions. In this work, we have attempted to determine whether the drug binds
co-operatively to the two sites by further analysis of the H33258 complex. In other
words, is there an enhancement of the binding affinity to the second site as soon as
the first is occupied? Following this, we are interested to investigate the origins of
the observed binding co-operativity and also examine the role of DNA structure and
flexibility in such a phenomenon, since the DNA is a highly flexible molecule and
permits structural changes on ligand binding, as demonstrated by the work with
distamycin.
In this study, we examined extensively the complex of H33258 with
d(CTTTTGCAAAAG)2 by NMR spectroscopy and restrained molecular dynamics
using the AMBER 95 force field with an explicit solvent model. We will examine
sequence-dependent effects on H33258 groove preference and orientation and also
shed light on the origins of the co-operative process. The structure and dynamics of
the high-resolution complex are analysed and compared with those of the unbound
DNA to examine how the DNA structure is affected upon ligand binding. The
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dynamics and the structure of the AT-tracts in the free duplex are also examined by
NMR based on imino proton exchange times 'rex. The complex of H33258 with a
related duplex d(GAAAAGCTTTTC)2, where the orientation of the AT-tracts has
been inverted, is also studied.
2.2 Materials and methods
2.2.1 DNA synthesis
The oligonucleotides d(CTTTTGCAAAAGh and d(GAAAAGCTTTTC)2
were synthesized on an Applied Biosystems DNA synthesiser using standard solid-
phase phosphoramidite chemistry, and purified trityl-on by reverse phase HPLC
using TEEA buffer, pH=7.0 and acetonitrile gradient. The trityl group was cleaved
by treatment with 50% aqueous acid for 1 h at 350 C. Acetic acid was extracted into
ether (3 x 200 ml) and the oligonucleotides finally dialysed to remove residual TEEA
and acetic acid then dialysed against 1 M NaCI and 100 mM Na2P04 (2000 ml) to
introduce Na+ as the counter ion. The Na+ ions bind the negative phosphate
backbone of the DNA and stabilise the duplex. Finally, the sample was dialysed
twice with water (2000 ml) to reduce the salt concentration. The oligonucleotides
were shown to be > 95% pure in duplex form by IH NMR spectroscopy.
2.2.2 Sample preparation
The final salt concentration of the purified oligonucleotides was adjusted to
100 mM NaCI and 10 mM NaH2P04 with the addition of stock solutions (125 III
NaCI 0.5 M, 10 III NaH2P04 0.5 M). The oligonucleotide samples were quantified
spectrophotometrically using extinction coefficients determined by the nearest-
neighbour method (39). The oligonucleotides were lyophilised and dissolved in 0.6
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ml 020, with the addition of2,2,3,3-[2~]-trimethylsilypropanoic acid TSP (3 ul of a
1mM solution) as an internal NMR reference (0.0 ppm). The oligonucleotides were
also prevented from decomposing by additions of sodium azide NaN3 (10 J.l.Iof a 6
mM solution), an antibacterial agent, and the disodium salt of
ethylenediaminetetraacetic acid EDTA (10 J.l.Iof a 6 mM solution), a metal chelating
agent. Finally the pH of the sample was adjusted to 7.0 with appropriate additions of
NaOD solution in 020.
The sample of Hoechst 33258 was purchased from Sigma and was used
without further purification after checking its purity by IH NMR. Its concentration
was determined spectrophotometrically at 25°C using the following extinction
coefficient Em = 42000 M-1cm-l. The 2:1 complex of DNA and H33258 was
generated by titrating small aliquots of the drug solution in D20 (-10 mM) into a
solution of the duplex. The stochiometry was monitored by IH NMR and stopped
when the resonances of the free DNA were fully replaced with those of the 2:1
complex. The NMR sample was lyophilised again and dissolved in 90% H20 and
10% 020 solution (0.6 ml), for the determination of the exchangeable proton
resonances.
2.2.3 NMR analysis
All IH NMR spectra were recorded at 500 MHz on a Bruker Avance DRX-
500 spectrometer and NMR data collected and processed on R4600PC and R5000SC
Silicon Graphics Indy Workstations using Broker X-WinNMR software. Standard
phase-sensitive 20 NMR pulse sequences were used throughout, including NOESY,
DQF-COSY, TOCSY, HMQC and WATERGATE-NOESY for solvent suppression
in 90% H20 solutions (26). Quadrature detection for fl was achieved using time
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proportional phase incrementation (TPPI). In 020 solutions, the carrier frequency
was placed at the centre of the spectrum at the frequency of the HOD solvent
resonance to allow pre saturation by low power continuous wave irradiation during
the relaxation delay. In H20 solutions, the transmitter was placed at the frequencies
of the H20 resonance and solvent suppression was achieved by using the
WATERGA TE pulse sequence.
NOESY spectra were acquired at mixing times between 50 and 300 ms and,
typically, 2048 complex data points in t2 were collected for each of 512 11 increments
with 64 transients for each. WATERGATE-NOESY spectra at 250 ms, 100 ms and
75 ms mixing times were collected using a sample in 90% H20 and 10% 020
solution over 2048 data points in t2 and 512 points in tl with 64 transients for each,
and employed a 10 ppm spectral width. Spectra were zero filled to 2048 x 1024 prior
to Fourier transformation, apodised typically with a sine-squared window function in
both dimensions and also treated with automatic baseline correction. Measurements
of imino proton line widths as a function of [NH3] used the jump-return pulse
sequence for solvent suppression.
2.2.4 NOE restraints
Intensities of the assigned peaks for each mixing time were converted to
distances by using the inverse sixth power relationship between NOE intensity and
interproton distance:
Where Dij is the interproton distance calculated for the cross-peak between i and j
protons, Dre/ is the interproton distance of the reference cross-peak, Iij is the intensity
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of the NOE cross-peak between i and j and Ire! is the intensity of the reference NOE
cross-peak of known distance. In order to be more accurate in getting the distance
restraints, different internal distances were used (Dre) for the three different sets of
protons: sugar protons, base protons and methyl protons. The NOEs that involve
sugar protons were referenced with sugar H2'-H2" distance (1.85 A), the base
protons were referenced with cytosine H5-H6 distance (2.45 A) and the thymine
CHrCH6 reference distance (3.0 A) was applied to the NOEs involving methyl
protons.
Interproton distances in both the 2: 1 complex and the free DNA were derived
by integration of NOEs assigned from 75, 100 and 125 ms NOESY spectra in 020,
and 200 and 100 ms NOESY data in H20 solutions. Final distances were calculated
using the extrapolation method as described by Baleja et al. (40). The extrapolation
method is the most accurate method of estimating the correct distance by minimising
the spin diffusion effects on NOE data. Distances from each mixing time were
extrapolated back to zero mixing time. The inherent error associated with distance
calculations from the NOE data led to a 20% upper bound error being applied to all
distances involving the non-exchangeable protons. All distances involving the
exchangeable protons were given a 40% upper bound error due to the degree of
exchange with the solvent. Finally, distance restraints were compared visually with
the distances of a structure derived from unrestrained molecular dynamics
simulation, by using MolMol software for molecular graphics and display (41). A
total of 326 and 420 distance restraints were used for structural refinements of the
free duplexes d(CTTTTGCAAAAGh and d(GAAAAGCTTTTCh and 464 for the
2: 1 complex, including 56 drug-DNA NOEs. Tables with the list of the NOE
restraints are found in appendix 2.
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2.2.5 Structure calculations of d(CTTTTGCAAAAG)l and
d(GAAAAGCTTTTC)z
Molecular modelling was performed on an Origin 200 Silicon Graphics
server using the AMBER 94 force field (43) with explicit solvent models and Particle
Mesh Ewald method (PME) (44) for the treatment of electrostatics. Energy
minimisations, restrained and unrestrained molecular dynamics were carried out
using the SANDER module of AMBER 4.1. Calculations with SANDER were
performed with a 2 fs time step; the SHAKE algorithm (tolerance 0.00005 A) was
applied to all bonds to remove bond stretching and a 9 A cut off was applied to the
Lennard Jones interactions. The restrained molecular dynamics were performed at
constant pressure 1.0 atm with isotropic position scaling and at 300 K, utilising the
Berendsen algorithm for temperature coupling. Translational and rotational motions
were removed every 100 fs. All calculations were carried out with the PME method
using a 9 A cut-off for direct space non-bonded calculations and a 0.00001 Ewald
convergence tolerance for the inclusion of long-range electrostatics in our
calculations.
The initial model of the dodecamer d(CTTTTGCAAAAG)2 as a canonical
B-DNA was created using the AMBER 4.1 modules NUKlT, NUCGEN and LEAP.
Previous work by Bostock-Smith et al. (42) showed that when starting from A- or
B-form DNA, the final conformation is independent of starting structure, with
equilibration faster for B-form DNA. The duplex system was neutralized, requiring
22 sodium ions placed at the most negative locations but no closer than 5 A to any
other atom in the system using Coloumbic potential terms with the LEAP module.
The DNA molecule was solvated in a periodic TIP3 water box of approximate
dimensions 40 A x 40 A x 60 A that extended to a distance of 5 A from any solute
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atom and contained 1748 water molecules. The final information about the structure
is included in the topology and coordinate files, and these were used for molecular
dynamics simulations.
The starting structure was allowed to equilibrate fully before the distance
restrained MD calculations were applied using the following specific protocol.
Minimisation with 5000 step conjugate gradient was applied first to water only, then
to water and sodium ions and finally to all components of the system. Next, lOps of
dynamics were run at lOOK on the water only with the DNA and sodium ions
constrained. A further lOps of dynamics with PME allowed the water and sodium
ions to move, but not the DNA. PME was applied to all subsequent simulations. In
the following 5 ps of dynamics the temperature of the system was increased from
100 K to 300 K. In the next runs, each of them of 10 ps dynamics, the DNA force
constant is gradually reduced from 100 to SO,25, 10, 5 and 2.5 kcal morIA-2• The
equilibration step ends with 100 ps of dynamics on the whole, fully unrestrained
system. This equilibration protocol of free DNA is described step by step in table
2.1.
Distance restraints with a force constant of 30 kcal morl A-2 were introduced
gradually to the system over a period of 20 ps, with the temperature stable at 300 K
and PME on. The NOE-restrained B-DNA dynamics simulation was extended to 1
ns and snapshots of each ps were extracted from the whole simulation. The energy
penalty from 36 distance restraint violations was 32.15 kcal mol' l, most of them
found at the terminal residues. The maximum distance violation was 0.46 A, 21
restraints were violated by < 0.1 A, a further 9 restraints by < 0.2 A, and 5 restraints
by < 0.4 A. A 1 ns NOE restrained simulation of d(CAAAAGCTTTTGh was
performed and analysed following the same methods as for the
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d(C1T1TGCAAAAG)2. Distance restraint violations from 62 restraints contributed
to an energy penalty of 62.15 kcal mol-I. The maximum distance violation was 0.29
A, 15 restraints were violated by < 0.29 A, 27 restraints by < 0.2 A, and 20 restraints
by < 0.1 A. The average structure and the RMSDs over the course of the trajectory
were calculated using the CARNAL module of AMBER 4.1 and helicoidal structural
properties were analysed using CURVES 5.1 (45). Average structures were
calculated over the final500 ps of the simulations and energy-minimised.
Table 2.1 Molecular dynamics equilibration protocol of the free d(CTTTTGCAAAAG)2 and
d(GAAAAGCTTTC)2'
Steps Time Notes
1 5000 steps Minimisation of water
2 5000 steps Minimisation of water and Na +
3 5000 steps Minimisation of whole system
4 0-10 ps MD at lOOK on water, DNA and Na+ constrained
5 10-20 ps MD at lOOK on water and Na '. DNA constrained
6 20-25 ps Temperature rise to 300K
7 35-45 ps MD on system, DNA is held with 100 kcal morl A-2
8 45-55 ps MD on system, DNA is held with 50 kcal mol" A-2
9 55-65 ps MD on system, DNA is held with 25 kcal mol" A-2
10 65-75 ps MD on system, DNA is held with 10 kcal morl A-2
11 75-85 ps MD on system, DNA is held with 5 kcal mol" A-2
12 85-95 ps MD on system, DNA is held with 2.5 kcal mol" A-2
13 95-195 ps MD on system, DNA fully free, no restraints
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2.2.6 Structure calculations of 2: 1 H33258-d(CTTTTGCAAAAG)1 complex
Force field parameters of Hoechst 33258 atoms were determined by using
AMBER 94 force field parameters and missing parameters were estimated from
similar atom types within the AMBER parameter set. The electrostatic potential
around the Hoechst 33258 was first calculated as a grid of points by an ab initio
method at the G-13C* basis set level using Gausian 98 software (46). The charges at
the atom centres (appendix 3.1) were fitted to reproduce the electrostatic potential
using the RESP program in the AMBER suite and maintain consistency with the
AMBER force field charges. Molecular dynamics in vacuo of the drug alone showed
that the torsion angles of the aromatic rings are inherently non-planar and the
piperizine ring has some increased flexibility.
The starting model structure canonical B-DNA of the dodecamer
d(CTTTTGCAAAAGh was generated using the NUCGEN module of AMBER 4.1.
Counterions (20 Na+) were added around the phosphates to neutralise charges and
the system was solvated by a periodic box of 216 TIP3P molecule waters to a
minimum distance of 5 A around the solute. This resulted in a solvent box size of 40
A x 40 A x 60 A, solvating the complex with around 1700 water molecules. The two
drug molecules were docked in three different positions to avoid biasing the binding
sites: position a) into the minor groove and positioned by observing several NOE
distances, positions b) and c) place the drug by one base pair along the groove and
out of the groove by approximately 3 A.
Minimisation was performed with a 50 step steepest descent and a 5000 step
conjugate gradient to water and counterions first with the DNA and drug coordinates
frozen, followed by a further 5000 steps on all the components of the system. Next
molecular dynamics were run at 100 K on the water alone with the DNA, the drug
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and counterions constrained to their initial coordinates with a force constant of 100
kcal mort A-2• After this initial equilibration subsequent dynamics were carried out
using the particle mesh Ewald method within AMBER 4.1. Successive lOps of
dynamics, with the PME method turned on, allowed the counterions first and then the
drug to move, but the DNA remained constrained. In further 5 ps of dynamics the
systems were heated to 300 K and held there for another 5 ps, giving a total of 40 ps
equilibration.
In the following lOps of dynamics a set of 56 intermolecular restraints were
introduced gradually with the drug molecules fully free but the DNA still constrained
with a force constant of 100 kcal mort A-2• After a further 40 ps of dynamics with
the same conditions the system was cooled down from 300 K to 1 Kover 5 ps with
the restraints on and held there at 1K for 5 ps. The systems were minimised with no
restraints applied and RMSD values were calculated between the starting and final
minimised structures using MolMol software.
One structure from the three complexes that satisfied the intermolecular
distance restraints best was selected for the continuation of dynamics and allowed to
run for 1 ns. The temperature of the system was ramped to 300 K from 1 K over a
period of 10 ps with the DNA constrained with a force constant of 100 kcal mort A"2.
At the same time, the whole set of drug-DNA and DNA-DNA distance restraints
were introduced with a force constant of 30 kcal mort A-2• In successive 10 ps runs
the dynamics of the complex continued with the force constant on the DNA reducing
to 50, 25, 10,5 and finally 2 kcal mort A-2• Restrained dynamics followed for 1 ns
with the drug and DNA fully free. Snapshots of the simulations were collected every
ps and the structures were determined to be equilibrated by RMSD analysis. The
-I
energy penalty from distance restraint violations was 21.36 kcal mol with only 28
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distance violations. The maximum distance violation was 0.24 A, 8 restraints were
violated by < 0.1 A, 14 restraints by < 0.2 A, and 6 restraints by < 0.24 A.
Helicoidal parameters were analysed with CURVES 5.1 and average structures were
calculated over the equilibrated trajectories with the CARNAL module of AMBER
4.1.
2.3 Results and Discussion
2.3.1 NMR assignments of the free d(CTTTTGCAAAAG)l
Proton resonances of both exchangeable and non-exchangeable protons were
assigned using well-established procedures (47). Nucleotides are numbered
sequentially from the 5'-end of the dodecamer d-
(CI-T2-T3-T4-T5-G6-C7-A8-A9-AlO-All-G12). Firstly, the scalar spin-spin
couplings observed in TOCSY and DQF-COSY permitted almost complete
identification of the deoxyribose spin-systems, although there is significant overlap
of the H3'-H4' and H4'-H5'/H5" peaks. Scalar couplings also permitted the
identification of cytosine H5-H6 and thymine CH3-H6 resonances. Secondly,
through-space interactions observed in NOESY spectra allowed sequential
assignment of the base and the deoxyribose spin systems. Chemical shift
assignments of the DNA protons are presented in appendix 1.1.
The highlighted regions A and B of the 200 ms NOESY spectrum at 298 Kin
figure 2.3 include inter- and intranucleotide connectivities of H6/H8(i}-Hl '(i}-
H6/H8(i+ 1) and H6/H8(i}-H2' 12"(i}-H61H8(i+ 1), respectively. Sequential
assignment in figure 2.3A starts with the cross peak between intemucleotide protons
Cl H6-C 1HI' , proceeds to the cross peak between intranucleotide protons
CI HI' - T2H6 and continues to the next neighbouring nucleotide along the sequence.
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In figure 2.3B sequential connectivities between H6/H8 protons and H2'/H2" protons
are assigned independently using the same procedure. The distinction between H2'
and H2" protons was achieved by examination of the intensity of the NOE cross
peaks between these protons and HI' protons, as was suggested previously (47). The
distance between Hl'-H2' protons is always longer than the distance between
HI'-H2" protons, in respect to predominantly S-type sugar conformation indicated
by DQF-COSY and TOCSY data. Sequential NOEs AH2(i)-AH2(i+l) are observed
between neighbouring adenines along the AT-tract in the duplex and are
characteristic of base stacking interactions in AT-tracts. There are also interstrand
NOEs between adenine H2 and deoxyribose HI' of the complementary nucleotide to
the 5' neighbouring residue such as A9H2-T5HI', AlOH2-T4HI' and
A11H2- T3H 1'. These indicate that the AT-tract is highly propeller twisted, figure
2.3.
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Figure 2.3 Expanded regions of the 200 ms NOESY spectrum of d(CTTTTGCAAAAG)2
illustrating sequential assignment pathways between A) base H61H8 and deoxyribose HI'
protons and B) base H61H8 and deoxyribose H2'1H2" protons.
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2.3.2 NMR titration of H33258 to d(CTTTTGCAAAAG)l
Figure 2.4 shows portions of the ID IH-NMR spectra of the free
d(CTITIGCAAAAG)2 and the different ratios of Hoechst
33258-d(CTTTTGCAAAAG)2 complex. Upon drug titration, resonances
corresponding to the unbound DNA decreased and finally disappeared and new
resonances corresponding to the bound DNA appeared. At the point of one
equivalent of Hoechst 33258 per duplex there are resonances corresponding to both
the free and bound DNA. Observing easily distinguished regions of the spectrum,
such as the methyl region (1.3-1.8 ppm) and the aromatic region, enables new
resonances to be followed. Resonances of the complex formed can also be observed
in previously unoccupied spectral regions (6.5-6.0 ppm). Addition of further
quantities of the drug results in a decrease of the intensity of the signals of the free
DNA until, at a ratio of two H33258 molecules per duplex, a single species in
solution is retained. This is best illustrated from the thymine methyl resonances
between 1.0-1.5 ppm, where in the 2:1 complex four methyl resonances are clearly
resolved while at I: I ratio only resonances from the 2: 1 complex and the free DNA
are detected. The observation of four thymine methyl peaks in the NMR spectrum of
the 2: 1 complex confirms that two asymmetric H33258 molecules bind the duplex in
symmetrical orientation and so the duplex keeps the dyad symmetry of its
palindromic sequence, figure 2.5. Binding in parallel orientations would give rise to
a doubling of oligonucleotide resonances as this would lift the dyad symmetry of the
duplex. The absence of any recordable resonance of the 1:1 complex and the
presence of the 2:1 complex from low drug:duplex ratio such as 0.25:1 during the
titration suggests that the two H33258 molecules bind the duplex
d(CTITIGCAAAAGh in a highly co-operative manner.
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Figure 2.4 Titration of H33258 with d(CTTTTGCAAAAG)2' IH-NMR spectra recorded at
298 K illustrate the thymine methyl region and the aromatic region for different drug:duplex
ratios.
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Figure 2.S Schemeof the two typesof symmetricalbindingof H33258moleculesalong the
duplex. The head of the arrowrepresentsthe bulkyN-methylpiperazinering ofH33258.
2.3.3 NMR assignment of the 2:1 complex
Using scalar spin spin couplings observed from the TOCSY spectrum along
with through space interactions via NOE data it was possible to identify the
deoxyribose spin systems of the duplex. The NOESY spectrum, figure 2.6, of the
complex in 020 solution recorded at 300 ms mixing time was fully assigned by
following the same sequential pathways described for the free duplex. In figure 2.7,
two expanded regions A and B of the 300 ms NOESY spectrum are illustrated
showing the inter- and intranucleotide sequential connectivities of H61H8(i}-H1'(i}-
H6/H8(i+l) and H6/H8(i}-H2'/2"(i}-H61H8(i+I). Figure 2.7A shows the correlation
between H6(i)-CH3(i+ 1)-H6(i+ 1) along the C1-T5 segment of the duplex and
figure 2.7B indicates a number of intermolecular interactions. In NOESY spectra at
298 K a number of chemical exchange cross peaks are identified between
corresponding protons of the two forms of the duplex, suggesting that drug is
dissociating slowly from the complex.
Sequential NOEs AH2(i)-AH2(i+ 1) and interstrand NOEs between adenine
H2 and deoxyribose HI' of the complementary nucleotide to the 5' neighbouring
residue such as A9H2-T5Hl', AIOH2-T4HI' and AllH2-T3HI', are also
observed as in free DNA. Such interactions are indicative of highly propeller-
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Figure 2.7 Expanded regions of the 300 ms NOESY spectrum of the 2: 1 complex recorded
at 288 K in D20, illustrating sequential assignment pathways A) base H6/H8 and
deoxyribose HI' protons and B) base H61H8 and deoxyribose H2'1H2" protons. NOEs
labelled (a)-(g) are assigned as: (a) ph H31H5-T3Hl', (b) bzl H4-T3Hl', (c) bzl
H4-T4Hl', (d) ph H2/H6-T2Hl', (e) ph H21H6-T3Hl', (t) pip NMe-A8H2, (g) pip
NMe-A9H2.
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twisted AT-tract; this is characteristic ofH33258-DNA complexes and seems to play
a key role in drug specificity and stability (28-30). A high degree of propeller
twisting is consistent with the groove width of the AT-tract being significantly
narrow. H33258 proton resonances were primarily assigned from the aromatic
region of the TOCSY spectrum and from specific intermolecular NOEs with the
DNA protons in D20 and 90% H20 solutions, following a similar assignment
procedure (23). Chemical shift assignments of the DNA and H33258 protons are
presented in appendices 1.3 and 1.S.
Previous studies have shown that the differences of the 1H chemical shift
values between the free and the bound form of the DNA indicate the drug-binding
site (25,26). In figure 2.S chemical shift differences ~oof base resonances H6/H8,
H2, H51CH3 and deoxyribose HI' are highlighted. Negative shift differences
correspond to resonances that move upfield while positive shifts indicate a shift
downfield on H33258 binding. The largest chemical shift perturbations are
experienced along the AT-tracts. Specifically, the deoxyribose HI' resonances of
T2, T3, TS, All and Gl2 have experienced a large upfield shift (0.26-1.25 ppm)
while the base H2 resonances of A9, AIO and All incur large downfield shifts
(0.54-0.80 ppm). In contrast, the resonances of the base protons H61H8 and H51CH3
experience only small shift perturbations. The largest drug-induced perturbations are
found on the floor (AH2) and on the walls (HI ') of the minor groove and this locates
the two drug molecules with some precision in the minor groove along the AT-tracts.
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Figure 2.8 H33258 induced chemical shift perturbations of base H2, H61H8, H2 protons and
deoxyribose HI' protons.
The 2: I complex of H33258-d(CTTTTGCAAAAG)2 is characterised by 38
intermolecular NOEs between drug and DNA protons. Many of the relevant NOE
cross peaks are shown in figure 2.7. The intermolecular NOEs are summarised in
table 2.2 and presented schematically in figure 2.9. Specifically, intermolecular
NOEs are observed between protons on the concave edge of the drug and protons
found on the floor and the walls of the minor groove, such as AH2 and deoxyribose
HI' along the full length of the AT-tract. Looking at the schematic representation of
the intermolecular NOEs, we conclude unambiguously that drug molecules are
positioned within each AT-tract and that the symmetrical binding of the two drugs
keeps the N-methylpiperazine groups of the two molecules at the center of the duplex
and not at its edges. For example, NOEs from the N-methylpiperazine ring to A8H2,
A9H2 and A9H I' at one end of the binding site, and from the phenyl ring protons ph
H2,H6 to TI4HI', Tl5HI' and AIIH2 at the other end of the A-tract establish that
both bound H33258 molecules are located at the centre of the 5'-TTTT and 5'-
AAAA sequences each close to the T5-G6 steps. The N-methylpiperazine rings
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point towards the centre of the duplex and are accommodated within AT-tracts, while
the phenol rings are located close to the 3'-end of the duplex. There is no NOE
interaction between the G6 or C7 nucleotides of the duplex and the N-
methylpiperazine rings that might indicate a degree of GC recognition by H332S8
molecules.
5'- C7
H
OH
GI2 -3'
3'- GI8 TI7 CIJ -5'
Figure 2.9 Schematic representation of the intermolecular NOEs of the complex.
Table 2.2 Intermolecular NOEs of the 2: I complex from NOESY recorded in D20 and H20
at 288 K.
Drug protons DNA protons
ph H2/H6 T2Hl', T3Hl', AllH2, G12Hl', G12HS'/S", T2H3
ph H3IHS AllH2, AIOH2, G12Hl', T3Hl'
pip H21H6 A9H2, A8H2, A9Hl', A8HS'/HS", A8H4'
pip H3IHS A9H2, A9H2, T4Hl'
bzl H4 AIOH2, T3Hl', T4Hl', A9H2, T3H3
bzl H6 AllH4'
bzl H7 AllH4'
bzl H3 AIOH2, AIIH2
bz2H4 T2H6, A9H2, A9Hl', AIOH2, T3H3
bz2 H6 A8H5'/S"
bz2 H3 AIOH2, A9H2
pip N-Me A8H2, A9H2, A9Hl'
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2.3.4 Structure of the 2:1 complex
The NMR restrained molecular dynamics simulation was judged to
equilibrate and converge well within the 1ns of the run as judged by RMSD analysis.
The last 500 ps of the simulation were selected for structural analysis. The pairwise
RMS deviation from the mean structure over all heavy atoms over the final 500 ps of
the simulation was 1.13 (±O.l7) A. The average structure from the last 500 ps of the
simulation of the 2: 1 complex is shown in figure 2.10. Each drug is bound across the
TTTT tract such that the complex retains a pseudo two-fold symmetry. The aromatic
rings of the drug are accommodated well across the TTTT tract with the piperazine
rings fitted close to the TG (CA) steps of the duplex. The view into the minor
groove illustrates the proximity of the two charged piperazine rings. These are
separated by -15 A (N-N distance) with the intervening cavity filled with water
molecules. The pattern of hydrogen-bonding interactions with the floor of the
groove is shown in figure 2.11, with the drug forming cross-strand bifurcated
interactions between adenine N3 and thymine 02 hydrogen bond acceptors (table
2.3). Such interactions have been observed with H33258 complexes in several X-ray
and NMR structures (26,29,31,42). The pattern of interactions in the two binding
sites is essentially the same, hydrogen bonds of NH donors of the drug with the N3
of AIO and All are generally longer than those with the 02 of T3 and T4 on the
complementary strand with standard deviations in these distances over the course of
the equilibrated portions of the simulation of -0.3 A. The angles of the hydrogen
bonds N-H ..·A (A meaning the acceptor atom) shown on table 2.3 agree well with
the pattern of the three-centre hydrogen bonds. Small changes in the hydrogen-bond
distances and angles during the simulation are apparent due to the dynamic nature of
the H33258 binding and do not preclude the tight fit of the aromatic rings of the
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drugs in the minor groove. Although the charged piperazinium ring does not form
direct hydrogen bonds to the floor of the groove, analysis of the solvation shell
during the MD simulation shows persistent water-mediated interactions with the N3
of G6 in both ligand binding sites. Thus, electrostatic interactions mediated by water
molecules with the central part of the sequence may be important for the orientation
of the drug molecules within the particular complex.
The torsion angles between the phenyl-benzimidazole (ph-bzl), the
benzimidazole-benzimidazole (bzl-bz2) and the benzimidazole-piperazine (bz2-
pip) rings define the conformation of the bound ligands, figure 2.1. The average
values along with standard deviations over the last 500 ps are shown in table 2.3. To
maximise groove complementarity and optimise the hydrogen-bond interactions the
drug molecules have a slightly twisted conformation. The ph-bzl and bzl-bz2
torsion angles show only small deviations from planarity «200 in the mean
structure) while standard deviations from the mean values are also relatively small
during the course of the dynamics simulations. The planar aromatic rings of both
bound drug molecules appear to be conformationally restricted by Van der Waals
interactions with the groove walls and hydrogen bonds to the groove floor. In
contrast, the bz2-pip torsion angle shows greater dynamic freedom, sampling a range
of conformations within the wider region of the groove. The flexibility of the
H33258 conformation within the binding site is illustrated in figure 2.12 with three
random chosen snapshots of the trajectory. The NMR data are consistent with a
degree of flexibility for the N-methylpiperazine and phenol rings as the presence of
resonance averaging for ph H2, H6, ph H3, H5, and pip H2, H6, pip H3, H5 is a
result of rapid ring-flipping motion within the lifetime of drug binding.
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Figure 2.11 Direct and solvent-mediated hydrogen-bonding interactions of H33258 with the
floor of the AT minor groove (adenine N3, thymine 02 and w- water).
Figure 2.12 Close view of one binding site of the 2: 1 complex of H33258 with
d(CTTTTGCAAAAG)2 illustrating a) close Van der Waals contacts between the bound
ligand and the walls of the minor groove and b) the flexibility of the H33258 conformation
within the binding site from three random chosen snapshots of the trajectory.
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Table 2.3 Mean intermolecular hydrogen-bonding distances and angles and ligand torsion
angles, in the 2:1 complex with d(CTTTTGCAAAAG)2 taken over the final 500 ps of
restrained molecular dynamics simulations.
Hydrogen-bond distance (H-X, A) a
and anzles rN-H-A(N3)rr(02), degrees] b
H33258 (1)
Bzl NH All N3 2.91 (0.29) T3 02 2.11 (0.24)
f117.8 (13.9)1 f148.5 (17.3)1
Bz2NH AIO N3 2.54 (0.33) T4 02 2.53 (0.31)
[132.4 (19.2)1 [129.7 (22.1)]
H33258 (2)
Bz1 NH All N3 2.99 (0.28) T3 02 2.09 (0.19)
r112.4 (12.0)1 rt54.802.3)]
Bz2NH AI0 N3 2.76 (0.22) T4 02 2.22 (0.25)
[117.6 (12.6)1 rt46.3 (13.7)]
Torsion angles (degrees) a
ph-bzl bzl-bz2 bzz-pip
H33258 (1) 11.7(12.1) 9.0 (13.9) 17.4 (39.4)
H33258 (2) 12.3 (11.4) 17.6 (10.3) -24.3 (15.7)
a Mean values given with standard deviations in parentheses.
b Hydrogen-bond angles for bifurcated interactions typically lie between 120-160°.
2.3.5 Conformation and dynamics of bound and free d(CTTTTGCAAAAG)l
The DNA helical parameters have been analysed over the final 500 ps of the
dynamics simulation and average values along with standard deviations calculated,
table 2.4. Sequence-dependent variations in structure are illustrated in figure 2.13 for
propeller twist, groove width and roll angle. Most striking is the apparent widening
of the groove in the 5'~3' direction along both TTTT tracts, culminating in distinct
junctions with the central G-C base pairs. The mean propeller twist at the S'-end of
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each TITT sequence is highly negative (>20°). However, it diminishes towards the
centre of the sequence. Such a pronounced negative propeller twist across AT-tracts
is observed along with particularly narrow minor groove width of duplexes bound
tightly with H33258 in many X-ray structures (28-34). Minor groove width,
measured from the Pi to Pj+3 distance (less 5.8 A), also increases significantly from
the 5' -end and is widest across the central G-C step, showing a strong correlation
with propeller twist. Widening of the groove is evident from the structures shown in
figure 2.10 with the N-methylpiperazine rings sitting at the end of each TITT tract
close to the TpG step in the wider part of the groove. The average increase from the
terminal residue to the central GC residues is -3.5 A for both TTIT tracts. While
the roll angles within the T-tracts are relatively small, close to 0°, large positive roll
(> 10°) at the TpG and CpA steps where the piperazine rings are located are clearly
evident, typical of pyrimidine-purine steps (48). The above structural parameters
among others emphasise strongly the variation in structure between the ITIT tracts
and the central GC part of the duplex.
The structural analysis identifies distinct sequence-dependent features in
general agreement with earlier conclusions that the A-tract is not uniform in width
but tends to widen from the 5'- towards the 3'-end of Tn sequences (49,50). The N-
methylpiperazine ring is accommodated at the end of each of the T-tracts precisely in
the region where the groove widens towards the junction with the central GC base
pairs. As a consequence we see a distinct orientational preference for H33258,
which takes advantage of this sequence-dependent groove widening. Similar
bifurcated hydrogen-bonding interactions are possible in either orientation of the
H33258 molecules and this should not play an important role in determining the
orientational preference. The planar phenyl and benzimidazole portions of the
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molecule are accommodated in the region where the minor groove is at its narrowest
at 5'-end of the TTTT tract, where intermolecular Van der Waals interactions are
maximised. The tight fit between the walls of the groove and the bound ligand are
illustrated for one site in figure 2.12.
Table 2.4 Average values and standard deviations for pseudorotation angle, twist, roll, rise,
tilt, shift, slide, propeller twist, buckle angle, inclination, x-displacement and minor groove
distances. Values calculated from the final 500 ps of the 1 ns restrained simulations of the
the 2: 1 complex H33258-d(CTTTTGCAAAAG)2 (A), the free DNA
d(CTTTTGCAAAAG)2 (B) and the free DNA d(GAAAAGCTTTTC)2 (C).
A B C
average sd average sd average sd
Pucker (0) 116.0 31.9 121.1 41.8 134.3 34.1
Twist (0) 33.1 4.8 31.6 8.2 30.6 7.0
Roll (0) 3.7 6.6 6.2 11.6 5.3 6.5
Rise (0) 3.7 6.6 3.5 0.4 3.4 0.3
Tilt (0) 3.5 4.0 3.6 4.2 3.0 6.7
Slide (0)
-0.9 0.4 -0.6 0.7 -0.9 0.6
Shift (0)
-0.9 0.4 0.5 0.7 0.2 0.6
Propeller (0) -16.6 7.9 -23.5 12.9 -10.7 6.2
Buckle (0) -1.4 10.5 -0.6 17.4 -0.2 8.4
Inclination (0) 2.2 1.5 7.4 2.3 4.1 1.4
X-disp (A) -1.7 0.1 -1.7 0.2 -1.9 0.2
P24-P5 4.6 0.5 4.0 0.6 7.9 0.8
P23-P6 4.9 0.5 4.3 0.6 10.3 0.7
P22-P7 7.2 0.8 6.6 1.1 10.3 0.8
P21-P8 8.3 1.0 6.6 0.8 5.3 0.8
P20-P9 8.0 1.0 6.7 0.7 4.9 0.7
P19-P10 8.1 0.6 6.7 1.0 9.4 0.8
P18-P11 4.9 0.5 4.2 1.0 9.7 1.08
P17-P12 4.7 0.4 4.1 1.0 7.2 1.48
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Figure 2.13 Sequence-dependent analysis of propeller twist (a), roll angle (b) minor groove
width (Pi-Pj+3 distance minus 5.8 A) (c), in the 2:1 complex of H33258 with
d(CTTITGCAAAAG)2 (solid lines), and for the free DNA (dotted lines); errors bars
represent one standard deviation from the mean over the final 500 ps of the 1 ns dynamics
simulation.
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The structural features identified in the 2: 1 complex appear to account
reasonably clearly for the orientational preference observed for H33258. However,
to what extent are these structural features a consequence of induced fit by the bound
ligand, reflecting sequence-dependent DNA flexibility, rather than intrinsic
sequence-dependent DNA structure? Moreover, what are the changes in DNA
structure from the free to the fully bound state that would allow the co-operative
binding of H33258 molecules? To this end, we have calculated structures of the free
d(CTTTTGCAAAAG)2 duplex using a very similar NOE-restrained MD protocol to
examine these questions in more detail.
Simulation of the free d(CTTTTGCAAAAGh duplex was performed on a
canonical B-form starting structure for 1 ns utilising a set of 396 NOE distance
restraints. A stereo view of 5 structures is illustrated in figure 2.14, showing overlaid
snapshots from the rMD simulation taken at 100 ps intervals between 500 and 1000
ps. The RMSD from the mean structure is 0.82 (±0.13) A. DNA structural
parameters have been calculated over the final 500 ps of the dynamics simulation and
average values along with standard deviations calculated and presented in table 2.4.
Plots of propeller twist, groove width and roll for d(CTTTTGCAAAAG)2 are shown
in figure 2.13 with the data for the 2:1 complex. Many of the structural features
identified for the 2: 1 complex are also apparent for the structure of the free DNA. A
superposition of energy-minimised mean DNA structures for the free DNA and 2:1
complex (figure 2.15) shows a relatively small RMSD over all heavy atoms of 1.55
A.
Propeller twist is found to be greatest for A-T base pairs (>30°) at the 5'-end
of the TTTT tract, but this again decreases significantly towards the 3' -end of the
tract and across the central GC step. In parallel with this we again see a narrow
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groove in the A-tracts, which widens considerably towards the 3'-end of the TTTT
sequences suggesting that the two parameters are correlated (51). The minor groove
width in free DNA is wider at the central part of the sequence and widens further
with the binding of the H33258 molecules allowing optimal fit of the N-
methylpiperazine moieties. Analysis of sugar puckers shows that with the exception
of the more dynamic terminal residues, the deoxyribose rings adopt C2' -endo/C 1'-
exo conformations (P=144-188°), the typical S configuration of B-DNA.
Particularly, T5 and C7 at the TpG (CpA) junctions show a larger standard deviation
which indicates a greater degree of dynamic flexibility (see below).
Helical twist also shows some degree of sequence-dependence. While the
two A-tracts have high positive twist, the TpG and CpA steps have lower values <
30°, in contrast to previous studies where the twist is large (35°-38°) at these steps
(52, 53), but in good agreement with other H33258 duplexes where binding across
alternating pur-pyr sequences (ATAT) is also observed (30). Junctions are clearly
visible again at the TpG and CpA steps at the centre of the sequence where the roll
angles become large and positive. Roll angle shows a similar but opposite trend to
helical twist. Roll increases to a maximum at the TpG step, decreases at the
neighbour GpC step and again increase to a maximum at the CpA step. These
observations are consistent with positive roll at TpG (CpA) steps, reducing cross-
strand steric clashes in the minor groove (48). Helical twist and roll angle appear to
be anti-correlated in these simulations, as has been observed for MD simulations of a
30-mer duplex d(C6T4A4CGT4A4G6)2 (54).
The structural features identified in the complex are clearly evident in the
structure of the free DNA, suggesting that these are intrinsic sequence-dependent
features that appear to account for ligand binding in the observed position and
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orientation. In addition, a comparison of the DNA structure in free and fully bound
form provides no explanation for the observed co-operativity. Both mean structures
are very similar as judged by RMSD analysis and comparison of the fluctuation of
their structural features during the equilibrated portions of the rMD simulations. The
origins of the co-operativity may be understood when the structure of the 1:1
complex can be determined. This will allow us to characterise any structural changes
induced in the second binding site when the first H33258 molecule binds to the
DNA. However, to isolate the 1: 1 complex by NMR spectroscopy is not possible as
the specific system is highly co-operative and 2: 1 complex is formed at very low
drug:DNA ratios.
Figure 2.14 Stereoviews of five overlaid structures of d(CTTTTGCAAAAGh taken at 600,
700, SOO,900, 1000 ps during the MD simulation, viewed into the minor groove. The
RMSD between structures over all heavy atoms is 0.S2 (±0.13) A.
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Figure 2.15 Energy-minimised mean structure of the DNA from simulations of the free
DNA (green) and the 2: I complex (blue) (drug removed for clarity), the RMSD over all
heavy atoms is 1.55 A.
2.3.6 Evidence for co-operative A-tract stabilisation with dynamic GC junctions
The local structure of DNA can be considered a consequence of either nearest
neighbour effects, in which each base pair adopts a conformation dependent only on
adjacent interactions, or longer range co-operative phenomena. The structure of A-
tracts is generally regarded to fit into this latter category; as a sequence of successive
adenine bases increases in length there is evidence for a co-operative change in helix
structure (55-57). Moreover, A-tract sequences, when repeated in phase every
helical tum are known to lead to intrinsically bent or curved DNA, as evident from
gel retardation and cyclisation kinetic measurements (55). A nucleation length of at
least 4 consecutive adenine bases appears to be necessary to induce the "A-tract"
structure that is proposed to be stabilised by a minor groove hydration network (58).
This solvation network is disrupted by GC rich sequences and also TpA, but not ApT
steps. When An and Tn tracts are interrupted by intervening GC base pairs they act
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as independent structural elements (55, 56), as might be predicted for the sequence
d(CTITIGCAAAAG)2' We have investigated, from a dynamic perspective, to what
extent the formation of co-operative A-tract structure might be significant in the
present context of minor groove recognition, and to what extent the junctions with
the central GC base pairs identified in the structural analysis disrupt this structure.
Earlier studies have established from measurements of imino proton
exchange rates that AT base pairs within An tracts (n~4) show anomalously long
lifetimes, reflecting A-tract stabilisation (59). The imino proton spectrum of
d(CTTTTGCAAAAG)2 was examined at various concentrations of ammonia, which
is added as an exchange catalyst (56,59,60). The imino proton exchange times tex
measured from the excess line width in the presence and absence of ammonia
provide a direct measure of the lifetime of the base-paired (closed) state. When tex
is extrapolated to infinite catalyst concentration (1I[NH31 = 0), base-pair opening
becomes the rate-limiting step for proton exchange (60). Exchange times (tex)
versus lI[NH3] are plotted in figure 2.16 from data at 15°C. Imino protons of
C 1-0 12 and T2-A 11 exchange rapidly as a consequence of end fraying effects,
resulting in base pair lifetimes too short to measure «1 ms), even at SoC. The
lifetime for T3-A lOis -4 ms, typical of AT base pairs in mixed sequence DNA and,
in the present context, may also be influenced by end effects. In contrast, the
lifetime ofT4-A9 is anomalously long (-23 ms) and similar to that observed for the
central AT base pair of a number of A-tract sequences (56), indicative of enhanced
stability. The lifetime of the T5-A8 base pair, by comparison, is essentially normal
(-6 ms), indicating a breakdown of A-tract stabilisation at the OC junction. The
central GC base pairs are much more stable (tex -43 ms), consistent with previously
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observed lifetimes (59). The data suggest that d(CTTTTGCAAAAG)2 does have
some of the features of co-operative A-tract structures previously identified (56, 59),
such as the distinct junction at the TpG (CpA) step, identified in the structural
analysis. This is supported by our kinetic measurements of base-pair lifetimes.
Breakdown of A-tract structure, and greater intrinsic DNA flexibility, may be
important factors in site-specific recognition, and, in the present context orientational
specificity, by minor groove binding agents.
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Figure 2.16 Plot of imino proton exchange time lex (ms) versus 1/[NH31 (M-I) for the base
pairs of the d(CTTTTGCAAAAG)2 at 15°C. Extrapolation to 1I[NH3] = 0 provides a
measure of the base pair lifetime where imino proton exchange becomes limited only by
base pair opening.
2.3.7 Complex ofd(GAAAAGCTTTTC):z with Hoechst 33258
We have carried out complementary studies of the dodecamer duplex
d(GAAAAGCTTTTCh in which the orientation of the two A-tracts has been
inverted while simultaneously eliminating the TpG (CpA) junctions at the ends of
these tracts. The duplex d(GAAAAGCTTTTG)2 should be able to accommodate
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two bound H33258 molecules within the minor groove of both the A-tracts in a
similar way as the duplex d(GTTTTGCAAAAC)2. However, we want to test if the
elimination of the TpG (CpA) junctions from the sequence changes the orientational
preference of H33258, as we suggested earlier. In addition, can we still observe co-
operative binding of H33258 or are the junctions in the sequence important for
transferring the information from one site to the other after the initial binding
process? Thus we carried out analogous NMR and rMD studies.
IH-NMR titration studies (see chapter 3) show that H33258 does not bind
with the same orientational specificity seen with d(CTTTTGCAAAAGh. At a ratio
of drug to duplex of 2:1, we see evidence for multiple bound species in solution
consistent with the drug binding in a number of different orientations. The
complexity of the spectrum does not permit us to resolve the mixture of bound
species present. It was suggested that lowering the temperature would isolate a
symmetrical complex, as maybe the high temperature gives the energy needed for
switching between the different orientations or increase the presence of the
asymmetric complex. However, low temperatures again resulted in a 10 IH-NMR
spectrum of broad resonances. 20 NOESY spectra at several temperatures also
showed an excess of cross peaks at the aromatic region agreeing with a mixture of
bound species. These observations seem to add weight to our conclusion that the
TpG junctions strongly influence the orientational preference, while an ApG junction
does not result in distinct structural features capable of influencing H33258 minor
groove recognition and that the duplex d(GAAAAGCTTTTC)2 accommodates the
molecules easily with either orientation.
We have also carried out full NMR and rMD analysis of the free duplex
d(GAAAAGCTTTTC)2 in order to examine the sequence-dependent features of the
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structure and possibly explain the reasons of the observed binding preference of
H33258. A table with the assignments of the proton resonances and the NOE
distance restraints used for the molecular dynamics simulation can be found in
appendices 1.2 and 2.2. The DNA structural parameters have been analysed over the
equilibrated portion of the dynamics simulation and results are presented in table 2.4.
Ten overlaid snapshots from the rMD simulation are illustrated in figure 2.17
showing a sample of the conformational space occupied by the structure and the
variation in minor groove width from two views. The RMSD of the last 500
snapshots from the mean structure over all heavy atoms is 1.15 (±O.l8) A. Although
most of the DNA helical parameters of the d(GAAAAGCTTTTC)2 duplex have
similar mean values to d(CTTTTGCAAAAGh there are significant differences in
sequence variation of propeller twist and minor groove width.
Propeller twist is found moderately negative between 20°-10° towards the
end of the AT-tracts and the central Gpe step, while at the ApG and CpT steps
values are small -0°. This duplex with inverted AT-tracts has a wider AT minor
groove and narrows significantly towards the 3' -end of the AT-tract sequences, close
to the centre of the sequence. The minor groove width (figure 2.18) in this duplex
behaves exactly the opposite way compared to the duplex d(CTTTTGCAAAAGh, as
it widens towards AG steps and generally has a wider average groove width. The
difference in minor groove width is possibly responsible for the orientational
preference of H33258 since there are no distinct structural features to strongly
influence the orientation in the complex with d(GAAAAGCTTTTCk It seems that
the bulky N-methylpiperazine moiety can fit and allow for optimal interactions with
the groove in either orientation within the A-tract.
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Figure 2.17 Two views of the ten overlaid snapshots from the last 100 ps of the rMD
simulation showing the variation in minor groove width along the duplex of
d(GAAAAGCTTTTC)2'
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Figure 2.18 Sequence-dependent analysis of minor groove width (Pi-Pj+3 distance minus
5.8 A) in the free duplex d(GAAAAGCTTTTC)2'
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2.4 Conclusions
NMR and restrained molecular dynamics studies on the 2: 1 complex of
H33258 with d(CTTTTGCAAAAG)2 and on the free duplex show clearly that the
H33258 molecule recognises the sequence-dependent structural features of the
duplex and forms a single 2: 1 symmetrical complex. The bound orientation of
H33258 with this duplex is influenced by the widening of the minor groove towards
the center of the sequence with distinct TpG (CpA) junctions connecting the two
binding sites. This is also confirmed by the study of the d(GAAAAGCTTTTC)2
duplex, which has the AT-tracts inverted, where bound H33258 has no orientational
preference. The interaction with d(CTTTTGCAAAAG)2 appears to be a co-
operative process. However, based on the structural data we are unable to suggest
why the binding interaction of the second drug molecule is enhanced. Structural
analysis of the duplex shows that binding sites are largely predisposed to
accommodate H33258 and this can playa significant role when the first molecule
binds the duplex. In the following chapter H33258 co-operativity is investigated
further in this system and other duplexes.
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3. Co-operative interaction of Hoechst 33258
within the DNA minor groove
3.1 Introduction
The origins of co-operativity in protein-DNA and drug-DNA complexes
have generally become evident where structure determination has been performed.
Typically, close contacts are observed in the 2: 1 complex between the two ligand
molecules. Thus, the binding of the second ligand to the 1:1 complex is associated
with the formation of a greater number of favourable interactions than the binding of
the first ligand to the free DNA. In the case of echinomycin (chapter 1), it is unlikely
that co-operativity is mediated by direct contact between drug molecules, but that the
drug-induced conformational changes at one site are propagated to the other, through
effects on helical twist (helix unwinding) and minor groove width. In contrast, the
oligopeptide antibiotic distamycin has demonstrated side-by-side anti-parallel
binding to the DNA minor groove, with favourable 1t-1t interactions stabilising the
drug dimer (chapter 1). The 2: 1 binding mode has been shown to be highly co-
operative in the case of binding to AT rich sequences of DNA that do not have an
intrinsically narrow minor groove (such as TATAT and AAGTT), where there is
poor binding complementarity in the I: 1 complex. In the 2:1 complex, the groove
width increases further to accommodate the drug dimer requiring sufficient DNA
flexibility to optimise Van der Waals interactions between the drug and the walls of
the groove. In this case, there is a clear shape complementarity requirement for co-
operative binding that can be rationalised on the basis of a direct interaction between
two bound ligand molecules.
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For simple cases where two molecules of a ligand bind to the DNA target, a
co-operativity index (~o-op) can be defined (scheme 3.1) as the ratio of the
equilibrium constants KI and K2 for the two binding events in the formation of the
2: 1 complex [ligand(L):DNA(D)]. If ~o-op = 1, then there is no interaction between
sites where if Kco-op > 1, sites are co-operatively linked.
D+2L DL+L DL2
2:1 complexfree DNA 1:1 complex
Scheme 3.1 Equilibria involved in the formation of the 2:1 ligand-DNA complex and
definitionof Kco-op.
3.2 Hoechst 33258 co-operative binding to DNA
In chapter 2, we described the titration of the DNA dodecamer duplex
d(CTTTTGCAAAAG)2 with H33258 that is followed by NMR. Signals of the free
DNA are replaced by those of the 2:1 drug-DNA complex, without detection of any
intermediate I: 1 complex. In terms of the equilibria involved (scheme 3.1) and the
practical limits of NMR sensitivity, we have estimated a lower limit on the co-
operativity index, Kco-op, of approximately 1000, which equates to a MG for the two
binding events of -4 kcal mOrl. Interestingly, the NMR-derived structures of the
free DNA and 2:1 complex do not, in this case, give us any insight into the origins of
co-operativity in this system. The structure of the complex shows that the ligands are
not in contact and are oriented in the two AT-tracts in such a way that their positively
charged piperidine rings face each other across the intervening GC step with the
charged centres separated by -15 A. Restrained MD calculations on the 2:1
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complex, using an explicit solvent model, indicate that the intervening groove is
occupied by solvent and that water molecules may be involved in mediating
electrostatic interactions with the floor of the groove, as well as screening the two
positive charges from each other. The width of the minor groove in An sequences
tends to decrease from their 5' -end, and this is observed in this complex, with the
bulky piperazine ring of the drug located in the wider part of the groove close to the
TpG step. Thus, the orientation of the ligands in this structure appears to be, at least
in part, sterically driven.
In the present chapter, we present our efforts to establish co-operative binding
of H33258 with other methods than NMR titration and also to investigate further the
origins of co-operativity by studying the interaction of H33258 with other
oligonucleotides containing adjacent binding sites. In the attempt to shed some light
on the origins of co-operativity in this system, we have also used extended molecular
dynamics simulations to study the free DNA, the 2: 1 complex, and also the
theoretical 1:1 complex. In collaboration with Dr. Sarah Harris, Dr. Charlie
Laughton from the School of Pharmaceutical Sciences, University of Nottingham,
we used the simulation data and we have been able to calculate thermodynamic
quantities relating to the two binding events, which are not available using other
methods. The thermodynamic properties of each system suggest an explanation for
the observed co-operativity.
3.3 Methods for detecting co-operativity in ligand-DNA recognition
3.3.1 NMR titration
Co-operativity in ligand-DNA recognition has been detected by a number of
experimental methods. NMR spectroscopy is probably the most common technique
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that has been used for observing co-operative binding of ligands to short
oligonucleotides. NMR has also the advantage to allow further detailed structure
determination of the resulting complex, which in most cases has been proven
necessary to understand the origins of the co-operativity. However, NMR requires
large amounts of the DNA and ligand and the method is limited to short
oligonucleotides.
Figure 3.1 shows the ID IH-NMR titration spectra of a distamycin analogue
with the decamer d(CGTATATAGC)2 at 25°C with 0.0, 0.5, 1.0, 1.5, 2.0 molar
equivalents ligand added (1). Upon addition of the ligand, the complexity of the
NMR spectrum increases as evidenced by doubling the number of the DNA
resonances and appearance of a new set of resonances, indicating ligand
complexation. As the drug:DNA ratio is raised, the intensities of the new
resonances, bound DNA, increase (see peaks between 6.4-6.8 ppm) and the
resonances from the free DNA decrease, until at drug-DNA ratio 2: 1 only the
resonances from the fully saturated complex are observed. Clearly one set of new
resonances are maintained throughout the entire titration corresponding to one bound
species, which is the 2: 1 ligand-DNA complex. Even at low ligand:DNA
stochiometries such as 0.25: 1, no intermediate I: 1 complex resonances were
observed. The absence of any resonances of the 1:1 complex and the presence of
only the 2: 1 complex, from the beginning of the titration, demonstrates that two
ligands bind to the duplex d(CGTATATAGC)z with high co-operativity. The
observation of the three thymine methyl peaks (1.4-1.7 ppm) in the NMR spectrum
of the 2: 1 complex ensures that ligands bind the DNA duplex symmetrically and the
duplex keeps the dyad symmetry of the self-complementary sequence.
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Figure 3.1 ID IH-NMR titration spectra ofd(CGTATATAGC)2 with tetra(N-methylpyrrole-
2-carboxamide) carried out with 0.0, O.S, 1.0, 1.S, 2.0 molar equivalents ligand added (1).
3.3.2 Circular dichroism titration
Circular dichroism (CD) can serve as a useful analytical tool for detecting co-
operative binding in ligand-DNA recognition. CD spectral measurements have been
used by Chen et al (2) to evidence co-operative binding of distamycin in 2: 1 complex
formation. As mentioned earlier, distamycin can form a 1:1 complex with duplexes
containing binding sites with four base pairs, such as ATTA, and co-operative 2:1
complexes when binding sites contain five base-pairs such as AAGTT. On the basis
of this observation, CD spectral titrations and comparison of spectral characteristics
using these two types of oligonucleotides were made to provide evidence of
differentiation of the two binding modes of distamycin. CD spectral measurements
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were found to be successful since the dimer complex has a CD spectrum distinct
from that of the monomer binding mode. This is due to the different extents to which
the DNA duplex is distorted by the expansion of the minor groove.
Specifically, Chen et al (2) used oligomers containing AITA and AAGTT
binding sites to probe the possible spectral differences of the 1:1 and 2: 1 binding
modes. Distamycin is optically inactive when is free in solution, however in the
presence of DNA, a CD spectrum can be induced upon complex formation. Figure
3.2 shows CD spectra for d(GCGATTAGCG) (A) and d(GCGAAGITGCG) (B) in
the absence and in the presence of increasing amounts of distamycin. It is obvious
that CD spectral characteristics of the two binding modes are distinctly different.
The CD spectral changes of these two binding modes can be seen clearly from the
corresponding difference spectra having the DNA spectral contribution subtracted, in
(C) and (D) respectively.
Binding of distamycin to the AIT A containing duplex results in a CD
intensity enhancement of a band centring around 325 nm, some small changes near
250 and 230 nm are also observed (C). The rest of the spectrum remains almost the
same. The maintenance of an isoelliptic point near 240 nm suggests a two-state
process, with the distamycin forming a 1:1 complex. Distamycin binding to the
AAGIT containing duplex induces two large positive bands near 265 nm and 330
nm and some small negative band centring near 290 nm (D). The isoelliptic point
241 nm appears again as with the ATTA containing duplex, however additional
isoelliptic points at 284 nm and 306 nm emphasise again a two-state process. This
time, the two-state process signifies the highly co-operative binding of distamycin
molecules forming simultaneously the 2: 1 complex. In summary, this CD study
emphasises the distinctly different spectral characteristics of the binding of
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distamycin in a 1:1 and co-operative 2: 1 complex and illustrates the usefulness of CD
titration as a sensitive method of detecting co-operativity in ligand-DNA
recognition.
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Figure 3.2 CD spectra titration of distarnycin with d(GCGATTAGCG) (A) and
d(GCGAAGTTGCG) (B). The corresponding ligand induced spectra, having the DNA
spectral contributions subtracted, are shown in Cc) and (D) (2).
3.3.3 Footprinting analysis
Footprinting refers to an assay in which the binding of a ligand inhibits the
cleavage of the backbone of a nucleic acid by an enzymatic or chemical nuclease at
specific sequences (3). The reaction produces radioactively labelled DNA fragments
of varying length, which are separated by gel electrophoresis. The decrease in the
intensities of certain bands identifies the position of the bound ligand, resulting in a
drug footprint. Quantitative Dnase I footprinting was first used to estimate binding
affinity and co-operativity with DNA-binding proteins (4). Later an analogous
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procedure was developed to determine the binding affinity of low molecular weight
drugs to specific nucleotide sequences (5). The advantage of this method is the use
of longer DNA fragments than oligomers used in NMR and the potential of having
multiple binding sites within a DNA fragment. In addition, it allows binding of a
ligand simultaneously at several sites to be examined and thus estimates of the
relative strength of interaction with the different binding sites. Binding sites can be
designed distal or proximal of each other allowing us to evaluate the extent of co-
operativity in the ligand-DNA recognition.
Quantitative Dnase I footprinting has been applied to determine the co-
operative binding of echinomycin to specific DNA fragments (5). Figure 3.3 shows a
Dnase I footprinting of echinomycin on a 168 bp 32P-Iabelled DNA fragment,
containing four CpG binding sites, at varying concentrations of echinomycin (0.1-30
J.l.M).Control lane (marked 0) shows the products resulting from the digestion of the
DNA fragment in the absence of the ligand. Lanes G, G+A, T+C indicate the
location of guanine, purine and pyrimidine residues. The remaining lanes show the
products of Dnase I digestion of the DNA fragment with the presence of increasing
concentrations of echinomycin. Quantitative analysis of the concentration
dependence of the footprints produces binding isotherms for each of the four CpG
binding sites, present in the DNA fragment. Thus, the binding affinity for each
binding site can be calculated. Co-operative binding can be detected when binding
of the ligand to a specific site increases the binding affinity of the second ligand to an
adjacent site.
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Figure 3.3 DNase I footprinting of echinomycin on the 168bp DNA fragment containing
four CpG sites. The sequences on the right show the exact location of the ACGT and TCGA
sites to which echinomycin binds (5).
3.4 Materials and methods
3.4.1 Fluorescence spectroscopy
For continuous variation and equilibrium binding analysis, stock solutions of
the oligonucleotide at 500 ~M and 50 ~M, and stock solutions ofH33258 at 300 ~M,
30 ~M and 3 ~M were prepared. Solutions were prepared at pH 7.0 using a buffer
solution of 100 mM NaCl and lO mM NaH2P04. Fluorescence studies were
performed at a temperature of 20°C in lcrn path length polyrnethacrylate cuvettes,
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using a Perkin Elmer luminescence spectrometer LS 50 B. Binding stochiometry of
the H33258 to the duplex d(CTTTTGCAAAATGh was measured by using the
method of continuous variation analysis, described by Job (6). H33258 and DNA
concentrations were varied but the sum concentration ([DNA]+[HoechstD was kept
fixed and constant at 1 IlM. Different volumes of equimolar solutions of each
reactant were mixed to give a mole fraction of drug ranging from 0.05 to 1 IlM in
buffer (100 mM NaCI and 10 mM NaH2P04). Final volume was fixed at 3ml with
additions of appropriate volumes of buffer and H20. Excitation and emission
wavelengths were set at 362 nm and 503 nm with slit width kept at 2.5 nm.
Fluorescence emission maxima were collected after 4 scans and data plotted against
mole fraction of drug with each portion of data fitted using linear least squares
method.
In addition, equilibrium binding analysis was performed to obtain a binding
constant and binding free energy for the Hoechst 33258-d(CTTTTGCAAAATG)2
complex. Fluorescence titrations were carried out at 20 °C by using three different
(0.2, 0.5, 1.0 J.lM) but fixed concentrations of Hoechst and varying the duplex
concentration between InM and IIlM. The solution after each titration was stirred
for 3 minutes in lcm path length cuvette to establish homogeneity and equilibrium.
Fluorescence emission maxima were collected and plotted against DNA
concentration. A binding constant was obtained by fitting the data with the fitting
equation 3.4 that is derived from the 2: 1 binding mode of H33258 to the duplex.
In order to derive equation 3.4, we consider the 2:1 binding of the two drug
molecules as a one step interaction; this is supported by observations from IH-NMR
and fluorescence titrations that drug binding takes place in a highly co-operative
mode. Thus, the 2: 1binding model is described by the following equilibrium:
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where A is drug, B is DNA duplex and BAl is the doubly bound complex.
The equilibrium constant K, is expressed as:
equation 3.1
Also total concentrations of drug [A]tot and DNA duplex [B]tot are derived by the
following equations:
[ALo,= [A]+ 2[BAJ ~ [A]= [A],o,-2[BAJ
[BLo,=[B]+[BA2] ~ [B]=[BLo,-[BA2]
equation 3.2
equation 3.3
The equation 3.4 is derived by substituting equations 3.2 and 3.3 into 3.1 and solving
that equation for [B]tot
equation 3.4
3.4.2 CD experiments
Circular dichroic (CD) spectra were measured at room temperature with an
AVIV model 62 DS spectropolarimeter (Aviv Associates, Lakewood, NJ), using a
0.2 cm path length. CD spectral titrations were made by starting with
oligonucleotide concentrations of 80 JlM in nucleotide followed by incremental
additions of aliquots of Hoechst 33258 stock solution (1 mM). The oligomers and
H33258 were prepared from stock solutions in 100 mM NaCl, 1 mM NaH2P04 and
0.1 mM EDTA at pH=7.0 After each injection, the CD spectrum was recorded 5
times over the wavelength range 220-400 nm in 1.0 nm steps using a bandwidth of 4
nm, at 298 K. The CD data were baseline corrected by solvent subtraction, averaged
and smoothly fitted.
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3.4.3 NMR experiments
Stock solutions of the oligonucleotides and H33258 used in the following
NMR experiments were synthesised, purified and prepared with exactly the same
procedures as described in section 2.2.1 NMR titrations were carried out until the
stochiometry reaches the ratio 2: 1 ligand:DNA. NMR data were collected and
processed as described in section 2.2.3.
3.4.4 Molecular dynamics
All simulations were performed with the same parameters as described in
section 2.2.5 using the AMBER 5.1 and AMBER 6 suites of programs. Starting
structures for the free DNA and 2:1 complexes were taken from NMR restrained
molecular dynamics simulation (chapter 2). Starting structure of the 1:1 complex
was taken from the NMR structure of the 2:1 complex subtracting one drug molecule
from the initial structure. The systems were electrically neutralised by addition of
sodium counterions and immersed in a periodic box of around 40 x 40 x 60 A water
molecules, optimised, thermalised and equilibrated using our standard multistage
protocol (section 2.2.5). The final equilibrated structures were then used to initiate
three 5 ns unrestrained MD simulations at constant pressure (P=l atm) and
temperature (T=298 K). Shake was used to constrain all bonds, permitting a 2 fs
time step for integration of Newton equations. Snapshots of the simulations
collected every ps and the structures were determined to equilibrate by RMSD
analysis. Helicoidal parameters were analysed with CURVES 5.1 and average
structures and RMSDs were calculated over the equilibrated trajectories with
CARNAL module of AMBER. Energy analysis was achieved using the MD
implementation of the GB/SA method, configurational entropies and Molecular
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Interaction Potential (MIP) calculations were calculated as described in the relevant
publication (7).
3.5 Results and discussion
3.5.1 Fluorescence studies
The method of continuous variation analysis was used to obtain a Job plot for
binding of H33258 with d(CTTTTGCAAAATG)2 at fixed H33258-DNA
concentrations of IJ.lM. Binding studies have used this method and successfully
determined a single binding site (6) with different oligonucleotides, but have also
shown multiple or degenerate binding stochiometries with poly(dA-dT)2'
poly(dG-dC)2 and calf thymus DNA (8). Figure 3.4 shows an intersection for the
least squared fitted lines at 0.65 mole fraction of the drug, indicating a 2: I
stochiometry that is consistent with the NMR study of the complex.
Binding constant and free energy was determined for the interaction of
H33258 with the duplex d(CTTTTGCAAAATG)2' Fluorescence titrations were
carried out for three different but fixed concentrations of H33258 at 20°C and pH
7.0, figure 3.5. Binding constants were determined to be independent of the
concentration in the range of (0.2-1) J.lM. Non-linear least-squared fitting
determined a binding constant of Kb= 0.4 x 1015M-2and a binding free energy of AG
= -81.9 kJ morl at 20°C. This is the first time that binding affinity of H33258 for a
two binding site duplex has been reported and is in line with expectations.
Fluorescence titrations have determined previously the binding constant of H33258
with a A3T3(7) and a A2T2 (9) site in the range of 3.1-3.6 x 108 M-I. However,
footprinting studies (10) of H33258 with a series of binding sites concluded that
A2T2and a A3T3 sites are unusually good binding sites and enable much tighter
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binding than single TTTT or AAAA sites. It is important to note that these
thermodynamic values are referred to the overall 2: I interaction of Hoechst with the
duplex. There is no way to determine the binding constant of the 1: I interaction by
fluorescence, since the process of 2: 1 interaction is highly co-operative and
fluorescence titrations can not separate the two binding sites.
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Figure 3.4 Job plot ofHoechst 33258 with d(CTTTTGCAAAAGh
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Figure 3.5 Equilibrium binding curve ofH33258 with d(CTTTTGCAAAAGh.
3.5.2 CD analysis
CD spectral measurements successfully determined the detection of the co-
operative 2: I distamycin-binding mode. Therefore, we carried out an analogous
study to probe the possible CD spectral characteristics of the 1: 1, the 2: 1 and also the
co-operative 2: 1 binding interaction of H33258. We have examined the interaction
of H33258 to duplexes where only one H33258 molecule can bind such as
d(CGCAA TTGCG)2 and where two H33258 molecules can bind such as
d(CGAAAATTTTGC)2, d(CTTTTGCAAAAG)2, and d(GAAAAGCTTTTC)2' The
binding interaction of H33258 with the AATT site has been shown by NMR to lead
to only a 1:1 complex (11). H33258 binding to the AAAATTTT site has been
addressed by NMR and fluorescence titrations (12) and gives a single 1:1 complex,
however, it is likely that two H33258 molecules can be accommodated to the two
adjacent AAAA and TTTT binding sites. CD spectra titrations for
d(CGCAA TTGCG)2 (A), d(CGAAAA TTTTGC)2 (C), d(CTTTTGCAAAAG)2 (E),
and d(GAAAAGCTTTTC)2 (G) in the absence and presence of various amounts of
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H33258 are shown in figure 3.6. Figure 3.6 shows also the induced CD spectra
where the DNA contributions are subtracted in (B), (D), (F), and (H) respectively.
It is obvious that titration of H33258 to each oligonucleotide can induce a
sizeable CD spectrum, showing complex formation. Apparently, binding of H33258
to each duplex induces a spectrum with different characteristics. Titration to the
AATT containing duplex, (A) and (B), results in a CD enhancement of a band
centering around 340 nm, with little spectral alterations except for some changes near
275 nm, 250 nm and 225 nm. Binding of H33258 to the AAAATTTT containing
duplex, (C) and (D), induces a spectrum with a large positive band near 350nm, and
also some small bands around 300 nm, 270 nm, 245 nm and 225 nm. In addition, (E)
and (F) panels show that H33258 titration to the d(CTTTTGCAAAAGh induces a
CD spectrum with a large positive band near 350 nm and smaller changes at 270 nm,
245 nm and 225 nm. Finally, binding interaction to the d(GAAAAGCTTTTC)2, (G)
and (H), induces a spectrum with a large positive band near 350 nm and a smaller
band around 280 nm. Isoelliptic points for the four CD titration spectra are not
defined clearly probably due to instrumentation instability. However, there is
evidence for isoelliptic point for the CD spectra of d(CGAAAATTTTGCh (D),
d(CTTTTGCAAAAGh (F) and d(GAAAAGCTTTTC)2 at 280 nm, 290 nm, and
260nm respectively. The CD spectrum of d(CGCAATTGCGh (B), should also have
an isoelliptic point around 290 nm, but this is not clear, largely due to small
differences in intensity in the region 220-300 nm. Isoelliptic points provide strong
evidence that binding of H33258 to the three duplexes is a two-state process. This
specifically indicates that binding of H33258 to the two binding sites of the
d(CTTTTGCAAAAG)2 and d(GAAAAGCTTTTGh appears to be a highly co-
operative process.
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Figure 3.6 CD spectra comparison for 4~M (in duplex) d(CGCAATTGCGh (A),
d(CGAAAA TTTTGC)2 (C), d(CTTTTGCAAAAGh CB)and d(GAAAAGCTTTTC)2 (G) in
the presence of 0.0, 1.8, 3.6, 5.4, 8.2 f!M concentration of H33258. The corresponding
ligand induced spectra, having the DNA spectral contributions subtracted, are shown in (B),
(D), (F), and (H) respectively.
Induced CD spectra for each duplex gives a similar pattern in the DNA
spectral region, 220-330nm, with small alterations in the intensity of the appearing
bands. This pattern may be characteristic of the H33258 complexation. In addition,
looking closely at the intensity of the induced spectra, we observe that the large
positive band near 350nm from binding to d(CTTTTGCAAAAG)2 and
d(GAAAAGCTTTTCh has approximately double the magnitude of the
corresponding bands for the other duplexes. This observation suggests that binding
of H33258 with d(CTTTTGCAAAAG)2 leads to a 2: 1 complex while only 1:1
complex is possible with duplexes d(CGCAATTGCG)2 and d(CGAAAATTTTGC)2.
In addition, CD spectra (E), (F), and (G), CH) do not give evidence of H33258
binding to a 1:1 complex first and then to 2: 1 complex as they follow a similar
pattern with the other spectra, suggesting again the presence of co-operative binding.
In summary, these results have provided CD spectral characteristics of the
H33258-DNA recognition with different duplexes containing one and two binding
sites. CD spectral titration provided some evidence of differentiation when H33258
binds to a single site or to two sites, however, induced CD spectra have similar band
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intensities at the DNA spectral region. This is likely to happen, as the H33258
interaction with the DNA minor groove does not produce gross changes in DNA
structure even when H33258 binds to two adjacent binding sites. In other words, the
2: 1 binding motif of distamycin, where the DNA minor groove is expanded in order
to accommodate the dimer, is very different to the 2:1 binding of H33258 to
d(CTTTTGCAAAAG)2, where minor differences in DNA structure are observed
(13). In addition, isoelliptic points in the CD spectrum provide us with evidence to
suggest co-operative binding of H33258 with d(CTTTTGCAAAAGh and
d(GAAAAGCTTTTC)2.
3.5.3 NMR binding studies of 1133258
In chapter 2, we described NMR titration studies of the binding of H33258 to
the dodecamer duplex d(CTTTTGCAAAAG)z. NMR titration, leads us to conclude
that two H33258 molecules bind co-operatively to d(CTTTTGCAAAAG)2 and
further NMR-MD analysis suggested that the duplex has time-averaged sequence-
dependent features that account for the bound orientation of the two drug molecules.
On the basis of these results, we aimed to investigate the effect of the distance
between the binding sites on the co-operative binding of H33258. Our initial
oligonucleotide contains two TTTT binding sites separated by an intervening GC
base step, which isolates the two ligands by approximately 15 A (13). We have now
examined binding of H33258 to d(CTTTTGGCCAAAAGh in which the central GC
base step have been extended to GGCC base step and the binding sites has been
further separated. This duplex retains the TpG (CpA) junctions at the end of the
binding site, which appear to restrict the orientation of H33258. The duplex should
have analogous sequence-dependent features to those observed for the dodecamer
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d(CITITGCAAAAGh, however the distance between the sites is increased and this
may change the degree of co-operative binding if additional steps play a role in
transmitting the "information" between the binding sites.
Titration of d(CITITGGCCAAAAG)2 with H33258 was carried out at 25
°C in 0.25 molar equivalents per ligand addition and followed by IH-NMR. Figure
3.7 shows the 1D NMR spectra of the free duplex and at 1:1 and 2:1 ratios of
complex. Upon addition of the ligand, the NMR spectrum increases in complexity as
a new set of signals corresponding to bound DNA appear. Looking closely at the
methyl region (1.3-1.8 ppm), it is evident, that the intensity of the methyl peak,
corresponding to the four thymine methyl protons of the free DNA, decrease while
only four new resonances increase their intensity over the range 0.25:1 to 2:1
drug:DNA ratio. Resonances of the complex formed can also be observed in
previously unoccupied spectral regions (6.5-6.0 ppm).
Clearly, the same set of new resonances persisted up to a ligand to DNA ratio
of 2: 1 and a single 2: 1 H33258-d(CTTTTGGCCAAAAG)2 complex was formed
through the entire titration as there is no evidence for resonances from an
intermediate 1:1 complex, even at low drug-DNA stochiometries such as 0.25:1.
The fact that only one set of DNA resonances are observed with the 2: 1 complex are
also confirmed by 2D NMR, figure 3.S. This indicates that the self-complementary
duplex keeps the C2 symmetry in the complex and H33258 molecules bind again in
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Figure 3.7 lD 'H-NMR titration spectra of d(CTTTTGGCCAAAAG)2 with H33258
showing 0.0, 0.5, 1.0,2.0 molar equivalents ligand added.
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symmetrically-related orientations. To summarise, the NMR titration follows an
analogous trend with the titration of the dodecamer d(CTTTTGCAAAAG)2 and
shows that even when the intervening GC base step has been extended to GGCC, the
binding of H33258 at the two sites appears to be co-operative with a similar degree
of co-operativity.
We were surprised to observe again a high degree of co-operative binding
with the duplex d(CTTTTGGCCAAAAGh as we expected that the increased
distance between sites would at least change the degree of co-operativity and it
would be possible able to detect any 1:1 complex. The resonances of the 2: 1
complex have been assigned by a combination of 2D NMR techniques DQF-COSY,
TOCSY and NOESY. The pattern of the NOESY spectra (figure 3.8) and the
volumes of the cross peaks, after integration, of the 2: 1 complex with the duplex
d(CTTTTGGCCAAAAG)2 are very similar with the NOESY spectra of the
respective dodecamer duplex. The same applies for the number and the volume of
the intermolecular NOEs, indicating that H33258 molecules again are bound within
the TTTT tracts with the positively charged piperazine rings facing each other
towards the central GGCC steps.
The structure and dynamics of the central steps GC or GGCC of both the
duplexes should be expected to be very similar. An interesting feature of this type of
purine-pyrimidine intervening sequence predicted from extensive computational
studies (14), is that it is expected to have minimal motion and low flexibility. We
have suggested earlier that H33258 binding does not induce significant changes in
the structure of the dodecamer duplex; NMR analysis shows similar findings for the
binding of H33258 with the duplex d(CTTTIGGCCAAAAG)2. This allows us for
the first time to consider that overall flexibility of the DNA molecule can be
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Figure 3.8 NOESY spectrum of the 2: 1 H33258-d(CTTTTGGCCAAAAG)2 complex in
D20 solution, recorded at 298 K with mixing time 250 ms.
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affected by H33258 binding and this may be important for co-operative binding.
Thus, we decided to carry out extended molecular dynamics simulations to study the
free DNA, the 2: 1 complex and also the theoretical 1:1 complex of the duplex
d(CTTTTGCAAAAGh (see below) and explore all the possible factors that could be
responsible for the co-operativity.
We have also examined the binding of H33258 with the dodecamer duplex
d(GAAAAGCTTTTCh. The orientation of the AT-tracts in this sequence, by
comparison with the initial dodecamer duplex d(CTTTTGCAAAAG)2 have been
inverted while simultaneously the TpG (CpA) junctions, at the end of the tracts, have
been replaced with ApG (CpT) junctions. Our initial effort was to examine the
sequence-dependence of co-operativity by changing the distinct junctions next to the
intervening GC step that were evident in our previous NMR analysis (13) with the
duplex d(CTTTTGCAAAAG)2' ApG (CpT) junctions tend to narrow the minor
groove locally, so our intention was to investigate to what extent these alterations in
the minor groove width would affect the co-operative binding of H33258 and also
the preferred binding orientation. This is based on our hypothesis that the two
binding sites communicate through alterations in minor groove width. In other
words, binding of the first drug can induce changes in the minor groove width that
are transferred to the second binding site in such a way that the second drug binds
more favourably.
ID NMR titration spectra of H33258 with d(GAAAAGCTTTTC)2, recorded
at 25°C in 0.25 molar equivalents per ligand addition, are shown in figure 3.9. NMR
titration shows that the complexity of the spectrum increases upon ligand addition
and at a ratio of drug to duplex of 2: 1, we see a large number of broad new
resonances. Specifically, observing the methyl region (1.5-1.8 ppm) and the
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aromatic region (7.0-8.4 ppm), it is evident that peaks corresponding to the protons
of the free DNA are decreased and surrounded gradually with additional resonances,
while at the 2: 1 ratio the total number of resonances can not account for a single
species in solution. This is consistent with drugs bound in a number of different
orientations, forming more than one 2:1 complex. Possible complexes arising from
the orientational disorder of H33258 with d(GAAAAGCTTTTCh are shown
schematically in figure 3.10. The complexity of the spectrum does not permit us to
resolve the mixture of the bound species in solution. 2D NOESY spectra show an
excess of cross peaks in the aromatic region, consistent with a mixture of bound
species, figure 3.11. The ApG junctions do not appear to result in distinct structural
features capable of influencing H33258 minor groove recognition, in terms of its
binding orientation. To conclude, this study adds no further information about co-
operative binding between adjacent sites. Co-operative binding may still be present
with the duplex d(GAAAAGCTTTTC)2 as the CD spectral titrations suggested,
however it is H33258 orientational disorder that makes spectral analysis complicated.
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Figure 3.9 lD 'H-NMR titration spectra of d(GAAAAGCTTTTC)2 with H33258 showing
0.0,0.5, 1.0,2.0 molar equivalents ligand added.
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Figure 3.10 Representation of the possible types of complexes from the binding of two drug
molecules along the duplex d(GAAAAGCTTTTCh, The head of the arrow represents the
bulky N-methyl piperazine ring ofH33258,
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Figure 3.11 NOESY spectrum of the 2:1 H33258-d(GAAAAGCTITTC)2 complex in D20
solution, recorded at 298 K with mixing time 250 ms.
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3.5.4 Footprinting analysis
As it was mentioned earlier, quantitative footprinting analysis is very useful
when you need to measure binding affinities of different binding sites within the
same DNA fragment. Our aim this time was to examine the binding sites, we had
analysed by NMR that demonstrate co-operativity by quantitative footprinting
analysis and evaluate the degree of co-operativity between these sites. To this end,
we collaborated with Professor Keith R. Fox, University of Southampton, and we
designed a synthetic 68 base pair DNA fragment (figure 3.12) that contains the
sequences we have so far analysed by NMR d(CTTTIGCAAAAGh,
d(CTTTTGGCCAAAAG)2, d(GAAAAGCTTTTC)2' Details of the experimental
methodology followed are described elsewhere (10).
5'· GATCTITfGGCCAAAAGCGTACGCAAAAGCTITTGCGTACGCTITTGCAAAAGCGTACGCAAAAGATC
3'· CTAGAAAACCGGTITfCGCATGCGTITfCGAAAACGCATGCGAAAACGTITfCGCATGCGTITfCTAG
Figure 3.12 The 68 base pairs DNA fragment used to probe co-operative binding of
H33258.
DNase I footprints with the DNA fragments labelled at the 3'-end of the top
strand in the presence of varying concentrations ofH33258 (0.01-10 J-lM) are shown
in figure 3.13. The first lane of the Dnase I footprint is a specific marker for the G
and A bases. The second lane shows digestion of the DNA fragment in the absence
of H33258. The remaining lanes show the digestion of the DNA fragment in the
presence of H33258 at the concentrations shown at the top of each lane. The
location of each of the binding sites has been indicated with a solid line. It is
immediately apparent that DNase I footprints can be seen at each of the expected
TTTI binding site, however, visual inspection of the footprints show a similar
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degree of concentration dependence for all the binding sites. This is also confirmed
by quantitative analysis of the concentration dependence of each footprint.
This is achieved by measuring the intensity of the bands within each of the
footprinting sites using a microdensitometer. The bands are then normalised relative
to a band in the cleavage pattern, which is not affected by the ligand, and these
normalised values are plotted against ligand concentration. Footprint plots (figure
3.14) are then fitted by a simple binding curve (equation 3.5), which gives an
indication of the binding affinity K.
le = 10(l<J(L+K) equation 3.5
Ie is the band intensity in the presence of the ligand, 10 is the band intensity in the
control and L is the ligand concentration. The binding affinity for each binding site
is indicated on the plots. Footprinting plots show a similar degree of H33258
binding affinity for each of the various binding sites, which are not significantly
different to strongly indicate co-operativity.
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Figure 3.13 Dnase I footprinting of H33258 on the 68 base pairs DNA fragment at various
concentrations. Numbers on the top of each lane refer to the concentration ofH33258 (f!M)
and sequences on the left show the exact location of the binding sites to which H33258
binds.
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Figure 3.14 Footprinting plots showing the interaction of H33258 with various sites within
the DNA fragment. Data points were obtained from measuring the intensity of the bands
from the gels. Fitting data with equation 3.S results to binding affinities shown at each plot.
The quantitative footprinting studies presented here have been rather
disappointing as regards the demonstration of co-operative binding of H33258 with
the binding sites that NMR studies demonstrated. This seems confusing, since NMR
and CD titrations showed strong evidences of co-operative binding with no 1:1
complex detection. It is possible that co-operative binding of H33258 cannot be
observed distinctly at the low concentrations at which quantitative footprinting
experiments are carried out. In addition, co-operative binding of H33258 to duplex
DNA may be reduced and disappear when the DNA molecule is very long compared
to short oligonucleotides studied by NMR and CD spectroscopy here in these studies.
If this is the case, then the origins of the co-operativity are affected somehow by the
length of the sequence and this should be kept in mind.
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3.5.5 Molecular dynamics analysis
Long molecular dynamics simulations of the free d(CITTTGCAAAAG)2, the
2: 1 complex and the theoretical 1: 1 complex were performed for 5 ns under the same
conditions. All three simulations relaxed quickly from their initial conformations
and remained stable over the 5 ns simulation periods, judging from RMSD analysis
(not shown). Time-averaged structures were generated from the final 4 ns of each
simulation. The average structures of the free DNA and 2: 1 complex were found to
be in excellent agreement with the average NMR-derived structures. Heavy-atom
RMSD between the modelled and experimentally derived structures were 1.98 A for
the free DNA and 1.05 A for the 2: 1 complex. This was reduced to 1.65 A and 1.03
A respectively if terminal bases were excluded. Excellent agreement between
experimental (NMR) and theoretically derived (MD simulation) helical parameters
was also observed (figure 3.15; for comparison see figure 2.14 chapter 2). The MD
simulations predict that the conformation of the DNA in the 1:1 complex does not
differ greatly from that of the free DNA or the 2: 1 complex. It shows the expected
narrowing of the minor groove for the occupied A-tract, while the width of the
unoccupied A-tract remains close to its free DNA value. This suggests that co-
operativity does not relate to any dramatic conformational changes.
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Figure 3.15 Propeller twist, roll and minor groove widths for the time-averaged structures of
the free DNA (diamonds), 1:1 complex (squares) and 2: 1 complex (triangles).
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the thermodynamics of the unbound drug (scheme 3.2). This work was carried out in
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collaboration with Dr. Sarah Harris and Dr. Charlie Laughton from the School of
Pharmaceutical Sciences, University of Nottingham.
Go
free
IGL I I~G. ~Gb
-. -. Gl
I ~ Gl I ~GL GL I
1:1 2:1
~Ga = (GI + GL) - (Go + 2GL)
~Gb = G2 - (GI + Gt)
~~G = ~Gb - ~Ga
=Go+G2-2GI
Scheme 3.2 Partitioning of the free energy terms. Go: free energy of the free DNA; GL: free
energy of the free ligand; G1: free energy of the 1:1 drug-DNA complex; G2: free energy of
the 2: 1 drug-DNA complex.
It is useful to expand G, the total free energy of the system (including water and
counterions) as shown in equation 3.6:
G = Eintra + G solv _ rs= equation 3.6
The first term, s=, is the internal energy of the solute (DNA or DNA-drug
complex). The second term, Gsolv, is the free energy of solvation of the solute and
the third term, s=, is the configurational entropy of the solute. Using scheme 3.2
and equation 3.6, the free energy difference that constitutes co-operativity can be
computed as shown in equation 3.7. Note that Gsolv includes both enthalpic and
entropic terms related to the reorganisation of the solvent (water and counterions).
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ddG = (Eintra+Gsolv)o+ (Eintra+Gsolv)2_ (Eintra+Gsolv)t
- T(Sintrao+ sintra2- 2 sintr8,) equation.3.7
Trajectories were analysed using the GB/SA approach (see below) and the term
(Eintra+Gsolv)computed, though we cannot unambiguously separate out the two
contributions. Then, the trajectories were analysed in terms of i) internal energy and
solvation components (Eintra+Gsolv),and ii) configurational entropy components
(Sintra).Our aim is to elucidate which one, or more, of these terms is responsible for
the co-operativity observed in this system.
The internal energies, with solvation correction, of the free DNA, the 1:1
complex and the 2:1 complex in each snapshot from the equilibrated portions of the
trajectories were calculated using the GB/SA method. This method is implemented
in AMBER 6 and its validity was tested on nucleic acids molecular dynamics (16).
The resulting estimates (table 3.1) gives dd(Eintra+ Gso1v)= 3.3 ± 0.4 kcal mort.
Thus, on the basis of enthalpy considerations alone (including a solvation
correction), the interaction of H33258 with this DNA sequence is predicted to be
somewhat anti-co-operative.
Configurational entropies of the free DNA, the 1:1 complex and the 2:1
complex were calculated from the dynamics data via Principal Component Analysis,
using the method of Schlitter (17). Entropy values obtained in this way are sensitive
to the simulation length, therefore S was calculated for various sample window
widths, and Saoestimated by fitting the empirical equation 3.8:
a
S(t) = StD-273
t
equation 3.8
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Table 3.1 Thermodynamic parameterscalculatedfromtheMD simulationsof the freeDNA,
1:1 drug-DNA complex and 2:1 drug-DNA complex. All values are in kcal mol" ±
standarderrors, forT=300K.
System EIDt+GIOIV ~(EIDt+GooIv) TS", (system) T~"" TS"" T~S""
(DNA only)
Free DNA -4375.6 ± 0.2 830.6± 0.5 830.6± 0.5
29.0
-24.3 25.6
1:1 Complex
-4404.6 ± 0.2 854.9 ± 0.3 805.0± 0.5
25.7
-34.8 13.1
2:1 Complex -4430.3 ± 0.2 889.7 ± 0.1 791.9 ± 0.5
From the resulting values (table 3.1) ~~TS was calculated at 300K to be 10.4
± 0.7 kcal mol", figure 3.16. This implies that the binding of the first drug molecule
to the DNA is associated with a considerably greater entropic penalty than the
binding of the second. These calculations assume that changes in translational and
rotational entropy can be ignored. By statistical mechanics, the absolute translational
entropy of a molecule is dependent on its mass and its rotational entropy on the
moments of inertia. Ligand binding will have a very small effect on these quantities.
Indeed, quartz crystal microbalance experiments on related drug-DNA systems (18)
indicate that ligand binding is associated with no change in the effective mass of the
molecule, because an equivalent mass of tightly bound water is displaced from the
minor groove in the process. Combined with the value of M(Eintra+Gsolv) previously
obtained, MG for this system was calculated to be -7.1 ± 0.8 kcal mol". The result
is in good agreement with the NMR titration estimates and we predict that, in this
case, co-operativity is the result of the balance of entropic factors, which over-ride
the small intrinsically anti-co-operative nature of the enthalpic terms involved.
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Figure 3.16 Effect of sample window width on the values of the configurational entropies,
calculated by the method of Schlitter (17). The symbol coding is same as in figure 3.15. The
points are the experimental values, the lines are the results of the least squares fit to the
equation 3.8.
The GB/SA approach does not allow the energetics of the system to be
reliably decomposed into individual intramolecular energy and solvation terms.
However, we have obtained some qualitative insight into these through examination
of molecular interaction potential (MIP) maps (19) and hydration density maps (20).
Figure 3.17 shows the MlP map obtained for the time-averaged structures of the free
DNA and the 1:1 complex, when a molecule of H33258 is used as the probe. For the
free DNA, we see clear areas of density in both A-tracts. The density obtained for
the unoccupied site in the 1:1 complex is very similar, thus, there is no obvious
change in the affinity of the second site for H33258 once the first molecule of drug is
bound in the other site. Figure 3.18 shows the MIP maps obtained for the same
structures when a water molecule is used as the probe. Clear "spines of hydration"
are predicted in the unoccupied A-tracts of both structures, and again there is no
evident difference between the free DNA and 1:1 complex. This argues against co-
operativity being the result of easier displacement of water from the second binding
site, once the first molecule of drug is bound.
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Figure 3.17 MIP plots for the time-averaged structures of the free DNA (left), and 1:1
complex (right) obtained using H33258 as the probe. The map is contoured at a favourable
interaction potential of -32 kcal mol".
Figure 3.18 MIP plots for the time-averaged structures of the free DNA (left), and 1:1
complex (right) obtained using a water molecule as the probe. The map is contoured at a
favourable interaction potential of -10 kcal mol",
The MIP maps only relate to the enthalpic components of probe-target
recognition, but hydration density maps reflect, qualitatively, free energies of
solvation. The hydration density maps for the free DNA and 1:1 complexes are
shown in figure 3.19. Again, it is clear that, in areas not masked by the presence of a
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molecule of the drug, the hydration patterns for the DNA in the two situations are
very similar. These qualitative examinations suggest that the overall modestly
positive value of M(Eintra+Gsolv) is not the result of a near cancelling out of
individual ~~Eintra and ~~Gsolv terms that are large in magnitude but opposite in sign.
This adds further support for our argument that we can regard the configurational
entropy term as being the critical one.
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Figure 3.19 Hydration density maps for the free DNA and 1:1 complex, calculated by
integrating water occupancies over the full 4 ns of the equilibrated trajectories. The map is
contoured at a level corresponding to twice the density of the bulk solvent.
To gain further insight, the configurational entropy of the DNA component
alone wa calculated in the I: I and 2: 1 complexes and these values compared with
that for the free DNA (table 3.1). For the binding of the first drug, we find T~s to be
-25.5 ± 0.8 kcal marl, while for the binding of the second drug it is calculated to be
-13.1 ± 1.0 kcal marl. For the DNA alone then, T~~S is estimated to be 12.4 ± 1.1
kcal marl. This is somewhat larger than that previously calculated for the whole
drug-DNA system (lOA ± 0.7 kcal marl), and suggests therefore that when the
second drug binds, though the DNA itself is not greatly further restrained, the
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previously-bound drug molecule loses some of its residual flexibility. To investigate
this further, the trajectories were examined to see if the longitudinal motion of the
drug in the A-tract minor groove was reduced by the introduction of the new positive
charge further along this groove. However, analysis of selected drug-DNA distances
sensitive to such motion revealed no significant difference between the 1:1 and 2: 1
complexes. In addition, a general reduction in the flexibility of the drugs was
evident from the calculation of simple coordinate RMS fluctuations. In the 1:1
complex, the average RMS fluctuation of the drug atoms is 0.28 angstroms, while for
the 2: 1 complex it is 0.23 angstroms (averaged over both drug molecules).
In any system of this type, where the binding sites for the two ligand
molecules are physically separated, co-operativity relies on the ability of the receptor
to pass information regarding the occupancy or otherwise of one site to the other. To
examine this, we calculated the configurational entropies for each half of the DNA
separately, in each of the free, 1:1 and 2:1 complexes, table 3.2. First, we see that in
the free DNA, the two halves of the DNA are calculated to have very similar
entropies - a good test of the adequacy of the lengths of our simulations and the
sampling. Binding of the first drug molecule is accompanied by a large reduction in
the configurational entropy of that half of the DNA, as expected, but the
"information" regarding occupancy is clearly also passed to the second, unoccupied
half of the DNA for which the configurational entropy of the DNA is noticeably
reduced. Binding of the second drug molecule to this site results in further
conformational restriction, but interestingly results in a "message" being passed back
to the first occupied site that results in an increase in its configurational entropy. The
calculated entropies for the two half sites in the 2: 1 complex are in close agreement,
giving us some insight into the reliability of the approach. It is important to note that
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the entropy components calculated here cannot be summed to equate to the total
values calculated previously, since this approach neglects the configurational entropy
due to the relative motion of the two halves of the DNA.
Table 3.2 Configurationalentropies for top and bottom halves of the DNA in the free, 1:1
and 2:1 drug-DNA complexes. Valueswerecalculatedover the fu1l4 ns trajectoriesbut not
correctedto S.,. All valuesare in kcalmol", withT=300 K.
System Top Bottom
TS IL\S IS TL\S
Free DNA 366.3 368.4
-24.6 -4.6
1:1 complex 341.7 363.8
6.4 -16.9
2:1 complex 348.1 346.9
3.6 Conclusions
Several methods have been used in order to elucidate the co-operative
interaction of H33258 with duplexes containing two adjacent sites. Using NMR
methods, we have previously provided evidence of co-operative binding of H33258
with d(CTTTTGCAAAAGh and we also showed that co-operativity is present with
the similar duplex d(CTTTTGGCCAAAAG)2. In either NMR titration no evidences
of an intermediate I: 1 complex have been recorded. NMR spectral complexity
raised by H33258 orientational disorder did not allow us to evidence co-operativity
with d(GAAAAGCTTTTGh as we inverted the binding sites of the initial duplex
and changed the junctions of the A-tracts. Quantitative DNase I has been used to
probe the co-operative binding of H33258 with binding sites, within the same DNA
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fragment, that had been analysed by NMR. Binding affinities calculated for each
binding site are not significantly different and did not provide strong evidence of co-
operativity. In addition, CD spectral titrations of H33258 have been carried out and
provided evidence of differentiation between the 1:1 and 2: 1 complex formation, and
also confirmed the co-operative binding of H33258 within the (CTTTTGCAAAAG)2
and also d(GAAAGCTTTTCh.
We have also used extended molecular dynamics simulations to study the free
DNA, the 2: 1 complex, and also the theoretical 1:1 complex and been able to
calculate thermodynamic quantities relating to the two binding events, which were
not accessible using any other method. The sequence-dependent interaction of DNA
with molecules that bind in the minor groove involves a delicate interplay between
enthalpic and entropic components of the recognition process. In general, examples
of co-operativity in DNA recognition appear to owe this characteristic to enthalpic
factors, which are generally fairly evident, at least in qualitative form, from structure
determinations. These typically reveal close physical contacts between the two
ligands, and/or a major structural deformation of the DNA that requires both ligands
to stabilise it. In this case, NMR structure determination has shown that neither of
these factors is operating. The MD studies reported here lead us to conclude that in
this case, co-operativity is largely the result of the overall rigidity of the system.
Binding of the first ligand restricts the flexibility of the DNA well beyond the actual
binding site. Binding of the second ligand has little further effect. Both sites are
already structurally fairly well predisposed towards ligand binding. the small
adjustments required bear a modest enthalpic penalty, and though anti-cooperative,
are outweighed by the entropic term.
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The observation that ligand binding can sometimes induce changes in
conformational flexibility in sites of the structure distant from the binding site has
been demonstrated in the co-operative binding of two calcium ions to the EF-hand
protein calbindin D9k (21). Calcium ion binding to either site results in a slight
decrease in second site flexibility. In contrast, binding of the second calcium ion has
relatively small changes in flexibility.
In our system, the molecular origins of co-operativity in the absence of
conformational change cannot be understood unless the dynamic properties of the
system are taken into account. The results presented in this thesis illustrate the
power of molecular simulation methods to investigate such phenomena, and
highlight the general importance of flexibility in determining the properties of
biomolecules such as DNA. Yet an element of rigidity, as well, is the key to the
ability of this dodecamer to transmit "information" between the two drug binding
sites. In ongoing investigations, the modulation of co-operativity by the sequence
and length of the intervening DNA is being examined.
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4. DNA minor groove recognition by a bis-
benzimidazole analogue of Hoechst 33258
4.1 Introduction
Rational design of small molecules capable of recognising selectively the
DNA minor groove of AT-rich or mixed sequences needs our clear understanding of
the interactions involved. A number of NMR and X-ray crystal structures (1) have
been reported for minor groove drugs complexed with short oligonucleotides
containing AT-rich sequences, however, the relative importance of the various
factors contributing to DNA minor groove recognition is still a matter of discussion.
Generally, these structures show that all drugs bind in the narrow minor groove of
the AT-rich sequences allowing optimal Van der Waals contacts with the floor and
the walls of the minor groove, though, hydrogen-bonding interaction between the
ligand and the base pair acceptors on the floor of the groove has been frequently
observed (2). Thus, sequence selectivity of groove binders is more likely to be
controlled by their ability to recognise variation in groove width.
The bis-benzimidazole family of ligands have been used as a starting point
for rational design of new anticancer agents because of their synthetic accessibility
and high binding affinities (I), figure l.t. In chapter 2, it is described that some
crystal structures locate the sterically bulky, non-planar N-methylpiperazine ring of
H33258 I in the wider minor groove associated with GC base pairs at the end of the
narrower AT-tract. The crystal structure of a H33258 analogue 2, in which the N-
methylpiperazine has been replaced by the smaller, more planar 4,5-dihydro-3H-
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imidazol-I-ium (imidazoline) ring, bound with d(CGCGAAITCGCG)2 duplex,
results in a narrower minor groove that reflects the decrease in steric bulk (3).
Although the imidazoline ring can be accommodated in a narrower AT minor
groove, the geometry of the ring prevents it from hydrogen bonding with the groove
floor. The increase in stability, observed by melting experiments, of the complex
compared to H33258 complex with the same duplex is attributed to the better Van
der Waals complementarity rather than hydrogen bonding. The NMR study of the
complex of Hoechst 43254 with d(GGTAAITACC)2 (4) duplex, in which the N-
methylpiperazine ring of H33258 has been replaced by a I, 3, 4, 5-
tetrahydropyrimidin-I-ium ring 3, shows that the drug prefers to bind in the narrower
AT minor groove as a result of both reduced steric bulk and incompatibility of the
hydrogen-bond donor of the pyrimidinium ring with the 2-amino group of guanine.
However, the increase in thermal stability in this complex is suggested to be
dominated by the additional hydrogen bonding from the pyrimidinium ring to the
floor of the groove.
The crystal structure of a tris(benzimidazole) analogue 4 of H33258, called
TRIBIZ, bound to the d(CGCAAAITTGCGh duplex has been determined (5). This
study examined the relative importance of isohelicity, a measure of Van der Waals
complementarity, and phasing of the ligand hydrogen-bonding groups with the base
pairs along the binding site. The structure shows that the ligand adopts a highly
twisted conformation, with an overall twist 50°, that enables it to follow the helical
curvature and maintain hydrogen-bonding complementarity with the floor of the
groove. The phasing of the ligand is also ensured by the DNA unwinding slightly
across the AT-tract. The ligand fails to have an optimal isohelical fit to the DNA
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curvature suggesting that ligand isohelicity is less important than phasing for
stabilisation of the TRIBIZ ligand.
~~
N
HN /
~OCH3
Figure 4.1 Chemical structures ofHoechst analogues 1-4.
In order to examine the relative importance of isohelicity and phasing of the
minor groove binders, we selected an analogue of H33258, namely Hoechst 10
(H 10), in which the N-methylpiperazine ring is linked to the phenyl end of the
molecule rather than to the benzimidazole ring (figure 4.2) giving the molecule a
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more linear arrangement. The overall shape of the ligand is less isohelical with the
curvature of the minor groove, although, the phasing of the ligand hydrogen-bonding
groups with the floor of the groove should remain the same as in H33258.
Fluorescence titration studies using the DNA decamer d(GCAAATTTGC)2 showed
that HIO and H33258 bind with an indistinguishable binding affinity, ~~G -0.3 kJ
mol" (6). Thus, the intrinsic difference in curvature between HIO and H33258
seems to have a little impact on DNA binding affinity. In this context, we studied
the interaction of HIO with the DNA decamer d(GCAAATTTGC)2 by NMR and
employed a restrained molecular dynamics protocol that allows us to examine the
key structural features of the complex.
bzl bz2
ph
pip
G
~-H
CH3
Figure 4.2 Chemical structure of Hoechst 10.
4.2 Materials and methods
4.2.1 Sample preparation and analysis
The DNA decamer d(GCAAA TTTCG)2 was synthesised and purified as
described in section 2.2.1. The bis-benzimidazole analogue HIO was provided by
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Hoechst, Germany and was used without any further purification after checking its
purity by IH NMR. The drug-DNA complex was formed by titrating small aliquots
of the drug solution in D20 (-10 mM) into a solution of the oligonucleotide in
100mM NaCI and lOmM Na02P04• Titration was monitored by IH NMR and
stopped when the resonances of the free DNA were fully replaced by those of the 1:1
complex. NMR data were collected on a 2mM solution of the complex at pH=7.0
and 298 K as described in section 2.2.3. NMR restraints in the 1:1 complex were
derived by integration of NOEs assigned from 75, 100 and 125 ms NOESY spectra
in 020, and 200 and 100 ms NOESY data in H20 solutions and calibration to a
number of fixed reference distances: sugar H2'-H2", cytosine H5-H6, thymine
CHrH6, Bzl H6-H7, Bz2 H6-H7 following the methodology described in section
2.2.4. A total of 316 distance restraints were used for structure calculations of the
1:1 HI0-d(GCAAATTTCGh complex including a set of 33 drug-DNA NOEs.
Tables with the list of the NOE restraints are found in appendix 2.4.
4.2.2 Structure calculations
Energy minimisations and restrained molecular dynamics of the 1:1
HlO-d(GCAAATTTCGh complex were carried out using the SANDER module of
AMBER 6 following the same procedure described in section 2.2.6. Force field
parameters of HI 0 atoms were determined by using AMBER 95 force field
parameters and partial charges (appendix 3.3) calculated using the HF/6-
31G(d)/RESP methodology in order to maintain consistency with the AMBER force
field charges. The structure of the decamer d(GCAAATTTGC)2 was built initially as
a canonical B-DNA with 18 Na+ ions added to neutralise negative charges of the
system and solvated by a periodic box of216 TlP3P waters to a minimum distance of
DNA minor groove recognition by a bis-benzimidazole analogue of Hoechst 33258 122
5 A around the solute. The periodic box contained 3407 water molecules resulting in
the size of 45 A x 50 A x 60 A. The HI 0 molecule was docked in three different
positions to avoid bias of the binding sites (section 2.2.6), and one of the three
complexes was selected based on the fitness of the drug-DNA restraints for a further
of 1 ns restrained molecular dynamics. Snapshots of the simulations collected every
ps and the structures were determined to equilibrate by RMSD analysis. Structures
calculated after equilibration satisfied adequate the set of 316 restraints and a
minimised structure has 43 distance violations that correspond to a 27.67 kcal mol"
energy penalty. The maximum distance violation was 0.38 A, 9 restraints were
violated by > 0.2 A and 20 restraints by > 0.1 A. Helicoidal parameters were
analysed with CURVES 5.1 and average structure was calculated over the
equilibrated trajectory with CARNAL module of AMBER 6.
4.3 Results and discussion
4.3.1 Structural analysis by NMR
The NMR experiments show that drug binding lifts the C2v symmetry of the
DNA decamer such that the two strands are not equivalent in the complex. This is
clearly determined in the thymine methyl region, where six methyl resonances are
identified, suggesting that the drug binds in a single high affinity binding site.
Preliminary NMR analysis of the complex has been previously described (7).
NOESY spectra (figure 4.3) of the 1:1 complex contain a number of chemical
exchange cross peaks between corresponding protons in the non-equivalent strands
of the duplex, indicating a slow dissociation of the drug from the complex and
rebinding in a 1800 related orientation with respect to each of the strands.
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DNA chemical shift resonances have been identified following previously
described methods in section 2.3.1 from a combination of NOESY and TOCSY
spectra in 020 and H20 solutions. A full list of chemical shifts assignments for the
complex is found in appendices 1.S and 1.9. Part of the 250 ms NOESY spectrum
(figure 4.4) shows the NOE sequential intra- and intemucleotide connectivities
between HI '-H8/H6 protons for each strand. A number of drug-DNA NOEs is also
illustrated. The oligonucleotide numbering scheme adopted is as follows: d(5-
GI-C2-A3-A4-A5-T6-T7-T8-G9-ClO)·d(5'CII-GI2-A13-AI4-AI5-TI6-Tl
7- Tl8-G 19-C20). Drug protons are labelled according to the numbering scheme
shown in figure 4.2. The assignment pathways in figure 4.4 reveal that
H8-H 1'intranucleotide cross peaks for the symmetry related base pairs G1IG11 and
GIO/G20, and also H6-HI'cross peaks ofC2/Cl2 and C9/Cl9 are very similar. In
contrast, the larger chemical shift differences are detected for the complementary
adenine and thymine pairs at the centre of the sequence. This implies that the ligand
binds towards the center of the duplex and not close to the strand ends.
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Figure 4.4 Portion of the 250 ms NOESY spectrum of the 1:1 complex illustrating the intra-
and intermolecular HI '-H6/H8 sequential NOE connectivities within each strand.
Drug-DNA NOEs labelled (a) - (I) are assigned as: (a) ph H31H5-A14 HI '(b) ph
H31H5-A15 HI'(c) ph H31H5-T7 HI'(d) bzl H7-A5 HI'(e) bzl H7-Tl7 HI'(t) bzI
H7- T6 HI '(g) ph H2/H6-AlS HI '(h) ph H21H6- Tl6 HI '(i) bzI H4- Tl6 HI '(j) bz2
H4-Tl6 HI '(k) bzI H4-Tl7 HI '(1) bz2 H4-Tl7 HI'.
The chemical shifts of HI0 (appendix 1.9) were readily identified from a
combination of TOCSY and NOESY data as previously described for H33258 (8).
The resonances of bzl H6/H7, bz2 H6/H7, ph H2,H6/H3,H5 protons were easily
identified from the three distinctive cross peaks in the aromatic region of the TOCSY
spectrum. These cross-peaks are assigned specifically on the basis of their
intermolecular NOEs. The resonance of the methoxy protons at 4.37 ppm has a NOE
with bzl H6/H7 protons allowing us to distinguish them from the bz2 H6/H7
protons. Only a single resonance is observed for the symmetrical H2, H6 and H3,
H5 protons of the phenyl ring, which suggests a rapid conformational averaging
between the two sides of the ring, consistent with 1800 flip around the bz2-ph bond.
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This rapid internal dynamic motion of the drug is in a faster time scale than the rate
of dissociation of the drug from the duplex. The ph H3/H5 protons are distinguished
from the ph H2/H6 because of their strong NOE to the pip H2/H6 protons. The
methylene protons of the N-methylpiperazine ring are assigned on the basis of the
NOE effects observed from the N-methyl protons, identified at 3.08 ppm. The
benzimidazole NH proton resonances, identified in 90% H20, were assigned
specifically by the observation of the NOE between bz2 NH-ph H21H6. The
benzimidazole NH proton assignment allowed for the identification of the bzl H4
and bz2 H4. In addition, latter assignments are confirmed from the strong interaction
between the bzl H4 proton and the methoxy protons. The aromatic region of the
NOESY spectrum (figure 4.5) highlights intramolecular drug NOEs such as bzl
H6/H7, bz2 H6/H7 and ph H2,H61H3,H5 and a number of drug-DNA NOEs
involving base H2 atoms of the adenine residues. NOEs between base H61H8
protons are also illustrated and indicate good stacking interactions between the
corresponding bases.
The binding site of H lOin the complex is identified with some precision from
the set of 37 intermoleculr NOEs (table 4.1) of the drug protons and DNA protons
found on the walls and the floor of the groove. Figure 4.6 summarises schematically
the intermolecular NOEs that establish unambiguously the orientation of the drug in
the groove. Many of the NOEs are highlighted in the portions of the NOESY spectra
in figure 4.4 and 4.5. For instance, NOE signals are established from the
benzimidazole methoxy group to the base H2 protons of A3 and A4, and deoxyribose
HI 'protons of A3, A4 and Tl7 nucleotides and from the N-methylpiperazine ring to
the base H2 of A14 and A13 and deoxyribose HI 'protons of the AI4, Al3 and T8
nucleotides. In addition, the drug-induced perturbations of the DNA chemical shifts
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are significant only for the deoxyribose HI 'and base H2 protons of the A3T3 tract.
There is no interaction between protons at the edges of the ligand with GC bases and
clearly the intermolecular NOEs locate the bound ligand relative centrally within the
A3T3 tract. This indicates that the sterically bulky N-methylpiperazine is located
close to the end of the A3T3 tract but does not have any preference for GC
recognition.
Figure 4.5 Portion of the 250 ms NOESY spectrum of the 1: I complex illustrating several
intramolecular and intermolecular NOEs. NOEs labelled (a) - (u) are assigned as: (a) bz2
H6-bz2 H7 (b) ph H21H6-ph H31H5 (c) bzlH6-bzl H7 (d) ph H21H6-A14 H2 (e) bzl
H7-A4 H2 (f) bzl H4-A4 H2 (g) bzl H4-A5 H2 (h) AI4 H2-AI5 H2 (i) ph H31H5-AI5
H2 (j) bzl H4-bzl H7 (k) bzl H7-A5 H2 (I) ph H21H6-A15 H2 (m) bz2 H4-A15 H2 (n)
bz2 H4-bz2 H7 (0) AI5 H8-Tl6 H6 (p) T7 H6-T8H6 (q) G9 H8-ClO H6, GI9 H8-C20
H6 (r) TI8 H8-CI9 H6 (s) T8 H8-G9 H8 (t) T6 H6-A5 H8 (u) Tl7 H6- Tl6 H6.
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Table 4.1 Intermolecular NOEs in the 1:1 HI0-d(GCAAATTTCGh complex.
Drug protons DNA protons
ph H2/H6 AI4 H2, AI5 HI', AI5 H2, TI6 HI'
ph H3/H5 AI4 H2, AI5 HI', AI5 H2, T7 HI', AI4 HI'
pip H2/H6 AI4 HI " AI4 H2
pip H31H5 AI4 HI', AI4 H2
bzl H7 A5 HI " TI6 HI', T17 HI', A5 H2, A4 H2
bzl H4 A5 H2, TI6 HI " TI7 HI', A4 H2
bz2H4 T16 HI', T17 HI', AI5 H2
O-Me AS H2, A4 H2, A4 HI', T17 HI', AS HI', A3H2
N-Me A13H2, AI3HI " T8HI'
bz l H3 A5H2
bz2H3 AI5H2, A14H2
bzl bz2
!"YN;--Q-_~ ph
AJ-~ N~I "
H3CO H H ~ pip
Q-H,
CH3
TI8 T17 T16 AI5 A14 AI3
Figure 4.6 Schematic representations of some of the intermolecular NOEs observed in the
1:1 complex. Only the central base pairs of the sequence are illustrated.
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4.3.2 Structure of the 1:1 HI0-d(GCAAATTTGC)1 complex
The NMR restrained molecular dynamics simulation produced stable
structures within the Ins of the run with RMS deviation from the mean structure over
all heavy atoms 1.10 ± 0.16 A. The last 500 ps of the simulation was selected for
structural analysis and the average structure of the I: I complex from this part was
minimised and shown in figure 4.7. The agreement between the experimental and
calculated distances, specifically between the intermolecular distances, is consistent
with the drug binding at a single site. The drug is bound in a single location within
the minor groove of the 5' -AATTT sequence with the N-methylpiperazine ring
spanning towards the 3'-end of it. Similarly, X-ray crystal structures of
d(CGCAAATTTGCG)2 complexed with H33258 determined the location of the drug
within AATTT (9) and ATITG (10) sequences with the N-methylpiperazine ring
close to the GC regions.
There are a number of close Van der Waals contacts between the ring
subunits of the drug and the walls of the minor groove, which involve hydrogen
atoms attached to the Cl', C4'and C5'on the phosphodiester backbone. The
methoxy group laying deep in the groove and is interacting with groove walls,
CI'and 04'atoms of A5 and also with the floor of the groove with C2 atoms of A4
and AS and 02 of T17. The benzimidazole I ring has close contacts with the Cl',
04'and C4'atoms ofTI7 from one strand and Cl 'and 04'atoms ofT6 and C5'atom
of T7 from the second strand. The benzimidazole 2 ring has close contacts with the
Cl', 04', C4'and C5'atoms ofTl6 from one strand and Cl ',04', C4'and C5'atoms
of T7 from the second strand. Close contacts between the phenyl ring and the
CI'atom of Al5 and Cl', 04'and C4'atoms ofT8 from the second strand are also
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observed. The bulky N-methylpiperazine ring, which is accommodated where the
minor groove is wider at the 3'-end of the binding site (see below), has preferably a
chair conformation that is involved in Van der Waals contacts (including the methyl
group) with the Cl', 04'and C4'atoms of both Al5 and A14. The carbon-carbon
distance of these interactions with the walls of the groove is between 3.3 and 4.1 A.
In addition, each subunit of the drug except the N-methylpiperazine ring has close
contacts -3.5 A with atoms at the floor of the groove like C2 atoms of the adenines.
Thus, HI 0 in this complex has a number of intermolecular non-bonded contacts with
the minor groove of the 5-AATIT sequence and in agreement with binding studies
(6), the more linear shape of the molecule seems not to be crucial factor for strong
binding affinity.
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In contrast with the TRIBIZ complex (5), there is no need for HI0 to adopt a
highly twisted conformation in order to follow the helical curvature of the minor
groove. Specifically, the benzimidazole-benzimidazole (bzl-bz2) and the
benzimidazole-phenyl (bz2-ph) torsion angles have average values of 18.8 ± 9.5 and
-1.2 ± 10.1, respectively over the last 500 ps. The torsion angle between the phenyl
and the piperazine ring (Ph-pip) has an average value of 90.6 ± 12.1. The torsion
angle values of the bz l-bz2 and bz2-ph rings in this complex are within the range
reported for X-ray and NMR structures of H32258 complexes (4). Hydrogen-bond
contacts between HI 0 and the DNA decamer are apparent, table 4.2. The NH atom
of benzimidazole 1 forms three-centre hydrogen bonds to 02 atoms of thymines T6
and Tl6 and the NH atom of benzimidazole 2 forms hydrogen bond to 02 of
thymine T7. The average hydrogen-bond distance between bz2 NH proton and N3
of adenine A15 is 3.5 ± 0.2 A but with an acceptable angle of 127.4 ± 9.6 0, which
suggests that this is rather a weak interaction. However, most of the three-centre
hydrogen bonds on biological small molecules exhibit unsymmetrical geometry with
major and minor component (2). Therefore, it is not uncommon for the minor
components of three-centre hydrogen bond to show H---A distance of > 2.9 A.
H33258 benzimidazole moieties in crystal structures (9,10) with
d(CGCAAATTTGCGh duplex found to form hydrogen bonds with the same
adenine and thymine bases. Thus, the weak interaction between bz2 NH proton and
A15 N3 atom is likely due to a NOE restraint effect and not the inherent ability of the
ligand to hydrogen bond. In addition, the piperazine ring is not involved in any
direct hydrogen bond with the DNA. Figure 4.8 shows HI 0 within the binding site
and highlights the atoms that contribute to hydrogen bonds.
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Table 4.2 Mean intermolecular hydrogen-bonding distances and angles, in the 1:1 complex
with d(GCAAATTTGC)2 taken over the final 500 ps of restrained molecular dynamics
simulations.
Hydrogen-bond distance (H---X, A)
and angles IN-H---A(N3)IT(02), degrees]
HIO
Bz1 NH T6 02 2.1 (0.2) Tl6 02 2.7 (0.3)
1144.0 (7.6)] [127.0110.42]
Bz2NH A1S N3 3.S (0.2) T7 02 2.1 (0.2)
[127.4 (9.6)] [142.3 (ll.lli_
Figure 4.8 HI 0 within the binding site of the 1:1 HI O-d(GCAAATTTCG)2 complex. Red
lines highlight the hydrogen-bond contacts with the DNA adenine N3 and thymine 02
hydrogen-bond acceptors.
The DNA helical parameters have been analysed over the final SOO ps of the
dynamics simulation and average values along with standard deviations calculated,
table 4.3. Table 4.3 also includes values of the helical parameters from the native
crystal structure d(CGCAAATTTCGC)2 (II). We have also calculated the variation
of propeller twist, helical twist, roll angle and minor groove along the sequence
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during the last 500 ps of the simulation and plotted them (figure 4.9) along with the
relative values from the native crystal structure d(CGCAAATITCGCh. Overall, the
structure of the duplex is within the range of B-DNA conformation. The structural
parameters of the AAATIT sequence in the 1:1 complex are not significant different
from those in the native structure, however, sequence-dependent effects in propeller
twist and helical twist are evident in the complex.
Table 4.3. Average values and standard deviations for main helical structural features of
d(GCAAATTTCG)2 (A) calculated from the final 500 ps of the 1 ns restrained simulations
of the 1:1 complex. Corresponding values from the native crystal structure of
d(CGCAAATTTCGCh (B) are also given.
A B
average sd X-ray
Pucker (0) 132.2 31.6 138.6
Twist (0) 31.7 8.5 35.5
Roll (0) 6.8 8.6 1.3
Rise (0) 3.4 0.4 3.4
Tilt (0) 2.6 8.6 5.1
Slide (0) -0.6 0.7 -0.1
Shift (0) 0.3 0.8 0.4
Propeller (0) -12.3 15.9 -12.2
Inclination (0) 3.6 2.7 0.5
X-disp (A) -1.1 0.2 -0.3
P20-P4 9.4 1.1 8.9
PI9-P5 7.0 1.0 6.9
P18-P6 7.7 0.7 5.5
PI7-P7 5.8 0.5 6.2
P16-P8 5.5 0.4 5.8
PIS-P9 6.4 0.5 6.9
P14-PIO 8.0 0.7 8.6
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Figure 4.8 Sequence-dependent analysis of propeller twist, helical twist, roll angle and
minor groove width (Pi-Pj+3 distance minus 5.8 A) in the 1:1 complex of RIO with
d(GCAAATTTGC)2 (black markers), and for the native duplex d(CGCAAATTTGCG)2
(magenta markers); errors bars represent one standard deviation from the mean value over
the final 500 ps of the I ns dynamics simulation.
Propeller twist is similar across the sequence in the free and bound state with
values typical of AT rich sequences (12), but the central AS- T16 and T6-A 15 base
pairs of the complex have significantly negative (~ -36°) twist in the structure. The
higher propeller twist for the central base pairs in the AAA TTT tract compared to the
native structure is not correlated with narrower minor groove in the structure of the
complex. The plot of minor groove width shows a general trend of narrowing
towards the centre of the AAATTT tract. Drug binding causes only a local increase
in the groove width suggesting that the minor groove of the duplex has an optimum
width for HI 0 interaction. However, the variation from the average values suggests
that a degree of minor groove breathing is important for adjusting the intermolecular
interactions.
The helical twist of the duplex in the 1:1 complex has an average value of
31.7°, typical of 8-DNA duplexes (12), and the average helical twist of the
AAATTT sequence is 34° and 36° for the complex and the native structures,
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respectively. However, the helical twist shows sequence-dependent effect at the
AS- T6 base-pair step, which has significantly low average value of -19°. The low
helical twist of the A5- T6 step indicates a local unwinding of the duplex, which may
be correlated with the local increase in minor groove width. In contrast,
exceptionally high twist of the helix is observed at the A3-A4 (-49°) step, which
compensates for the low value of the AS- T6 step. Such high twist values are also
evident in ApT steps of the TRIBIZ complex with a non-complementary duplex
containing a AAATAT sequence (13). Interestingly, the average values of the roll
angle of the 1:1 complex structure, except at the A3-A4 step, are positively
increased compared to the native structure. However, the increase in roll angle, at
least for this complex structure, is not associated with changes to the minor groove
width.
In the 1:1 complex, HI 0 binds strongly within the AAITT sequence with a
number of non-bonded Van der Waals interactions with the walls and the floor of the
groove. Bifurcated hydrogen bonds from the benzimidazoles to DNA acceptors on
the floor of the groove are also present in the complex, but one of them appears not
optimum. The N-methylpiperazine group due to steric requirements binds where the
minor groove starts to widen, while hydrogen bonding between the benzimidazole
moieties is possible with a number of AT bases. Thus, the position of the drug is
determined by optimal fit with the groove. This also has been seen in a number of
minor groove complexes including H33258 and TRIBIZ complexes with AAAITT
sequences (9,5). Isohelicity of the ligand is optimal when there are close Van der
Waals contacts between the C2 atoms of adenines and atoms at the concave surface
of the ligand. In our complex, such contacts are evident from all the aromatic ring
subunits of H IO. Although the shape of H lOis less isohelical with the curvature of
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the minor groove, isohelicity and hydrogen bonding are ensured without any
significant distortion of the drug conformation. HI 0 binding induces some changes
to the DNA conformation, best described by propeller twist, helical twist and roll
angle. The structural analysis show that the DNA sequence has an optimum minor
groove width for HI 0 binding and is also flexible enough to adopt the geometrically
optimal conformation compatible with the necessary binding interactions. Phasing of
HIO within the minor groove appears to be achieved partially through induce-fit.
4.4 Conclusions
Binding studies by fluorescence titration showed previously that both HIO
and H33258 have almost the same binding affinity with the DNA decamer
d(GCAAATTTGCh. The structure of the 1:1 HIO-d(GCAAATTTGC)2 complex
studied here revealed that even though the drug is less isohelical than H33258, the
drug forms a number of non-bonded Van der Waals interactions while phasing with
the hydrogen-bond acceptors of the bases-pairs is also observed. The structure of
d(GCAAATTTGCh is shown to be flexible enough to adopt a conformation for
increasing intermolecular interactions, showing the important role of DNA structural
flexibility in drug-DNA recognition. Isohelicity and phasing have a role in drug
design of minor groove agents, however, when sequences with more than four AT
bases are targeted then DNA flexibility and sequence-dependent structure must also
be considered.
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5. Investigations
quadruplex DNA
into the structure of
5.1 Introduction
Nucleic acid molecules can adopt several different conformations from the
well established A, Band Z duplex forms to recently studied structures such as
triplexes, i-DNA formed by cytosine-rich sequences and G-quadruplex formed by
guanine-rich sequences (1). There has been a great interest in studying the structure,
stability and regulating factors of formation of G-quadruplex DNA since it was
found that telomeric DNA (2-5), gene promoter regions (6-7) and immunoglobulin
switch regions (8) have continuous repeats of G-rich sequences. Such DNA
sequences have the ability to form G-quadruplex structures and in many cases this is
well demonstrated under laboratory conditions (9-11). In addition, a number of
proteins have been identified that exhibit specific recognition of parallel-stranded G-
quadruplexes (12-13) or promote G-quadruplex formation (14). Although such
DNA sequences have a strong propensity to form G-quadruplex structures, evidence
ofa functional role of the G-quadruplex structure in vivo remains elusive.
Telomeres are found at the ends of chromosomes and contain tandem repeats
of guanine-rich DNA sequences of several kilobases that protect them from
recombination, nuclease degradation and end-to-end fusions (2-3). Examples of such
sequence repeats are TTAGGG, TTGGGG, TTTTGGGG, TTTAGGG and
TTTTAGGG, which are found in telomeres of human, Tetrahymena, Oxytricha,
Arabidopsis, Chrorella and Chlamydomona, respectively (3). Telomeric sequences
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have the potential to form structures held together by guanine tetrads by either the
folding back of a repetitive sequence or formation of a hairpin dimer. Thus, G-
quadruplex formation may be involved in capping the chromosome end with a
structure resistant to nucleases or to association of chromosomes. Recent efforts
suggest that G-quadruplex structure plays an important role in the regulation of
telomerase action suggesting a potential role as a therapeutic target for telomerase
inhibition in cancer therapy (15-16).
The basic unit of the G-quadruplex is the G-tetrad, which has a geometry
formed by a hydrogen-bonded network of square, planar aligned guanines, figure 5.1.
The adjacent guanines found in the G-tetrads are hydrogen-bonded through their
Watson-Crick and Hoogsteen edges with their carbonyl groups directed towards the
interior of the G-tetrad. One of the amino protons of the guanines is involved in
hydrogen bonding with the adjacent guanine and the other is exposed to the solvent.
The G-quadruplex formation requires the presence of a monovalent cation such as
Na+ or K+, with the K+ cations forming the most stable structure (17). The precise
localisation of'Na" is well defined in the high resolution crystal structure (0.95 A) of
d(TG4T). Co-ordination sites associated with the 06 atoms of guanine are found
midway between G-tetrad planes and involve octahedral co-ordination of Na+ or K+
(18), figure 5.1. An NMR approach for direct observation of interaction between
NH4+ and the quadruplex d(G4T4G4)210cated the cation binding site equidistant from
each G tetrad while no binding site was observed between the T4 loops (19).
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Figure S.l Hydrogen-bonding alignment of guanine nuc1eotides in a guanine tetrad and
coordination scheme of K+midway between G-tetrad planes.
Extensive structural studies by X-ray and NMR approaches on telomeric
DNA sequences indicate that they form different G-quadruplex folding topologies
depending on the nature of the sequence, the length of the sequence and the presence
of different cations in solution (11). The quadruplex structures can adopt parallel or
anti parallel strand orientation and the glycosidic torsion angles of guanine
nucleotides can vary between syn and anti conformation, There are three general
types of quadruplex structure based on the structures resolved so far. These are
classified by the relative directionality of individual strands and the conformation of
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glycosidic torsion angles of guanine nucleotides within the G-tetrads. First, the
quadruplex structure formed by association of four parallel strands has all the
guanine nucleotides with anti conformation. Second, the syn-anti-syn-anti type
structure has the guanine residues alternating between syn and anti conformation
within G-tetrads and adjacent strands having antiparallel directionality. Finally, the
structure can have guanines within each tetrad that alternate syn-syn-anti-anti, with
adjacent strands having both parallel and antiparallel directionalities, figure 5.2.
Figure 5.2 Examples of the different folding topology of the quadruplex structures: (a)
parallel d(TTGGGGT)4 (20), (b) antiparaUel dimer d(GGGGTTTTGGGG)2 (21), (c)
parallel-antiparallel intramolecular structure d(AGGG(TT AGGG)3 (22). G-tetrads are
coloured in blue.
The quadruplex structures of the last two categories that contain anti parallel
strands and have a combination of syn and anti glycosidic conformations are formed
exclusively from dimeric hairpins (figure 5.2b) or unimolecular structures (figure
S.2e). The Oxytricha telomeric sequence d(GGGGTTTTGGGG)2 forms a
quadruplex structure in a crystalline state by association of two hairpin sequences,
with each strand having an antiparallel neighbouring strand where the glycosidic
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torsion angles of the guanines alternate syn-anti-syn-anti in each G-tetrad. The
human telomeric sequence d(AGGG(TTAGGG)3 forms an intramolecular
quadruplex structure in Na+ solution, with each strand having one antiparallel and
one parallel neighbouring strand and syn-syn-anti-anti glycosidic torsion angles
conformation in each G-tetrad. The significant difference between these quadruplex
structures and the parallel structure is the existence of loop connectivities, which
usually consist of adenine and thymine residues. The orientation of loop
connectivities is dependent on the sequence and plays a role in the general folding
topology of the quadruplex structure.
Parallel-stranded G-quadruplex structures of the following sequences
d(T2G4T)4 in K+(20), d(T4G4)4in K+(21), d(TG4T)4 in Na+(22) have been solved in
solution by a combined NMR and molecular dynamics approach. These structures
consist of four right-handed helixes with all the residues adopting ant; glycosidic
torsion angles and predominantly C2' -endo sugar pucker conformations. Each G-
tetrad in these studies is well defined, adopting a coplanar alignment and stacking
well between the two adjacent G-tetrads with minimal overlap of guanine base
planes. However, the thymine residues are less well defined, sampling multiple
conformations in solution and presenting no evidence of T-tetrad formation. The
crystal structure of the d(TG4T) sequence (22) at 0.95 A resolution shows
qualitatively similar conformation with the solution structure, except that the thymine
residues do not contribute to the four-stranded conformation and project away from
the core quadruplex structure. This study also resolved the position of sodium ions
between the tetrad planes in co-ordination with the 06 of the guanine residues and
defined water molecules within the tetraplex helical grooves clustering around the
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backbone phosphates, suggesting a role of water molecules in the stacking behaviour
of the guanines.
A closely related RNA quadruplex structure of d(UGGGGU)4 (23) in K+
solution shows significant stacking of the terminal uracils with the guanine tetrads.
Also, at low temperature the 3' terminal uracils appear to form a U-tetrad as uracil
imino protons are observed to be protected from solvent exchange. This is not
observed with the terminal thymines of the previously mentioned studies because of
lack of NOEs to define the conformation of the terminal residues, even though
thymine residues are capable of forming stable T-tetrads when sandwiched between
guanine residues (24). Recently, a parallel-stranded solution structure of
d(TGGTGGC)4 in K+solution (25) revealed a stable T-tetrad formation in the center
of the quadruplex despite underwinding of the right-handed helix and poor stacking
across the T4-G5 step. Thymines at the 5' terminal also form a stable T-tetrad, but
only when the pH is shifted from 7.0 to 4.8.
The subject of tetrad formation and stacking interactions with guanine tetrads
by the neighbouring nucleotides in parallel-stranded quadruplexes has been explored
with the NMR quadruplex structures of d(AGGGT)4 and d(TAGGGT)4 in the
presence of K+ ions (26). This comparison study revealed that although the G3
segments in the quadruplexes have largely similar structures, only the adenine
residues in the d(AGGGT)4 structure form an A-tetrad and have good stacking with
the adjacent G-tetrad. This was the first time that adenine residues demonstrated the
potential to be held in a plane by hydrogen bonds, although they are positioned at the
end of the sequence. Surprisingly, thymine and adenine residues in the d(TAGGGT)4
quadruplex structure sample a range of conformations resulting in poor stacking and
formation of A-tetrads. It is obvious that there is a certain degree of mobility of the
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terminal residues in the quadruplex structures that prevents good stacking with the
core G-quadruplex structure, which usually affects the stability and conformation of
the adjacent residues. Thus, formation of tetrad square alignment by other residues
except guanines is highly dependent on the content of the sequence and their location
within it.
Intramolecular G-quadruplexes, which contain repeats of guanine-rich DNA
sequences, have attracted much interest in the last decade, as they are more likely to
be formed at the 3' overhang of telomeric DNA. Intermolecular G-quadruplexes
may have less biological significance, but are likely to play a role in vivo in
phenomena such as recombination and end to end pairing. In addition to the strong
interest in the structure and stability of G-quadruplexes, there is also the need to
explore the role of the guanine and other neighbouring residues in the G-quadruplex
structure and stability and how adjacent residues are perceived in molecular
recognition by proteins and small ligands. Thus, we have carried out a careful NMR-
molecular dynamics approach to determine the details of the quadruplex structure
d(TTAGGGT)4, which contains the human telomeric repeat TTAGGG with an extra
T at the 3' end of the sequence. This extra thymine residue prevents the possible
formation of multiple conformations and aggregates in solution through end to end
stacking between G-tetrads of different molecules. This study presents the
experimental evidence for formation of the parallel quadruplex structure
d(TTAGGGT)4 and explores the stability and dynamics of the structure by NMR
and MD studies. Such information from this quadruplex structure is valuable in
order to understand the molecular basis of ligand recognition.
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5.2 Materials and methods
5.2.1 DNA samples
The oligonucleotide d(TI AGGGT) was synthesized and purified as described
in Section 2.2.1, and shown to be > 95% pure and in the quadruplex form by IH
NMR spectroscopy. The oligonucleotide sample was quantified
spectrophotometrically usmg a calculated extinction coefficient at 260 nm
determined by the nearest-neighbour method (27). The NMR sample of
d(TI AGGGT) was prepared at a concentration of single strand of 6.4 mM (or 1.6
mM in quadruplex) in 0.6 ml in 90% H20, 10% D20 solution, having a final salt
concentration of lOOmM KCI and 10mM K2HP04. The quadruplex was lyophilised
again and dissolved in D20 solution (0.6 ml) for the observation of non-
exchangeable proton resonances.
5.2.2 NMR experiments
Standard phase-sensitive 2D NMR pulse sequences were used to record
NOESY, TOCSY and DQF-COSY spectra. One-dimensional NMR experiments
were recorded over 16384 data points in t2 for each 512 points in tl with spectral
width of 20 ppm and a delay time of 1.5 s, at a temperature of 5-65 QC. NOESY
spectra at various mixing times 300 ms, 200 ms, 150 ms, 100 ms, 70 ms, were
recorded over 2048 data points in t2 and 512 points in tl with 64 transients for each,
with a spectral width of 10000 Hz and a delay time of 1.5 s, at a temperature of 25
QC. TOCSY spectra using a 75 ms spin lock and DQF-COSY data were recorded
over 2048 data points in hand 512 points in tl with 48 transients for each with a
spectral width of 10 ppm and a delay time of 1.5 s, at a temperature of 25°C.
WATERGATE-NOESY spectra at 300 ms, 200 ms, 100 ms and 75 ms mixing times
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were acquired using a sample in 90% H20 and 10% D20 solution over 2048 data
points in t2 and 512 points in tl with 64 transients for each, and employed a 20 ppm
spectral width and a delay time of 1.5 s, at temperatures between 5 °C and 25°C.
Two-dimensional data were zero filled to 4k x 2k prior to Fourier transformation,
apodised typically with a 90° shifted sine bell squared function in both dimensions
and also treated with automatic baseline correction.
5.2.3 NMR restraints
Interproton distances of the non-exchangeable and exchangeable protons
were derived from integration of their NOE cross peak volumes from NOESY
experiments in 150 ms, 100 ms, 75 ms in D20 and 200 ms and 100 ms in H20
solutions. Distances were determined by extrapolation to zero mixing time (28),
using the thymine H6-Me fixed distance (3.0 A) for NOEs involving base protons,
and the sugar 112'-112" fixed distance (1.85 A) for NOEs involving only sugar
protons. For well resolved non-exchangeable cross peaks the distances were given
upper and lower error bounds of 15% of the calculated distance, for partially
overlapped non-exchangeable cross peaks the distances were given upper and lower
error bounds of 20%, while for the exchangeable cross peaks 25% upper and lower
error bounds were used. NOEs that involve the guanine NH2 protons were quite
broad and the NOE restraints for these protons were defined with wider bounds,
2.5-5.0 A. Hydrogen-bond restraints were included for atoms involved in the ideal
hydrogen-bonding geometry of the G-tetrad. The heavy atom-heavy atom distance
restraints for 06-N6 and N7-N7 distances were set to 2.85 ± 0.10 A.
Distance restraints were checked for large geometrical inconsistencies by
comparing visually with the distances of the energy-minimised quadruplex structure
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derived from unrestrained molecular dynamics simulation using MolMol software
(29). In order to distinguish ambiguities in NOE restraints between interstrand and
intrastrand NOE interactions resulting from the symmetry of the quadruplex structure
the energy-minimised structure was considered. Interstrand restraints were manually
determined by matching their calculated distance with the distances of the initial
energy-minimised structure. Those distance restraints that included violations over
0.5 A were adjusted after restrained energy minimisation was carried out to derive a
set of restraints that will be consistent with the geometrical limits of the structure. A
total set of 728 restraints was used for energy minimizations and restrained
molecular dynamics simulations. Tables with the lists of the NOE restraints are
found in appendix 2.5.
5.2.4 Structure calculations
Energy minimisations and restrained molecular dynamics calculations were
performed on an Origin 200 Silicon Graphics Server using the AMBER 6 suite (30)
of programs employing the AMBER 94 force field with modifications (31) and the
Particle Mesh Ewald (PME) (32) method for the treatment of long-range
electrostatics. The initial co-ordinates for the starting model of the quadruplex were
taken from the NMR structure of the d(TTGGGGT)4 quadruplex (20) (Protein Data
Bank accession entry number 139d), choosing randomly one of the deposited
structures. The starting model of the d(TTAGGGT) quadruplex was generated by
replacing the guanine nucleotides in the third position of the sequence from the 5'
end with adenine nucleotides using the LEAP module of AMBER 6. The DNA
molecule was solvated in a periodic TIP3 water box of approximate dimensions 60 A
x 60 A x 60 A, which extended to a distance of IDA from any solute atom and
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contained 5030 water molecules. Two internal potassium ions were manually
positioned in the central channel between adjacent G-quartets using standard
parameters for the AMBER force field. The potassium ions were positioned
equidistant from two adjacent G-quartets to allow octahedral coordination with
guanine carbonyl oxygen 06 atoms. The quadruplex system was neutralised
externally requiring 22 potassium ions placed at the most negative locations using
Coloumbic potential terms with the LEAP module. All the potassium ions including
those placed in the central channel were treated as part of the solvent.
Energy minimisations and restrained molecular dynamics were carried out
using the SANDER module of AMBER 6. Calculations with SANDER were
performed with a 2 fs time step, with the SHAKE algorithm (tolerance 0.00005 A)
applied to all bonds to remove bond stretching, and a 9 A cut off to the Lennard
Jones interactions. The restrained molecular dynamics were performed at 300K and
a constant pressure of 1.0 atm with isotropic position scaling utilising the Berendsen
algorithm for temperature coupling. Translational and rotational motions were
removed every 100 fs. All calculations were carried out with the PME method using
a 9 A cut-off for direct space non-bonded calculations and a 0.00001 Ewald
convergence tolerance for the inclusion of long-range electrostatics in our
calculations.
The quadruplex system was allowed to equilibrate fully before the molecular
dynamics calculations, following the same protocol as in section 2.2.5. Minimisation
was performed with 50 steps of steepest descent and 5000 steps of conjugate gradient
to first the water and counterions, with the DNA coordinates frozen, followed by a
further 5000 steps on all the components of the system. Next, 10 ps unrestrained
molecular dynamics were run at WOK on the water alone with the DNA and
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potassium ions constrained, followed for another lOps to allow the potassium ions to
move. In the following 5 ps of dynamics the temperature of the system was
increased from lOOKto 300K. The next runs, each of them of lOps dynamics, the
DNA force constant is gradually reduced from 100 to 50, 25, 10, 5 and 2.5
kcal morIA-2• The equilibration step ends with 100 ps of dynamics on the whole
fully unrestrained system. The system now is fully equilibrated and NOE restraints
can be applied to the quadruplex system. Distance restraints were introduced
gradually on the system over the first lOps of 100 ps MD run with the temperature
stable at 300K and PME on. All NOE restraints were introduced in the form of
square well potentials with a force constant of 50 kcal morl A-I for the hydrogen-
bond restraints and 30 kcal mol" kl for all the other NOE distance restraints. A
total of 1000 ps simulation was performed under the same conditions, after which the
system was energy minimized also with NOE restraints.
Calculated structures satisfied the majority of the NOE restraints from the set
of 728 restraints. The average minimised structure had no restraint violation > 0.3
A, while there were 18 restraint violations between 0.2-0.3 A, 41 restraints between
0.1-0.2 A and 29 restraints < 0.1 A that contributed to a 48.22 kcal mol" energy
penalty. Snapshots of each picosecond were extracted from the whole simulation
and the structures were determined to be equilibrated on the basis of RMSD analysis.
Time-averaged structures were calculated with the CARNAL module of AMBER.
Helicoidal structural properties, sugar pucker and backbone torsion angles have been
analysed using CURVES (33). The helicoidal parameters were measured
individually for each strand of the G-quadruplex and the four strands were found to
have very similar values.
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5.2.5 Analysis of thermodynamic parameters
The melting transition of d(TTAGGGT) was investigated by NMR. A two
state transition model for the association of d(TTAGGGT) to the quadruplex form
was assumed from the pattern of the peaks in 1D IH NMR spectra at various
temperatures (278-338 K) in which the two species (single strand <=> quadruplex)
are in reversible exchange. Concentrations of the single- and four-stranded species
of the d(TTAGGGT) were determined by integration of peaks (adenine H8 proton
and thymine H6 proton) associated with the two forms in the aromatic peak region of
the ID IH NMR spectra. The equilibrium constant for this system is expressed as:
Keq= [quad] = fq. crl4 5 1
[single]4 [fa. Ct]4 eq. .
fqand fs are the fractions of quadruplex and single-stranded species, respectively, and
Cl is the total concentration of the oligonucleotide in single-stranded form. Fractions
of the two species in the solution calculated from integration data included an
uncertainty of 5-1 0%. The Keq value was determined for each temperature (278-338
K), which enable us to calculate the temperature dependence of the change in free
energy of association ~Go= -RT In(Keq)(eq. 5.2). The linearity of the temperature
dependence of the ~Go confirms the two-state transition model for the association of
d(TTAGGGT) and enables us to calculate the change in enthalpy mo and entropy
~So at 298 K by linear fitting of the equation ~Go= ~Ho - T~So (eq. 5.3), with
Kaleidagraph Software (Synergy, Inc.). Enthalpy and entropy values were calculated
from the slope and y-intercept of the plot of ~Go versus T.
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5.3 Results and Discussion
5.3.1 NMR spectral features
The 10 tH-NMR spectra (6-12 ppm) of the d(TTAGGGT)4 in K+, H20
solution, showing the exchangeable imino and non-exchangeable base protons at
different temperatures are plotted in figure 5.3. Three distinct exchangeable imino
protons are observed in the region of 10-11.5 ppm, two exchangeable amino protons
are observed at 9.3 and 7.1 ppm, and non-exchangeable base protons are detected
between 7.0-8.5 ppm. The exchangeable imino protons persist up to very high
temperatures indicating high stability, as observed from the NMR temperature
dependence study in figure 5.3. The imino protons also appear in the spectrum after
dilution of the sample in 020 solution, especially the imino proton that resonates at
10.5 ppm, showing slow exchange with the solvent. High melting temperature and
low solvent accessibility are characteristic features of the guanine imino protons that
form G-quadruplex structure, as a number of previous NMR studies have established
(22,26,34,35). The NMR spectra in the base region at low temperatures show two
sets of resonances, with one set corresponding to a major conformation, the
quadruplex conformation. Increase of the temperature generates two distinct sets of
resonances as observed from clear duplication of the base protons, which are
replaced with a single set of resonances at very high temperature, figure 5.3. The
former indicates the melting of the quadruplex conformation, seen at low
temperature, into the single strand d(TTAGGGT). In addition, NMR spectra of
d(TTAGGGT) at low temperature show base protons of the single strand in slow
equilibrium with the quadruplex structure. The number of peaks in the base region
shows that the intermolecular G-quadruplex structure formed by d(TTAGGGT) is
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highly symmetrical and the four strands are equivalent, thus there is only one
resonance observed for each base and sugar proton, figure 5.3.
The melting temperature Tm of the quadruplex d(TT AGGGT)4 (single
stranded and quadruplex equally populated) is -60 °C at a strand concentration of 6.4
mM. The melting temperature Tm of quadruplex structures is concentration
dependent (38) and increases with increases of strand concentration, however a
similar Tm has been found from NMR melting studies for the quadruplex
d(AGGGT)4 at similar concentration (26). The presence of resonances from both the
single- and the four-stranded forms of the d(TT AGGGT) that are detected in the
same spectrum, enables us determine the change in the population of the folded and
unfolded states of the quadruplex d(TT AGGGT)4 as a function of temperature. The
aromatic peaks of the A3 and T7 residues were used for calculating the populations.
The uncertainty of integration data in the temperature range 278-293 K is greater
due to signal broadening; however, the results of the fitting are very similar whether
these data are taken into account or not. The equilibrium constant 1<eq (eq. 5.1) and
free energy of association ~Go (eq. 5.2) are calculated for each temperature and then
the relationship of the change in ~GO with temperature T is plotted, figure 5.4. The
linear relationship of the ~Go with T is consistent with MI and ~S being independent
of temperature (~Cp=O); fitting the data to eq. 5.3 can provide a full thermodynamic
characterisation of the quadruplex folding. Thus, at 298 K we determined the
following thermodynamic profile for the formation of d(TT AGGGT)4 : ~Ho = -256
KJmort, ~so = -763 JK-tmort, ~GO = -28.9 KJmorl_ In terms of G-tetrad
formation (table 5.1) these values agree very well with previous calorimetric
experiments with the parallel four-stranded quadruplex of d(TGGGT)4 in K+ solution
(38).

Investigations into the structure of quadruplex DNA 157
The resulting values establish that at 298 K the intermolecular folding of
d(TTAGGGT)4 to quadruplex formation is enthalpy driven with a negative entropic
factor, resulting from the cost of ordering the flexible backbone and in bringing four
strands together in the complex. The data are consistent with the majority of the
enthalpic driving force being derived from G-quadruplex formation (stacking and K+
complexation) with a small contribution from adjacent nucleotides (A and T).
Table 5.1 Thermodynamic parameters per G-tetrad of the d(TTAGGGT)4, d(TGGGT)4
quadruplexes determined at 298 K. *Data from (38).
~SO JK'mor'
d(TTAGGGT)
-85.3 -256 -9.6
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-87.8 -259 -9.6
1 10·
y e deltaGvT2(-50000.-50.0)
0 rror
a
b 15.' 32
- -1 104 R 0.99784 NAL
0
E
-2 10·..,
-
Cl
-3 104<l
-4 104
+
-5 104
270 280 290 300 310 320 330 340
T (K)
Figure 5.4 Temperature dependence of the free energy of associ~tion ,1Go dete~ined ~r.om
the relative populations of the folded and unfolded states by H NMR peak intensities.
Linear fitting of the data to eq 5.3 resulted in a correlation coefficient R = 0.99.
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5.3.2 Exchangeable protons assignments
Resonance assignments of the exchangeable and non-exchangeable protons
were based on the NOE information from NOESY spectra (figure 5.5) at various
mixing times 70-400 ms and on through-bond scalar coupling interactions observed
in TOCSY and DQF-COSY spectra. The chemical shifts of all protons of
d(TTAGGGT) were obtained readily following standard assignment procedures for
nucleic acids protons, see appendix 1.6. For assignment purposes nucleotides are
numbered sequentially from S' to 3' end, as d(T1-T2-A3-G4-GS-G6-T7).
Expanded regions A, Band C of the NOESY spectrum of d(TTAGGGT)4 in
H20 solution, recorded at 300 ms mixing time and 293 K, are plotted in figure 5.6.
NOEs between adjacent guanine imino protons in the sequence, G4NH-GSNH and
GSNH-G6NH, are detected in figure 5.6A. In addition, guanine imino protons show
NOEs with their own base protons (a-b cross peaks) and also to their 5' flanking
base protons (c-i cross peaks) in the A3-G4-GS-G6 part of the d(TTAGGGT)4
quadruplex structure, figure 5.6B. Thus, the 11.0 ppm imino proton of G6 exhibits
NOEs with the base protons of G6H8, G5H8 and the 10.7 ppm imino proton of the
G5 exhibits NOEs with the base protons of GSH8 and G4H8. We also observe
NOEs between the base protons A3H8, A3H2, G4H8 and the imino proton of G4 at
11.0 ppm. These NOEs are evidence of the interstrand interactions between the
guanine residues that are involved in G-tetrad formation, as they cannot be accounted
for by NOEs within the same strand. In addition, such NOEs provide evidence of
good stacking interactions between adjacent G-tetrads formed by G6, G5, G4
residues and also show stacking interactions of the G4-tetrad with the A3 residues
within the d(TTAGGGT)4 quadruplex structure.
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The expanded region of the NOESY spectrum in figure 5.6C includes NOEs
between each guanine imino proton and its own guanine amino protons that resonate
at two distinct chemical shifts. The G4 imino proton shows NOEs with its 9.15 ppm
and 5.70 ppm amino protons (i, k cross peaks), the G5 imino proton with its 9.10
ppm and 5.90 ppm amino protons (1, m cross peaks) and the G6 imino proton with its
9.00 ppm and 5.75 ppm amino protons (n, 0 cross peaks). Characteristic of the
amino NOEs is broadness implying a degree of exchange with the solvent. The
observation of two distinct amino protons is consistent with slow rotation of the C-N
bond at low temperature. One hydrogen of the amino group resonates near 6.00 ppm
and is exposed to the solvent while the other hydrogen near 9.00 ppm exhibits a NOE
with the base H8 proton of the inter-tetrad guanine (cross peaks not shown),
confirming that G residues form G-tetrads with the hydrogen-bonding alignment in
the figure 5.1. All of the assigned NOEs for d(TTAGGGT)4 confirm that the
nucleotides in the sequence form a symmetric right-handed twisted parallel-stranded
quadruplex structure. In an antiparallel structure, we would for example expect to
observe NOEs between H8 and NH protons of the G4-G6 residues.
The amino proton of adenine residue A3NH2is well observed in the 1D NMR
spectrum at 7.1 ppm and exhibits NOE with the G4NH proton but also shows an
NOE with the base A3H2 proton, figure 5.7. This NOE from the adenine amino
protons to its own base proton H2 would not be observed due to their large
separation unless it is attributed to an intertetrad interaction between A residues. In
addition, the persistence of the ANH2 resonance at high temperature, figure 5.3,
similar to the guanine imino protons, shows evidence of higher stability than could
arise from the formation of stable A-A interactions in a A-tetrad structure, figure
5.S. Similar findings involving adenine nucleotides are reported for the d(AGGGT)4
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quadruplex structure, but surprisingly not with the d(T AGGGT)4 structure (26). The
thymine imino protons exchange fast with the solvent and we do not observe NOEs
between them and other protons in the NOESY spectrum of H20 solution, even at
low temperature. There is no direct evidence of hydrogen-bond pairing of the
thymine residues that would suggest the formation of a hydrogen-bonded T-tetrad
analogous to the G-tetrad (figure 5.1). Thus the NMR data suggests that only the
purine residues of the sequence form tetrads in the quadruplex structure and the
thymine residues of each strand do not have a well-defined conformation.
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Figure 5.6 Expanded regions A, Band C of the NOESY spectrum of d(TT AGGGT)4 in H20
solution, recorded at 300 ms mixing time and 293 K. NOEs labelled (a) - (0) are assigned
as; (a) G4NH-G5NH (b) G4NH-G5NH (c) G4NH-A3H8 (d) G4NH-A3H2 (e)
G4NH-G4H8 (f) G5NH-G4H8 (g) GSNH-GSH8 (h) G6NH-G5H8 (i) G6NH-G6H8 (j)
G4NH-G4NH2 (k) G4NH-G4NH2* (I) GSNH-GSNH2 (m) GSNH-GSNH2* (n)
G6NH-G6NH2 (0) G6NH-G6NH2*. Hydrogens of the amino groups exposed to the
solvent are discriminated as NH2*.
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Figure 5.7 xpanded region of the NOESY spectrum of d(TTAGGGT)4 in H20 solution,
recorded at 300 m mixing time and 293 K, showing H8/H6-Hl' NOE sequential pathway
and also the N between ANH2 and A3H2 protons .
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Figur 5.8 Hydrogen-bonding alignment of adenine nucleotides in a A-tetrad.
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5.3.3 Non exchangeable protons assignments
Portions of the NOESY spectrum in D20 solution recorded at 250 ms mixing
time and 29S K are plotted in figure 5.7 and 5.9. Expansion of the NOESY spectrum
in figure 5.7 shows the sequential pathway followed for the assignment of the sugar
HI' protons and the base HS/H6 protons of each nucleotide in the
d(Tl-T2-A3-G4-G5-G6-T7)4 quadruplex structure. We can trace all the
sequential connectivities of each HS/H6 base proton involving its own and its 5'
flanking HI' sugar protons. Expansion A of the NOESY spectrum in figure 5.9
shows NOE connectivities between the base HS/H6 protons and their own and their
5' flanking H2'/H2" sugar protons, while expansion B in figure 5.9 shows NOE
connectivities between the base HS/H6 protons and their own and their 5' flanking
H3' sugar protons. The intensities of the NOE cross peaks between base H81H6
protons to sugar protons HI', H2', H2", H3' are similar not only for the core G4, G5,
G6, but also for the TI, T2, A3 and T7 residues in the d(TTAGGGT)4 quadruplex
structure. This suggests that the nucleotides along the four strands in the
symmetrical quadruplex structure are in close distance to their adjacent nucleotides
on the same strand. The non-exchangeable NOE assignments show clearly that the
Tl, T2 and T7 nucleotides are not randomly located, even though it is unlikely that
they hydrogen bond with their interstrand neighbouring nucleotides, but they are
involved in stacking with their neighbouring nucleotides on the same strand and
contribute to the formation and stabil~tyof the quadruplex structure. In addition, all
the sequential assignment pathways observed in the NOESY spectra follow only one
direction from the base to the 5' flanking sugar HI', H2'/H2" and H3' protons,
which indicates that each individual strand has the right handed helical alignment, as
observed in the B-DNA helix.
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Assignments of all the sugar spin systems HI', H2', H2", H3', H4', H5 'IHS"
were obtained from a combination of NOESY and TOCSY spectra. The H2' and
H2" resonances were assigned stereospecifically on the basis of their NOE cross
peak intensities in a short mixing time (70 ms) NOESY spectrum. In any sugar
conformation the interproton distance between HI-H2' is always shorter than the
II I-H2" distance. The resonances of the H2" for all the nucleotides in the
d(TTAGGGT)4 quadruplex appear downfield of the resonance of the H2' protons, as
happens predominantly with the B-DNA helix. The coupling constants measured
from DQF-COSY spectra for the H2'-H2" cross peaks were found to be large (>13
J Iz) and characteristic of the sugar conformation being predominantly S-type (36).
Interproton distances between H8 and its own HI' protons for the guanine
residues G4, GS, G6 and also for the other base residues were quantified in a short
mixing time NOESY and found to be weaker than the intensity of the NOE between
base 116and methyl protons CH) in any of the TI, T2, T7 thymine residues. All the
distance restraints determined for the base H61H8-H I' sugar protons have a distance
> 3.0 A. The distance between intra-nucleotide H6-CH) protons in a thymine
residue is fixed to 3.0 A where anti and syn glycosidic conformations can be
differentiated by distances of 3.7 A and 2.5 A, respectively, between the H8 and HI'
protons. (37). This indicates that all residues in the d(TAGGGT)4 quadruplex
structure adopt anti glycosidic torsion angle conformation. This agrees with what
has been found with all the intermolecular G-quadruplex structures except
d(AGGGn4, where the terminal A has been proposed to adopt a syn conformation
(26). The data presented here for d(TTAGGGT)4 is not consistent with A adopting
the syn conformation.
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Figure 5.9 Expanded regions A and B of the NOESY spectrum of d(TT AGGGT)4 in D20
solution, recorded at 250 ms mixing time and 298 K, showing NOEs between H81H6 base
protons and HI', H2' 1H2" (A) and H3' (B) sugar protons.
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5.3.4 NMR restraints
NOE restraints include distances between non-exchangeable protons (152
restraints). exchangeable protons (24 restraints) and in addition hydrogen-bonding
restraints (24 restraints) in order to define the hydrogen-bonding alignment of
guanines in a Gstetrad, figure 5.1. We did not add any hydrogen-bonding restraints
between adenine residues even though NMR data indicate evidence of A-tetrad
formation, In addition. there are no hydrogen-bonding restraints for the thymine
residues TI. T2 and T7 in the d(TTAGGGT)4 quadruplex structure. The interstrand
NOEs in the parallel quadruplex structure have been assigned based on the initial
energy-minimised structure of the quadruplex d(TAGGGT)4. We observe interstrand
NOEs only for the AGGG segment and no NOE between thymine nucleotides, which
implies a better definition of the quadruplex structure in this particular region.
Figure 5.10 shows the distribution of exchangeable. non-exchangeable and
hydrogen-bonding restraints for each residue within one strand. There is almost the
same number of restraints of non- exchangeable protons for all the seven residues
while exchangeable restraints are observed only for guanine residues and adenine
residues. There are 178 NOEs in total per strand. excluding hydrogen-bond
restraints. which were quadrupled during structure calculations due to the four-fold
symmetry of the quadruplex.
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Figure 5.10 Histogram for the NOE restraints associated with each residue in the
d(TTAGGGT) sequence. The blue bar represents the non-exchangeable NOE restraints, the
red bar the exchangeable NOE restraints and last the green bar the hydrogen-bond restraints.
5.3.5 Restrained molecular dynamics calculations
Our structure calculations were based on a starting model of the
d(TTAGGGT)4 quadruplex, generated from a deposited structure of the
d(TTGGGGT)4 quadruplex with appropriate modifications using the LEAP module
of AMBER 6. The starting structure is consistent with the NMR data in a qualitative
form. There is a parallel alignment of the four strands in the quadruplex and each
strand possesses a right-handed twisted helical alignment similar to B-DNA helix, as
indicated from the pattern of the NOE interactions across the whole sequence. The
nucleotides in each strand are aligned with the potential for hydrogen-bonding
interactions within individual tetrads with the glycosidic torsion angle in an anti
conformation. Distances calculated for the base H8/H6 protons with the sugar HI'
proton for each nucleotide from NOESY spectra at short mixing time suggest that the
glycosidic torsion angle of each nucleotide adopts an anti conformation.
The vast majority of NMR approaches to quadruplex structure determination
have used restrained molecular dynamics in vacuo and in the absence of counterions,
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except for an NMR-MD simulation study of the hairpin quadruplex structure
d[(G3T4G3)h that involved explicit water molecules and counterions external and
internal to the structure (37). A detailed approach to the determination of a
quadruplex structure should not ignore these factors as it is well established that the
local conformation of the quadruplex is dependent on the presence of counterions
and hydration of the molecule. Our NMR-MD approach included explicit solvent
molecules and potassium ions both external to the solute and bound internally within
the quadruplex structure. We used the particle mesh ewald method for accurate
modelling of long-range electrostatics and for obtaining stable trajectories under
these conditions. Although the exact location of the potassium ions cannot be
determined from our experimental data, we positioned two ions within the three
stacked G-tetrads as defined by the X-ray study of the d(TGGGGT) (22).
Our protocol for the NMR-MD calculations initially included a careful
equilibration of the initial structure and then a slow heating to target temperature 300
K, while gradually allowing the DNA co-ordinates to move free and unrestrained.
Then NMR restraints are introduced to the equilibrated structure and the system is
allowed to undergo 1 ns restrained molecular dynamics to satisfy the NMR restraints
and search adequate conformational space under the influence of water molecules
and cations. The NMR restraints are satisfied well within the 1 ns simulation and
there are only small violations, associated mainly with the terminal residues. The
NMR-MD calculations were judged to equilibrate and converge well within the 1 ns
of the run as shown from RMSD analysis in figure 5.11. The last 500 ps of the
simulation were selected for structural analysis. The pairwise RMSD from the mean
structure over all heavy atoms over the final 500 ps of the simulation is 1.65 (±0.22)
A.
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Figure 5.11 RMSD analysis of 1000 snapshots of the d(TTAGGGT)4 structure taken from
the 1 ns restrained MD simulation.
5.3.6 Quadruplex structure
The structure of the quadruplex d(TTAGGGT)4 in figure 5.12 and 5.13
represents the average minimised structure calculated from the last 500 ps of the
restrained MD simulation. The right-handed parallel quadruplex structure shows the
guanine residues to have an almost planar conformation and all form a well-defined
G-tetrad conformation. Although the NMR refinement did not use any hydrogen-
bond restraints between the adenine residues on adjacent strands, the structure shows
clearly that there is a formation of a certain planar conformation of the adenine
residues that allows them to hydrogen bond with each other. Each of the thymine
bases of the structure has a buckled conformation and do not form any specific
hydrogen-bonding alignment. These general features of the structure agree with our
NMR evidence and emphasize that the purine residues in the structure are able to
form tetrads, stack on top of each other and stabilize the quadruplex structure, while
the thymine residues have a more flexible conformation. The latter point is also
emphasised from figure 5.14, which shows five randomly chosen structures
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superimposed. The loose conformation of the thymine residues reflects the lack of
interstrand NOEs between thymine nucleotides.
The core quadruplex structure in figure 5.15 from the average minimised
structure of d(TTAGGGT)4, consisting of the purine bases of the AGGG core, has
been further analysed in terms of hydrogen bonding and helical parameters. The
average distances, with standard deviations between atoms involved in formation of
hydrogen bonds from the whole set of 500 structures, are shown in table 5.3.
Distances of the Hoogsteen NI-06 and N2-N7 hydrogen bonds between the
guanine bases of the three G-tetrads show that all hydrogen bonds are formed and
maintained in all the structures. In addition, there is no significant difference in
hydrogen-bond distances between the G-tetrads. The hydrogen bonds formed by the
NI-N6 atoms of the adenine bases have a little more flexibility, but they still are
well defined in all calculated structures, though no specific H-bond restraints were
included. Our calculations for hydrogen-bond distances between 04-N3 and 02-N3
atoms found in thymine bases confirmed that thymines do not form any recognisable
hydrogen-bonding alignment in an analogous fashion to the purine residues in the
sequence.
It is worth noting that during the course of unrestrained molecular dynamics
of the quadruplex d(TTAGGGT)4 structure hydrogen bonds between the guanine and
adenine residues are also stable. Analogous analysis of the unrestrained simulation
showed that distances of the Hoogsteen NI-06 and N2-N7 hydrogen bonds within
G-tetrads have an average value of3.00 ± 0.15 A, while the NI-N7 hydrogen bonds
have an average distance value of 3.12 ± 0.20 A. These results emphasise that stable
G-tetrads and A-tetrad is a characteristic of the quadruplex d(TTAGGGT)4 structure
and not an effect of the hydrogen-bond restraints.
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Figure 5.12 Average minimised structure of d(TT AGGGT)4 from the last 500 snapshots (1
per ps) of the I ns restrained simulation. Guanines are coloured in blue, adenines in dark
orange and thymines in dark green.
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Figure S.J 3 chcmatic representation of the average minimised structure of d(TT AGGGT)4
howing the backbone as ribbons and bases as planes.
Figure 5.) 4 Five randomly chosen structures of d(TT AGGGT)4 from the last 500
snapshots (500 p ) of the 1 n restrained simulation. Guanines are coloured in blue, adenines
in dark orange and thymines in dark green.
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Figure 5.15 ore quadruplex (AGGG)4 from the average minimised structure of
d(Tf A G Tk uanine are coloured in blue, adenines in dark orange and K+ ions lie
between of the -tctrads,
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Table S.3 Average hydrogen-bond distance and standard deviation (parentheses) for core
quadruplex (AGGGk
Residue N7-N2 H-bond Nl-06 H-bond Nl-N6 H-bond
G4 2.94 (0.07) 2.89 (0.07)
GS 2.96 (0.06) 2.89 (0.07)
G6 2.97 (0.06) 2.87 (0.07)
A3 3.12 (0.16)
It is also evident from the figure 5.15 that the core quadruplex forms a cavity
through the centre of its structure, which is maintained in all the calculated
structures. Inside this cavity and between two neighbouring O-tetrads the potassium
ions are located almost intact from where they were initially positioned. Although
the exact number of potassium ions in the quadruplex structure is unanswered, the
present findings show that the potassium ions playa role in the stabilisation of the
local conformation of the guanine residues in quadruplex structures. Titration
studies by others have established the K+binding stochiometry, consistent with this
model (41).
5.3.7 Distinctive features of d(TTAGGGT)4 structure
Variation of the helicoidal parameters, table 5.4, for the quadruplex
d(TTAGGGT)4 has been calculated over the last 500 structures (500 ps) of the
restrained MD simulation using the CURVES program (33). The helicoidal
parameters have been analysed for each individual strand and each strand found to
have very similar values. These include the glycosidic torsion angle X and the
pseudorotation angle P of all the nucleotides in the sequence and also helical twist
and axial rise at the A3-04, 04-05 and 05-06 steps. The glycosidic torsion angles
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X, as was suggested from the NMR data, are clearly in the anti conformation for all
the nucleotides including A3 (centered on -121°). This value agrees very well with
the previous reported value of -115° of a similar quadruplex structure
d(TTGGGGT)4 (20). However, this contrasts with the data of Hosur et al. (26) for
d(AGGGn4, where the adenine was shown to be in the syn conformation on the
basis of quantitative NOE calculations. Thus, additional thymines on the 5' end
appear to have a significant effect in stabilizing and modulating nucleotide
conformation.
Table 5.4 Average value and standard deviation (parentheses) over all four strands of helical
twist, axial rise for the (AGGG). segment and glycosidic torsion angle I, pseudorotation
phase angle P of d(lT AGGGT)• .
Twist e) Rise (A)
A3-G4 25 (3) 3.0 (0.3)
G4-G5 29 (2) 3.5 (0.2)
GS-G6 26 (2) 3.7 (0.2)
X angle (0) Phase P e)
TI -146 (17) 140 (19)
T2 -136 (14) 100 (14)
A3 -119 (10) 133 (21)
G4 -117 (9) 134 (10)
G5 -III (9) 143 (12)
G6 -115 (10) 145 (9)
T7 -109 (15) 127 (24)
The pseudorotation angle P is in the range of the S type sugar conformation
for all the residues with a mean value of 132°, although some variations amongst
residues are observed. This value is rather smaller than mean values observed for the
canonical B-DNA conformation. The purine bases of the AGGG segment contribute
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to axial rise values of 3.0 A, 3.5 A, 3.7 A and helical twist of 25°, 29°, 26° for the
A3-G4, G4-GS, GS-G6 base steps, respectively. The helical twist for the purine
steps is smaller than the average value of 36° for canonical B-DNA conformation,
but is in the range of helical twist 25-30° of guanine residues forming G-tetrads
(20,22,25). The twist angle is largest at the central G4-G5 step but decreases at the
neighbouring A3-G4 and G5-G6 steps. This sequence-dependent variation is likely
to be an indication of the differences in base stacking patterns between purine
residues on adjacent tetrads formed by the AGGG segment.
Figure 5.16 shows the base stacking of the tetrads formed by (a) A3-G4, (b)
G4-G5, (c) GS-G6 steps and the conformation of the A3-tetrad (d) in the average
minimised structure. Generally base stacking is observed between rings of purine
residues on the same strand, as in B-DNA structure. This stacking pattern is usually
observed in parallel G-quadruplex structures (20,22,26). The purine nucleotides in
the structure adopt a hydrogen-bond alignment, which involves hydrogen-bond
donors available to acceptors of the adjacent nucleotide in the same tetrad. The 06
atoms of the carboxyl groups of guanine nucleotides point towards the cavity of the
structure and are assumed to coordinate with the potassium ions. The base stacking
for the guanine residues in G4-GS and GS-G6 is similar, with the imino and amino
protons of the G4 and GS nucleotides stacked on the six-membered ring of the G5
and G6 nucleotides, respectively. The guanine nucleotides of the G5-tetrad show the
best overlap with the G4- and G6-tetrads and this may explain why the G5NH
resonance exchanges more slowly than the imino protons of the G4 and G6
nucleotides when dissolved in D20 solution.
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Our NMR data highlight a number of additional NOEs, particularly from
G4NH to A3H8 and A3H2, that indicate good stacking interactions between the two
sets of purine bases. In addition the amino proton of A3 shows similar stability to
the guanine imino protons and exhibits NOEs with G4NH and A3H2. The A3NH2-
A3H2 NOE is not expected to arise as an intranucleotide NOE but is consistent with
an interaction between adenine bases within an A-tetrad conformation. The
formation of an A-tetrad has been reported only for d(AGGGT)4 (26), but with
different conformational properties. Hosur et al (26) suggested that adenine
nucleotides have two distinct patterns of A-tetrad alignment distinguished by the
NOEs between ANH2-AH2 and ANH2-AH8, respectively. Observation of these
NOEs simultaneously suggests a dynamic behaviour of the A-tetrad exchanging
between the two hydrogen-bonding patterns. The dynamism between the two
alignments was also evident in their structure calculations, resulting in two different
base stacking patterns with the adjacent G-tetrad.
On the contrary, in our quadruplex structure d(TTAGGGT)4 there is only one
strong NOE between the A3NH2-A3H2 that can force the adenine nucleotides to a
single tetrad alignment as shown in figure 5.16d. The adenine nucleotides are
stabilised in this A-tetrad alignment by hydrogen bonds between the NH2-N1 atoms,
figure 5.S. The C6-NH2 of the adenines point into the central cavity of the
quadruplex structure in a similar way to that observed for the 06 atoms of the
guanines. The base stacking between the A3-G4 step shows partial stacking of the
six-membered ring of the adenine with the five-membered ring of the guanine
nucleotide of the same strand. The amino protons A3NH2 stack on top of the imino
proton G4NH from the adjacent strand. The base stacking pattern for A3-G4 step in
the present structure is also different from that reported for d(AGGGT)4 (26)
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quadruplex. This is justified from the difference in glycosidic torsion angles of the
adenine residues in these two structures. We can not explain why adenine
nuc1eotides have a syn conformation in d(AGGGT)4 (26) and anti conformation in
d(TAGGGT)4 (26) and d(TTAGGGT)4, but this is likely an effect from the additional
thymine residues on the 5' end.
b
Figure 5.16 Stacking pattern between a) A3-G4, b) G4-G5, c) G6-T7 tetrads and d) A3-
tetrad conformation in the average minimised structure of the d(TTAGGGTk
5.4 Conclusions
We have determined the high resolution structure of the quadruplex
d(TTAGGGT)4 by a NMR restrained molecular dynamics approach that includes
explicit treatment of solvent and counterions. The d(TT AGGGT)4 quadruplex forms
a stable structure mainly in the purine core due to strong stacking interactions. The
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hydrogen bonding of the G-tetrads persists in all structures with minimum deviation
from ideal geometries. Our structure determination supported by NMR data showed
that adenine nucleotides on separate strands could also form stable hydrogen-bonded
tetrads. The A-tetrad observed in our sequence d(TTAGGGT)4 behaves differently
from the one reported in d(AGGGT)4. We observe a single preferred conformation
with all adenine nucleotides adopting anti glycosidic torsion angles. However, the
A-tetrad in the calculated structures is more flexible than G-tetrads as indicated from
the hydrogen-bond distances of the adenine N6-Nl atoms. The thymine nucleotides
have a much more flexible conformation and do not appear to form hydrogen-bonded
T-tetrads, but do appear to stack with their adjacent nucleotides in B-like DNA
conformation. We can observe a broad imino resonance at 5 "C, which could be
attributed to the thymine NH though there is no evidence for hydrogen bonding. We
can presume that generally pyrimidine nucleotides are unable to form stable tetrads
unless they are surrounded and stabilised by purine tetrads.
Previous investigations have provided us with the NMR characteristics of
sequences containing the human telomeric repeat, but structure determination of such
a quadruplex has not been reported in the literature. Thus, from this point of view
the high resolution structure of the d(TTAGGGT)4 adds valuable information to the
family of parallel quadruplex structures determined so far. The quadruplex structure
of the d(TTAGGGT)4 also provides us with an NMR model for ligand recognition
studies. Knowledge of the characteristics of such complex structures is essential in
order to understand the molecular basis of ligand recognition and examine the effect
of ligand binding on such structures. On-going research has highlighted the role of
ligand-quadruplex interactions in telomerase inhibition and anticancer activity.
Drug-quadruplex interactions are the subject of the next chapter.
Investigations into the structure of quadruplex DNA 181
5.5 References
1. Neidle, S. 1998 Oxford Handbook of Nucleic Acid Structure, Oxford University
Press, New York.
2. Blackburn, E. H. 1991 Structure and Function of Telomeres. Nature 350, 569-
573.
3. Zakian, V. A. 1995 Telomeres - Beginning to Understand the End. Science 270,
1601-1607.
4. Greider, C. W. & Blackburn, E. H. 1996 Telomeres, Telomerase and Cancer. Sci.
Am. 274,92-97.
5. Shippen, D. E. 1993 Telomeres and Telomerases. CurroOpin. Gen. Dev. 3, 759-
763.
6. Simonsson, T., Pecinka, P. & Kubista, M. 1998 DNA Tetraplex Formation in the
Control Region of c-myc. Nucleic Acids Res. 26, 1167-1172.
7. Woodford, K. J., Howell, R. M. & Usdin, K. 1994 A Novel K'vDependent DNA-
Synthesis Arrest Site in a Commonly Occurring Sequence Motif in Eukaryotes. J.
Bioi. Chern. 269,27029-27035.
8. Shimizu, A. & Honjo, T. 1984 Immunoglobulin Class Switching. Cell 36, 801-
803.
9. Feigon, J., Koshlap, K. M. & Smith, F. W. 1995 H-l NMR Spectroscopy of DNA
Triplexes and Quadruplexes. Nuclear Magn. Reson. Nucleic Acids 261, 225-255.
10. Shafer, R. H. 1998 Stability and Structure of Model DNA Triplexes and
Quadruplexes and their Interactions with Small Ligands. Prog. Nucleic Acid Res.
Mol. Bioi. 59, 55-94.
11. Patel, D. J., Bouaziz, S., Ketttani, A. & Wang, Y. 1998 Oxford Handbook of
Nucleic Acid Structure, p. 389-453, Oxford University Press, New York.
12. Walsh, K. & Gualberto, A. 1992 Myod Binds to the Guanine Tetrad Nucleic-
Acid Structure. J. Bioi. Chern.267, 13714-13718.
13. Erlitzki, R. & Fry, M. 1997 Sequence Specific Binding Protein of Single-
Stranded and Unimolecular Quadruplex Telomeric DNA from Rat Hepatocytes.
J. Bioi. Chern. 272, 15881-15890.
Investigations into the structure of quadruplex DNA 182
14. Sundquist, W. I. & Heaphy, S. 1993 Evidence for Interstrand Quadruplex
Formation in the Dimerization of Human Immunodeficiency Virus-l Genomic
RNA. Proc. Natl. Acad. Sci. U. S. A. 90,3393-3397.
15. Raymond, E., Soria, 1. C., Izbicka, E., Boussin, F., Hurley, L. & Von Hoff, D. D.
2000 DNA G-quadruplexes, Telomere-Specific Proteins and Telomere-
Associated Enzymes as Potential Targets for New Anticancer Drugs. Invest. New
Drugs 18, 123-137.
16. Han, H., Bennett, R. J. & Hurley, L. H. 1999 PIPER, A G4-DNA Interactive
Compound, Prevents the Unwinding of G-quadruplex DNA by Yeast Sgsl
Helicase. Clin. Cancer Res. 5,607.
17. Williamson, 1. R. 1993 Guanine Quartets. CurroOpin. Struct. Bioi. 3,357-362.
18. Phillips, K., Dauter, Z., Murchie, A. I.H., Lilley, D. M. J. & Luisi, B. 1997 The
Crystal Structure of a Parallel-Stranded Guanine Tetraplex at 0.95 Angstrom
Resolution. J. Mol. Bioi. 273, 171-182.
19. Hud, N. V., Sklenar, V. & Feigon, J. 1999 Localization of Ammonium lone in
the Minor Groove of DNA Duplexes in Solution and the Origin of DNA A-tract
Bending. J. Mol. Bioi. 286,651-660.
20. Wang, Y. & Patel, D. J. 1993 Solution Structure of a Parallel-Stranded G-
Quadruplex DNA. J. Mol. Bioi. 234, 1171-1183.
21. Kang, C., Zhang, X. H., Ratliff, R., Moyzis, R. & Rich, A. 1992 Crystal-
Structure of Four-Stranded Oxytricha Telomeric DNA. Nature 356, 126-131.
22. Wang, Y. & Patel, D. J. 1993 Solution Structure of the Human Telomeric Repeat
d[AG3(T2AG3hl G-Tetraplex. Structure 1, 263-282.
23. Gupta, G., Garcia, A. E., Guo, Q., Lu, M. & Kallenbach, N. R. 1993 Structure of
a Parallel-Stranded Tetramer of the Oxytricha Telomeric DNA-Sequence
d(T4G4}.Biochemistry 32, 7098-7103.
24. Aboulela, F., Murchie, A. I.H., Norman, D. G. & Lilley, D. M. 1. 1994 Solution
Structure ofa Parallel-Stranded Tetraplex Formed by d(TG4T) in the Presence of
Sodium-Ions by Nuclear-Magnetic- Resonance Spectroscopy. J. Mol. Bioi. 243,
458-471.
25. Cheong, C. J. & Moore, P. B. 1992 Solution Structure of an Unusually Stable
Rna Tetraplex Containing G-Quartet and U-Quartet Structures. Biochemistry 31,
8406-8414.
Investigations into the structure of quadruplex DNA 183
26. Venczel, E. A. & Sen, D. 1993 Parallel and Antiparallel G-DNA Structures from
a Complex Telomeric Sequence. Biochemistry 32, 6220-6228.
27. Patel, P. K. & Hosur, R. V. 1999 NMR Observation of T-tetrads in a Parallel
Stranded DNA Quadruplex Formed by Saccharomyces Cerevisiae Telomere
Repeats. Nucleic Acids Res. 27,2457-2464.
28. Patel, P. K., Koti, A. S. R. & Hosur, R. V. 1999 NMR Studies on Truncated
Sequences of Human Telomeric DNA: Observation of a Novel A-tetrad. Nucleic
Acids Res. 27, 3836-3843.
29. Cantor, C.R., Warshaw, M.M. & Shapiro, H. 1970 Oligonucleotide Interactions
III. Circular Dichroism Studies of the Conformation of Deoxyoligonucleotides.
Biopolymers 9, 1059-1077.
30. Baleja, J. D., Moult, J. & Sykes, B. D. 1990 Distance Measurement and Structure
Refinement with NOE Data. J. Magn. Res. 87,375-384.
31. Koradi, R., Billeter, M. & Wuthrich, K. 1996 MOLMOL: A Program for Display
and Analysis of Macromolecular Structures. J. Mol. Graph. 14, 51-55.
32. Case, D.A., Pearlman, D.A., Caldwell, lW., Cheatham III, T.E., Ross, W.S.,
Simmerling, C.L., Darden, T.L., Marz, K.M., Stanton, R.V., Cheng, A.L.,
Vincent, J.J., Crowley, M., Tsui, V., Radmer, R.J., Duan, Y., Pitera, J., Massova,
I., Seibel, G.L., Dingh, U.C., Weiner, P.K. & Kollman, P.A. (1999) AMBER 6,
University of California, San Francisco.
33. Cheatham, T. E., Cieplak, P. & Kollman, P. A. 1999 A Modified Version of the
Cornell et al. Force field with Improved Sugar Pucker Phases and Helical Repeat.
J. Biomol. Struct. Dyn. 16, 845-862.
34. Cheatham, T. E., Miller, J. L., Fox, T., Darden, T. A. & Kollman, P. A. 1995
Molecular-Dynamics Simulations on Solvated Biomolecular Systems - The
Particle Mesh Ewald Method Leads to Stable Trajectories of DNA, RNA, and
Proteins. J. Am. Chem. Soc. 117,4193-4194.
35. Lavery, R. & Sklenar, H. 1989 Defining the Structure oflrregular Nucleic-Acids
- Conventions and Principles. J. Biomol. Struct. Dyn. 6, 655-667.
36. Wang, Y. & Patel, D. J. 1992 Guanine Residues in d(T2AG3) and d(T2G4) Form
Parallel-Stranded Potassium Cation Stabilized G-Quadruplexes with
Antiglycosidic Torsion Angles in Solution. Biochemistry 31,8112-8119.
37. Wang, Y., Delossantos, C., Gao, X. L., Greene, K., Live, D. & Patel, D. J. 1991
Multinuclear Nuclear-Magnetic-Resonance Studies of Na + Cation - Stabilized
Investigations into the structure of quadruplex DNA 184
Complex Formed by d(GGTITTCGG) in Solution - Implications for G-Tetrad
Structures. J. Mol. Bioi. 222, 819-832.
38. Wijk, V. J., Huckriede, B.D., Ippel, I.H, Altona, C. 1992 Furanose Sugar
Conformations in DNA from NMR Coupling Constants Methods Enzymol. 211,
286-306.
39. Strahan, G. D., Keniry, M. A. & Shafer, R. H. 1998 NMR Structure Refinement
and Dynamics of the K+- d(G3T4G3)2 Quadruplex via Particle Mesh Ewald
Molecular Dynamics Simulations. Biophys. J. 75,968-981.
40. lin, R. Z., Gaffney, B. L., Wang, C., Jones, R. A. & Breslauer, K. J. 1992
Thermodynamics and Structure of a DNA Tetraplex - A Spectroscopic and
Calorimetric Study of the Tetramolecular Complexes of d(TG3T) and
d(TG3T2G3T). Proc. Natl. Acad. Sci. U. S. A. 89,8832-8836.
41. Marathias, V. M. & Bolton, P. H. 2000 Structures of the Potassium-Saturated,
2: 1, and Intermediate, 1:1, Forms of a Qudruplex DNA. Nucleic Acids Res. 28,
1967-1977.
6. Recognition and stabilisation of quadruplex
DNA by a potent new telomerase inhibitor
6.1 Introduction
Telomeres are repetitive DNA sequences at the ends of linear chromosomes
that protect the chromosome from recombination, end-to-end fusion and nuclease
degradation (1,2). In human cells the telomeric DNA is typically composed of 5-15
kb of double stranded pairs of tandem repeats of guanine rich sequences TTAGGG
with a single stranded 3' -end overhang necessary to ensure complete chromosomal
DNA replication. With each cell division, telomeres shorten by 50-200 base pairs
because synthesis of the lagging strand of DNA is unable to replicate the 3' -end
overhang (3,4). Thus, when the telomeres of normal cells shorten to a critical length
the cells stop growing and enter a state of senescence (5). At the stage of senescence
where telomeres are critically short, end-to-end fusion and chromosomal instability
leads to cell death. A cell can escape from this normal cycle and become immortal
by stabilising the length of its telomeres. This happens almost always under
activation of the telomerase enzyme (6).
Telomerase is a ribonucleoprotein that is responsible for adding telomeric
repeats TTAGGG and maintaining the length of the 3' -ends of chromosomes. The
major components. of telomerase are an endogenous RNA template (hRN) that
contains an 11bp sequence and acts as the template for addition of telomeric repeats
to the chromosome and also a reverse transcriptase component (hTERT) that
catalyses the addition of telomeric repeats (7-9). All human somatic cells contain
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the hRNA template but lack the hTERT that activates telomerase (8). Telomerase is
active in 85-90% of all human tumours but not in adjacent normal cells (6). It has
been suggested that tumour cells have unlimited proliferative potential beyond the
limits of the senescence cell state by activating the telomerase mechanism.
Consequently, telomerase has become a high profile target for the development of
novel anti-cancer agents (10-12).
It is well established that the endogenous RNA template region of the
telomerase requires a single-stranded, non-folded telomeric DNA primer for the
effective addition of the telomeric repeats (7-9). However, G-rich telomeric repeats
are able to assemble into novel four-stranded quadruplex structures consisting of
guanine tetrads and stabilised by monocovalent cations (Na+ and K+) (13-16).
Initially Zahler and co-workers showed that inhibition of telomerase activity was
possible through G-quadruplex stabilisation by K+ (17). Later, it was suggested that
formation of the G-quadruplex DNA is involved in the dissociation of the primer
from the RNA template. Experimental data indicated that incorporation of a 7-
deaza-dGTP nucleoside analogue instead of dGTP into the telomeric DNA primer
d(TTAGGG) was involved in telomerase inhibition, as the nucleoside analogue lacks
the N7 atom that is essential for the formation of G-quadruplex structure (18). Thus,
small molecules that bind and stabilise the folded quadruplex DNA structure
selectively over duplex DNA are potent telomerase inhibitors, with low levels of
general cytotoxicity. The distinct geometrical features of G-quadruplex DNA such
as four grooves and a channel of negative electrostatic potential can allow specific
recognition by small ligands, which either intercalate at GpG steps or at the ends at
XpG, GpX steps, or even bind to the grooves (10-12).
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Considering the high anti-tumour potential of ligands with the capability of
G-quadruplex stabilisation, several research groups have focused on structure-based
design approaches to the development of compounds that interact with G-
quadruplexes. Up to now, a number of compounds have been synthesised with
common feature of an extended aromatic ring system that is capable of interacting
with G-tetrads and have shown telomerase inhibition through the stabilisation of G-
quadruplexes, figure 6.1. Recently, dibenzophenanthroline derivatives (19) and 3, 6,
9 tri-substituted acridine inhibitors (20) were reported to inhibit telomerase action in
tumour cell lines with ICso values of up to 28 nM and 60 nM, respectively.
Inhibition by these compounds is correlated to selective stabilisation of the human
DNA quadruplex structure, as demonstrated by fluorescence resonance energy
transfer and surface plasmon resonance experiments, respectively. Other compounds
have also been reported to inhibit telomerase activity with smaller ICso values such
as tetra-(N-methyl-4-pyridyl) and tetra-(N-methyl-2-pyridyl) porphyrin compounds
(21, 22), 2,6-disubstituted anthraquinones (23), 2,7-disubstituted fluorenones (24),
and a dicationic perylene tetracarboxylic diimide derivative, abbreviated PIPER (25).
By using absorption or circular dichroism and NMR spectroscopy 2,6
diamidoanthraquinone, (N-methyl-pyridyl) porphyrins and the perylene derivative
(PIPER) have been shown to bind and stabilise parallel or anti-parallel G-quadruplex
structures.
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Figure 6.1Active telomeraseinhibitorsby interactionwithG-quadruplexDNA.
It is well demonstrated that such ligands bind to guadruplex DNA and that
this interaction is associated with telomerase inhibition. The spectroscopic data
suggest that such ligands intercalate externally to the surface of G-tetrads rather than
intercalate between the stacks of the G-tetrads. However, there is one exceptional
study that suggests intercalation of tetra-(N-methyl-2-pyridyl) porphyrin between the
G-tetrads based on calorimetric (ITC) and spectroscopic data (26). The same
porphyrin derivative was examined by an electrophoretic photocleavage assay (21),
and NMR, UV spectroscopy (22), but these data are consistent with the ligands
bound externally to the G-tetrads. Molecular modelling studies show that ligands are
able to form stable complexes by either intercalating or end-stacking with G-tetrads
adding weight to this controversy (26,27). There has been a paucity of detailed
structural data available on drug-quadruplex DNA complexes due to intractable
NMR spectra arising from extensive drug-induced line broadening. The only
structural data to date is of the NMR structure of the PIPER-quadruplex complex,
which forms either a sandwich complex bound between the blunt ends of a
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quadruplex dimer formed from d(TTAGGG)4, or intercalates by end-stacking at the
GpT step of d(TAGGGTTA)4 (25). However, more detailed structural studies are
required to establish where these G-quadruplex stabilising agents are actually located
within a drug-quadruplex DNA complex, and if there is indeed a universal mode of
binding with quadruplex DNA or whether intercalation between G-tetrads is also
possible.
Here we describe the interaction and stabilisation of quadruplex DNA by a
novel fluorinated polycyclic methylacridinium cation RHPS4 (figure 6.2), which
shows enhanced binding to higher-ordered DNA structures (triplex/quadruplex) over
duplex and single stranded DNA as measured by differential dialysis (28). RHPS4
has been shown to induce telomere shortening with an ICsovalue of 0.33 J.tM,while
decreasing tumour cell proliferation of breast 2INT cells at concentrations as low as
0.2 J.tM(29). RHPS4 is weakly cytotoxic (mean Glso value in the NCI 60 human
tumour cell panel is 13.18 J.tM),giving a therapeutic index (GIs()'1Cso) of 40 (28).
This activity does not appear to be associated with Taq polymerase and
topoisomerase II inhibition, strongly suggesting that RHPS4 is an inhibitor of
telomerase function. To investigate structural details of the drug-quadruplex
interaction, as part of future rational design processes, we have studied by NMR the
RHPS4 complex with the intermolecular parallel-stranded quadruplex
d(TTAGGGT)4, formed from the human telomeric repeat, figure 6.3. In addition,
this study represents one of a very limited number of drug-quadruplex DNA
structures so far characterized and provides new insights in the understanding of the
binding mode of such quadruplex stabilising agents.
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Figure 6.2 Structure of the RHPS4 compound with atom numbering scheme.
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Figure 6.3 Scheme of the intermolecular quadrulex d(TTAGGGT)4 showing potential sites
of intercalation at ApO, GpO and GpT sites.
6.2 Materials and Methods
6.2.1 Sample preparation
Preparation of the d(TT AGGGT)4 sample was described in section 5.2.1 of
chapter S. RHPS4 (3,II-Difluoro-6,8,13,-trimethyl-8H-quino[4,3,2,-kl]acridiniurn
methosulfate) was synthesized and purified by Robert Heald of the Cancer Research
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Laboratories in Nottingham following the described procedures (28). RHPS4 was
used without further purification after checking its purity by IH NMR. The
RHPS4-quadruplex complex was formed by titrating small aliquots of drug (-5 mM
solution) into a solution of the d(TTAGGGT)4 in 90% H20, 10% 020, containing
concentrations of 100 mM KCI, 10 mM K2HP04 and 1 mM EOTA at pH=7.0.
Titration experiment was carried out at 30 °C where the spectrum of the free
quadruplex is well resolved from the resonances of the single-stranded
d(TTAGGGT).
6.2.2 NMR experiments
All 'H NMR spectra were recorded at 500 MHz on a Bruker Avance ORX-
500 spectrometer and processed on R4600PC and RSOOOSCSilicon Graphics Indy
Workstations using Bruker X-WinNMR v2.6 software. Standard phase sensitive 20
NMR pulse sequences were used to obtain NOESY, TOCSY, OQF-COSY spectra in
020 and WATERGATE NOESY in 90% H20, 10% 020 solution. One dimensional
NMR experiments were recorded over 16000 data points in h for each 400-512
points in t, with spectral width of20000 Hz and a delay time of 1.5 s, at temperatures
between 5-85 °C. NOESY spectra at various mixing times 400 ms, 300 ms, 200 ms,
150 ms, 100 ms, were recorded over 2048 data points in hand 400-512 points in t,
with 64 transients for each, with spectral width of 10000 Hz and a delay time of 1.5
s, at temperature 30-45 °C. TOCSY using 75 ms spin lock and DQF-COSY were
recorded over 2048 data points in t2 and 400-512 points in t, with 48 transients for
each with spectral width of 10000 Hz and a delay time of 1.5 s, at temperature 45 °C.
WATERGATE-NOESY spectra at 300 ms, 200 ms, and 100 ms mixing times were
acquired using a sample in 90% H20 and 10% 020 solution over 2048 data points in
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12and 400-512 points in tl with 64 transients for each, and employed a 20,000 Hz
spectral width and a delay time of 1.5 s, at temperature 30-45 cC.
6.2.3 NMR restraints
A set of 668 NOE restraints (161 per strand and 24 for both RHPS4
molecules) for non-exchangeable, exchangeable and intermolecular drug-quadruplex
protons were determined from NOE cross-peak integration in 500 MHz NOESY
spectra collected at 318 K. Volume integrals were normalised to several fixed
reference distances within the DNA structure including deoxyribose H2'-H2" (1.85
A) and thymine CHrH6 (3.00 A). Distances were estimated from data at a number
of mixing times 100-200 ms in D20 and H20 solutions using linear regression to
extrapolate to 0 ms mixing time (30). As a consequence of the four-fold symmetry
of the quadruplex in solution, the set of NOEs assigned were quadrupled for each
strand. Distances calculated from the extrapolation method were assigned as strong
(1.8-3.0 A) medium (2.5-4.0 A) and weak (3.5-5.5 A). Interproton distances
involving exchangeable protons and also intermolecular NOEs between drug
molecules and quadruplex were given wider constraints to the range of 2.5-5.0 A.
No restraints corresponding to the ideal hydrogen-hond geometry were included
during structure calculations as a way to test the drug hinding effect on hydrogen-
bonding potential between the purine nucleotides. Distance restraints were checked
against energy-minimized structure for large geometrical inconsistencies using
MolMol (31). The highly dynamic nature of the RHPS4-quadruplex complex
precludes a high-resolution structural characterisation and no further effort was
extended to calculate more accurate distance restraints and force the structure to a
possible improper determination.
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6.2.4 Structure calculations
Energy minimisations and restrained molecular dynamics calculations were
performed on an Origin 200 Silicon Graphics Server using the AMBER 6 suite (32)
of programs employing the AMBER 95 force field with modifications (33) and
Particle Mesh Ewald (PME) (34) method for the treatment of long-range
electrostatics. The starting model of the RHPS4-quadruplex complex was generated
by using an average energy-minimised d(IT AGGGT)4 structure. Firstly, the binding
sites of the quadruplex were constructed by moving apart the ITA segment and 3'-
end thymine nucleotides from the G-tetrads to a separation distance of 6.5 A, using
the LEAP module of the AMBER 6 suite of programs. This manual generation of
the binding sites resulted in several violations of the phosphate backbone geometry,
which were corrected after a careful minimisation and equilibration of the structure.
The drug molecules were manually docked between A3-G4 and G6- T7 steps with
orientations according to the set of drug-quadruplex NOE restraints. The molecular
structure of the RIIPS4 was constructed and minimised using the Macromodel
software. The partial charges of the RHPS4 (appendix 3.3) were derived using the
IIF/6-31 G(d)/RESP methodology (35). Force field parameters for the atom types of
the drug were adapted from comparable standard parameters within the AMBER
parameter set pann98.dat.
The structure of the RHPS4-d(IT AGGGT)4 complex was solvated in a
periodic TIP3 water box of approximate dimensions 60 A x 60 A x 60 A, which
extended to a distance of loA from any solute atom and contained 5000 water
molecules. Two internal potassium ions K+, using standard parameters for the
AMBER force field, were manually positioned in the central channel between
adjacent G-quartets. The potassium ions were positioned equidistantly to two
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adjacent G-quartets to allow octahedral coordination with their four polarized
carbonyl oxygen 06 atoms. The quadruplex system was neutralized with 20
potassium ions placed at the most negative locations with the LEAP module. All the
potassium ions were treated as part of the solvent.
The drug-quadruplex system was allowed to equilibrate fully before we
performed restrained molecular dynamics. Minimisation was performed with 50
steps of steepest descent and 5000 steps of conjugate gradient on the water and
counterions first, with the d(TT AGGGT)4 coordinates frozen, followed by a further
5000 steps on all the components of the system. Next, 10 ps unrestrained molecular
dynamics were run at 100 K on the water alone with the DNA and potassium ions
constrained, followed by another lOps to allow the potassium ions to move. In the
following 5 ps of dynamics the temperature of the system was increased from 100 K
to 300 K. At this point the set of drug-quadruplex NOE restraints were introduced
gradually in the form of square well potentials with a force constant of 30 kcal mol"
A"2 in lOps. NOE restraints were assigned manually to specific bases within a given
tetrad and according to the orientation of the drug within binding sites. In the next
runs, each of them of lOps dynamics, the DNA force constant is gradually reduced
from 100 to SO, 25, 10, 5, and 2.5 kcal mol" A"2. Restrained molecular dynamics for
100 ps with the whole set of NOE restraints were followed with the drug and
d(TT AGGGT). fully free. Snapshots from the simulation were extracted at each
picosecond. In parallel, unrestrained molecular dynamics of the equilibrated
drug-quadruplex system were carried out in order to access the impact of the
restraints in the structure of the complex. The average structures and the RMSDs
from the averages structure were calculated using CARNAL module of AMBER
suite.
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6.3 Results and Discussion
6.3.1 ID NMR titration and spectral features
Although there have been a number of intermolecular and intramolecular G-
quadruplexes structures determined so far by NMR spectroscopy, the nature of
drug-quadruplex complexes previously studied made their detailed structural
characterisation extremely difficult. We have chosen to study the interaction of
RHPS4 with the parallel intermolecular quadruplex d(TTAGGGT)4 that contains the
human telomeric repeat and gives well resolved NMR spectra. We have previously
determined the III chemical shifts of the free quadruplex d(TTAGGGT)4 following
standard sequential assignment procedures via NOESY and TOCSY spectra (chapter
5).
RIIPS4 was titrated with the quadruplex d(TTAGGGT)4 at 303 K in 90%
}hO solution and the titration was followed by ID IH-NMR spectra as shown in
figure 6.4. The resonances of guanine imino protons between 10-12 ppm are good
probes to follow the titration as they are well separated from the crowded regions of
the non-exchangeable protons. Titration up to drug:quadruplex ratio of 1:1 causes a
shifting upfield and broadening of the guanine imino protons to base line. In other
regions of the spectrum such as the aromatic and thymine methyl regions new
resonances appear, however there is also a line broadening effect that prevents us
from following the new peaks arising. Titrating the drug beyond this point up to a
2: I ratio produces a new set of resonances that are much sharper and appreciable
shifted by up to 0.9 ppm, however the G4 imino protons remain exchange broadened.
Titration of the RHPS4 up to 2: I titration generally induces a sharper
spectrum that is better resolved, however there are still some broadening effects,
which does not allow us to attribute the number of resonances to a single species in
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the solution. There is also the possibility that there are still some resonances from
the single stranded form of the d(Tf AGGGT) present in the solution. The methyl
protons of the drug are easily distinguished, but most of the aromatic proton
resonances are overlapped with the aromatic peaks of the bound quadruplex. A
reasonable explanation for the observed data is that the drug binds to the quadruplex
d(Tf AGGGT)4 in a number of possible bound conformations in intermediate
exchange or binds to a number of sites with similar affinity. The different
broadening of the imino proton resonances of G4 versus G6 suggests different drug
mobility at different sites. Binding of the asymmetric RHPS4 in slow exchange in
either of the bound conformations would lift the symmetry of the quadruplex
structure contributing to the line broadening.
10 III-NMR spectra at various temperatures also suggest that the drug is in
intermediate exchange, figure 6.S. The number of proton resonances at temperatures
below 303 K cannot account for a single symmetrical 2: 1 complex. In addition,
NOESY spectra of the complex at low temperatures are less informative due to
dispersion of the NOE signal among different conformations. At temperatures above
303 K lines sharpen progressively indicating that the drug is in faster exchange on
the NMR time scale.
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Figure 6.5 ID IH-NMR spectra of 2: I RHPS4-d(TT AGGGT)4 complex at various
temperatures.
The spectrum at 318 K was generally of superior quality and the number of
peaks in the aromatic region corresponds to a single set of quadruplex resonances. In
addition, at 318 K, we can easily identify the resonances of the aromatic and methyl
protons of the bound RHPS4. Thus, 20 NMR data of the 2:1 drug-quadruplex were
collected at this temperature. The effect of RHPS4 on quadruplex stability is clearly
evident from the intensity of the guanine imino proton resonances. Guanine imino
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melted. However, imino but also aromatic and methyl resonances are still visible in
the drug complex at temperatures up to 353 K, figure 6.6. This difference in melting
temperature of at least 20°C indicates a strong stabilisation.
a)
b)
11 10 9 ppm
Figure 6.610 NMR data recorded in 90% H20 solution showing the melting of the guanine
imino proton resonances for G4, G5 and G6 and aromatic protons of the a) free
d(TTAGGGT)4 at 333 K and b) 2:1 complex RHPS4-d(TTAGGGT)4at 353 K.
6.3.2 NMR analysis of the 2: 1 complex
The single set of drug resonances recorded at 318 K indicates a fast exchange
between different orientations within the binding sites. Chemical shifts of drug
protons were readily assigned via a combination ofNOESY and TOCSY (figure 6.7)
experiments at 318 K. A full set of RHPS4 proton assignments is found in the
Appendix 1.10. A set of 24 intermolecular NOEs (table 6.1) of drug-quadruplex
interactions were identified and used to pinpoint the drug binding sites (figure 6.8).
By far, the largest number of NOEs involves the base and sugar protons of G4 and
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06, while no NOEs are identified to 05 at the centre of the O-tetrads stack. The
latter excludes any possibility of drug molecules intercalated between the 05-06
step. NOEs are detected at the A3-04 step to both purine nucleotides indicating that
the ApO step is a primary intercalation site. A number of NOEs to 06 show that the
drug also inserts, but to a lesser extent, at the 06- T7 step, however, no NOEs are
observed to T7 despite the perturbations to its chemical shifts. Two very strong
NOEs from the drug 8-CH3 to 04 NH and 06 NH show that end stacking on the 0-
quadruplex is energetically very favourable. NOEs from drug 8-CH3 and 13-CH3 to
04 H8 and G6 H8 and from drug H5, H7, H9, HIO, HI and HI2 protons to a number
of DNA base and sugar protons position the edges of the acridine ligand in the
grooves. A number ofNOE cross peaks between RHPS4 and protons of04, 06, and
A3 are shown in figure 6.9.
ppm
HIO-H9 _. ~
7.2
7.4
7.6
7.8
7.8 7.7 7.6 7.5 7.4 7.3 7.2 7.1 ppm
Figure 6.7 Portion of the TOCSY spectrum of the 2: I RHPS4-d(TT AGGGT)4 complex in
H20 solution, recorded at 318 K with mixing time 75 ms, showing the assignment of cross
coupling interactions within RHPS4.
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Table 6.1 The set of 24 intermolecular NOEs between RHPS4 molecules and A3, G4 and
G6 nuc1eotides of the quadruplex structure d(TTAGGGT)4 used in structure calculations.
RHPS4/nucleotide A3 G4 G6
6-Me H8 H3'
8-Me HI', H8 HI', H8, NH Ht', H8, NH
13-Me H8,NH H8,NH
H5 H4' H2'/H2"
H7 H2'/H2" HS' H2'/H2"
H9 H4', HS'
HI0/HI2 H2'/H2" NH NH
a)
b)
T T
T
T
Figure 6.8 Schematic representations of selected intermolecular NOEs between RHPS4 and
a) A3-G4 step and b) G6-T7 step.
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Figure 6.9 Portion of the 250 ms NOESY spectrum of the 2:1 RHPS4-d(TTAGGGT)4
complex recorded at 318 K highlighting a number of key NOEs. In the top panel, NOEs
labelled TI through to T7 represent intranucleotide base H6 or H8 to deoxyribose H2'1H2".
Dashed horizontal lines highlight intemucleotide NOE connectivities. Thymine methyl to
H6 NOEs are also assigned. Key drug-DNA NOEs are labelled a-j as follows: (a) 6-Me-
G4H8, (b) H7-G6H2'/H2", (c) H5-G6H2'1H2", (d) HIO or HI2-A3H2'1H2", (e)
H7-A3H2'/H2", lower panel; (t) 8-Me-A3H8, (g) 8-Me-G4H8, (h) 8-Me-G6H8, (i) 13-
Me-G4H8, and U) 13-Me-G6H81T7H6. RHPS4 numbering scheme is shown in figure 6.2.
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NOESY experiments at several mixing times (400-100 ms) were recorded on
the 2:1 RHPS~(TTAGGGT)4 complex at temperatures of318 K (figure 6.10) and
303 K in H20 and 020 solutions. Expanded regions A and B of the NOESY
spectrum of the complex in 020 solution showing H81H6-Hl' and H8/H6-H3' NOE
connectivities, recorded at 200 ms mixing time and 318 K are plotted in figure 6.11.
At 318 K, the intermolecular bound quadruplex structure retains a four-folded
symmetry and NOE signals for each strand are equivalent. Almost all NOE
connectivities can be followed between the non-exchangeable protons such as
H8/H6-H l' and H8/H6-H2' 1H2" along the sequence, allowing us to determine the
chemical shifts of all the protons already assigned for the free quadruplex
d(TTAGGGT)4. We also observe NOEs between base protons H8/H6 and its own
and 5' flanking sugar protons H2' /H2" and H3' as they are observed in free
quadruplex NOESY spectrum. While some of the NOE cross peaks concerning
thymine nucleotides are weak, the NOE cross peaks between guanines are strong and
show that they stack very well with each other. The effect of ligand binding on line
widths means that some weak NOEs observed in the free quadruplex are difficult to
detect in the bound state. Thus, there a few examples of NOEs that are not observed
in the bound state of the quadruplex d(TTAGGGT)4 such as the Hl'-H6 proton
connectivity between Tl- T2, T2-A3 and G6- T7 residues and also NOEs between
aromatic H8-H8 or H8-H6 protons.
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Figure 6.11 Expansions A and B of the 200 ms NOESY spectrum of the 2:1
RHPS4-d(TTAGGGT)4 complex in D20 recorded at 318 K, highlighting sequential
intranucleotide and internucleotide connectivities between base H8 or H6 to deoxyribose HI'
and H3' protons.
Sequential NOE connectivities along the TTA segment of the quadruplex
appear weak indicating weak stacking interactions between these nucleotides. In
addition, as in the free state, thymine imino protons of the bound quadruplex DNA
are not detected at temperatures above 283 K suggesting again that drug binding does
not stabilise the relatively loose conformation of the quadruplex at the 5' -end. The
differences in chemical shifts of non-exchangeable protons between the bound (2: 1
complex) and the free quadruplex d(TTAGGGT)4, show that the thymines Tl and T2
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are unperturbed by ligand binding. However, the base H6 and CH3 protons of T7
shift by 0.2 and 0.35 ppm, respectively. Proton resonances of the purine residues of
the quadruplex show only a small peturbation -0.1 ppm. Thus, the NOE
connectivities suggest that drug binding between the A3-G4 and G6- T7 sites
stabilizes mainly the core (GGG)4 quadruplex. Thymine nucleotides show no
evidence of T-tetrad formation or good stacking interactions and should have a
similar "loose" conformation as in the free quadruplex. A full set of DNA
assignments is found in the appendix 1.7.
Free quadruplex NOESY spectra in H20 solution showed all the NOEs
expected from the guanine imino and adenine amino protons that suggest alignment
of the residues in hydrogen-bonded tetrads. Guanine imino and adenine amino
protons of the AGGG segment are visible in the bound state and also have a high
melting temperature suggesting that the purine nucleotides form hydrogen-bonded
tetrads, even at the temperature of 318 K. Specifically, the 4-NH2 group of A3 is still
visible and stabilised against exchange, as well as being upfield shifted by 0.4 ppm,
suggesting that the A-tetrad is still intact in the drug complex. However, we could
not observe NOEs from the adenine residues between the amino NH2 protons and
base H2 proton that indicated A-tetrad formation in the free quadruplex state, nor do
we observe particularly strong NOEs with the drug protons. This is likely to arise
partly from the drug binding effect on line widths, but also due to dynamic effects of
the adenine residues caused by poorer stacking interactions with the x-system of the
drug compared to G4-tetrad.
In NOESY spectra in H20 solution (figure 6.12) we observe NOEs between
G4NH-G5NH, G5NH-G6NH, G6NH-G6H8, G6NH-G5H8, G5NH-G5H8 but do
not observe G5NH-G4H8, G4NH-G4H8 and also A3H8-G4NH, A3H2-G4NH.
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The last two NOEs should not be visible if drug intercalates between A3-G4 tetrads,
however, the sequential NOE pathway between guanine imino protons and base H8
protons in the AGGG segment is disrupted in the bound state because of the
extensive line broadening of the G4 imino proton. Localisation of line broadening
and unseen NOEs for A3 and G4 amino and imino protons, respectively, is an
indication that these nucleotides are most affected by drug binding. This strongly
suggests that the A3-G4 step is the primary intercalation site for RHPS4.
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Figure 6.12 Expanded region of the NOESY spectrum of the 2:1 RHPS4-d(TTAGGGT)4
complex in H20 solution, recorded at 318 K with mixing time 300 ms. NOEs labelled (a) -
(e) are assigned as: (a) G6NH-G6H8, (b) G6NH-G5H8, (c) G6NH-HI0IHI2, (d)
G5NH-G5H8, (c) G4NH-HIOIH12.
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The NMR titration spectra suggest that the drug complex is highly dynamic
with the ligand in intermediate exchange between different bound orientations at
room temperature. At higher temperatures (>318 K) the ligand is in faster exchange
with all possible orientations contributing to an average NOE intensity. The NOE
data clearly show that the ligand interacts with A3-G4 and G6- T7 steps and that the
RHPS4 complex is stabilised through extensive x-stacking with the G-tetrads. In
addition, NOE cross peak patterns suggest that ligand binding leaves the structure of
the G-tetrads largely unperturbed, nor are there significant conformational changes to
the rest of the quadruplex structure. In the complex of PIPER with d(TAGGGTTA)4,
formation of the 1:1 complex appears to favour end-stacking at the GpT step rather
than the ApG step which the authors attribute to the difficulty of disrupting the
stronger base stacking between purine tetrads (25). In contrast, in our complex
RHPS4 binding to both the GpT and ApG step appears to be energetically favourable
and RHPS4 appears to show relatively little discrimination between these two
intercalation sites. Our data suggest that end-stacking on the G-tetrads significantly
stabilises the quadruplex structure (~Tm >20 DC) even though the conformation of
the terminal thymine and adenine nuc1eotides appears to be reasonably dynamic.
The reported studies of the PIPER complex similarly observe fast exchange of the
ligand between different bound conformations while the core (GGG)4 structure of the
quadruplex remains unperturbed.
6.3.3 Molecular modelling of the 2: 1 complex
In order to extract structural information regarding the interaction of the
RHPS4 ligand with the distinct geometrical features of the d(TTAGGGT)4
quadruplex, we have carried out an MD approach using NOE restraints. Due to the
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asymmetry of the drug, some quadruplex resonances might be expected to be
multiplied upon drug binding however the single set of resonances observed
indicates a fast reorientation of the bound drug on the NMR time scale. The. four-
fold degeneracy of the quadruplex structure that is retained in solution at 318 K
complicates the determination of a unique solution structure since intermolecular
NOEs have to be assigned to specific nucleotides.
Based on the set of 24 drug-quadruplex NOEs, we have docked the drug
molecules at the A3-G4 and G6- T7 step with specific orientations in order to satisfy
the majority of the NOE restraints. Although we have modelled a single bound drug
conformation at the ApO and OpT intercalation sites, the dynamic nature of the
interaction, evident from IH (figure 6.5) and 19F (figure 6.13) temperature-dependent
line widths, does not preclude multiple interconverting conformations all of which
will contribute to the average NOE intensity. The analysis of NOEs from a single
DNA proton to several drug protons apparently remote from each other on the
acridine ring can arise from the drug rotating between the four equivalent stacked
conformations, though this is further complicated by the four-fold symmetry of the
quadruplex which makes each strand equivalent by NMR.
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Figure 6.13 19F ID NMR spectra at various temperatures illustrating the dependence in line
widths of the fluorine resonances for F3 and F11 fluorine atoms of the RHPS4 in the 2: 1
complex.
The initial structure of the complex had large geometrical violations arising
from the manual generation of the binding sites. A careful minimization and
equilbration of the structure was necessary. The equilibration was followed by lOOps
of NOE restrained MD simulation and energy minimisation. In the final energy-
minimised structure no restraint violations >0.3A were observed for the DNA,
however, 3 of the 24 drug-DNA NOEs were found to have distances over sA. The
majority of the drug-DNA NOEs is satisfied when the 8-CH3 and 6-CH3 groups of
the ligand are orientated towards the grooves and the l3-CH3 lies close to the central
ion channel of the quadruplex structure. The 1800 reorientation of the ligand having
the J3-CH3 pointing into the groove of the quadruplex structure is in accordance with
only a few drug-DNA NOEs, while most of the distances from the 8-CH3 and 6-CH3
and the aromatic protons to the quadruplex protons are found over sA. Thus, the set
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of drug-DNA NOEs suggest that there are a small number of more favourable
orientations for the drug. The low energy structure that satisfies the majority of the
distance restraints is shown in figure 6.14, with the partial positive charge on the
acridine 13-N acting as a pseudo potassium ion positioned above the centre of the G-
tetrad. In both ApG and GpT intercalation sites, the drug is seen to converge to the
same orientation while the n-system of the drug is seen to overlap with two bases of
each G-tetrad. The overlap between the 1t-systemof the drug and the complementary
G-tetrad of G4 and G6 (figure 6.15), suggests several key positions around the
acridine ring such as the position of the two fluorine atoms that may provide future
points for ligand substitution to enhance quadruplex affinity and specificity through
interactions in the grooves.
The structure of the RHPS4 complex shown in figure 6.14, which lacks
thymine nucleotides of the 5' end for clarification, has anti conformations for all
nucleotides and right-handed helical backbone geometry for each strand. The
guanine residues appear to have an almost planar conformation and stack on top of
each other while Hoogsteen NI-06 and N2-N7 hydrogen bonds maintain well-
difined G-tetrads. The adenine nucleotides are less stable than the guanines because
of only partial stacking interactions with the n-system of the drug. Significant
flexibility of the thymine nucleotides at the 5' end of the quadruplex structure is
observed, giving rise to a disordered conformation throughout the trajectory, as in the
unbound state.
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Figure 6.14 Structure of the 2: I complex with d(TTA *GGG*T)4 showing the AGGGT core
(for clarity) with RHPS4 intercalated at the A3-G4 and G6- T7 sites.
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Igure 6.15 The no tacking of the RHPS4 with the (a) G4 and (b) G6 tetrads showing the
orientation with re pect to the various grooves.
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Analysis of the unrestrained molecular dynamics simulation of the complex
over 1000 ps show that the structure (AGGG)4 remains largely unchanged from the
NMR-derived minimised structure. This RMSDs between the starting NMR
structure and those calculated from dynamics is 1.73 ± 0.16 A for (AGGG)4 and 2.63
± 0.38 A for all heavy atoms of (TTAGGGT)4. Variation of the NI-N6, NI-06 and
N2-N7 Hoogsteen hydrogen-bond distances for A-tetrad and G-tetrads during the
1000 ps of the simulation is plotted in figure 6.16. Variation of the hydrogen bonds
for the G-tetrads is not significant and within the limits of acceptable hydrogen-bond
distance, while the hydrogen-bond distance of NI-N6 shows more flexibility and
suggests a significant breathing of the A-tetrad structure. Average values of
Hoogsteen hydrogen bonds of G-tetrads (table 6.2) show no significant difference
compared to the free quadruplex structure (table 5.3). In contrast, the average
NI-N6 distance of A-tetrad is increased -0.35 A. Thus, the data suggest that
RHPS4 binding stabilises the core (GGG)4 quadruplex structure and while the A-
tetrad is less stable than in the unbound state, the overall effect of binding is
favourable.
Table 6.2 Average hydrogen-bond distances and standard deviation (parentheses) for core
quadruplcx (AGGG)4'
Residue N7-N2 H-bond NI-06 H-bond NI-N6 H-bond
G4 3.04 (0.15) 3.03 (0.15)
G5 2.99 (0.13) 2.99 (0.13)
G6 2.98 (0.13) 2.98 (0.13)
A3 3.46 (0.23)
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Figure 6.16 Variation of the Nl-N6 and N2-N7 Hoogsteen hydrogen-bond distances in A
a) for A-tetrad b) for G-tetrads respectively during the 1000 ps of the simulation.
6.4 Conclusions
R cent detailed studies of cationic porphyrin-DNA quadruplex interactions
have suggested both GpG intercalation and violation of the neighbouring site
exclusion principle (26). In contrast, the perylenetetracarboxylic diimide intercalator
(PIPER) described by Federoff et al. (25), and the polycyclic methylacridinium
cation reported here, are unable to disrupt the G-tetrad core by insertion at a GpG
step with displacement of stabilising K+ ions. Instead, the drug forms complex-
stabilising interactions by stacking on the ends of the G-quadruplex. Such a process
is likely to be energetically favourable compared to interior stacking with the G-
tetrads requiring disruption of the extremely stable stacking interaction at the GpG
steps and displacement of the monocovalent cations from the central channel of the
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structure. In addition, the kinetics of disruption and opening of the G-tetrads by the
ligand would be expected to be slow due to large activation barriers. Similar
conclusions have been drawn from modelling studies of a disubstituted
anthraquinone (27), and a number of tri-substituted acridine derivatives with the
human intramolecular quadruplex where the drug is proposed to bind to the TTA
cross-over loop while end-stacking with a G-tetrad (20).
The fluorinated polycyclic methylacridinium cation RHPS4 is a potent
telomerase inhibitor as tested in tumour cell lines (29) and interacts selectively with
high order DNA structures. Here, it has been shown that RHPS4 forms a stable G-
quadruplex complex with d(TTAGGGT)4 by end-stacking externally to the G-
tetrads of the ApG and GpT steps. The NMR data clearly suggest that the RHPS4
complex is dynamic in nature with the drug bound in different orientations that are
exchanging on the NMR time scale. However, the set of intermolecular NOEs
assigned for the complex are most satisfied with the drug positioned as in figure
6.14, enabling us to suggest key positions where further substitution may enhance G-
quadruplex affinity and specificity. Synthetic studies towards addition of side chains
to the core structure of the RHPS4 are in progress in collaboration with the CRC
laboratories in Nottingham. The RHPS4-d(TT AGGGT)4 complex represents one of
a very limited number of drug-quadruplex structures so far characterised and
provides further support for the model that G-quadruplex stabilising ligands bind on
the exterior of the G-tetrads stack.
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Appendix 1
Appendix 1.1 IH chemical shifts of the d(CTTTTGCAAAAG)2 duplex at 298K.
HI' H2' H2" H3' H4' H6/H8 H5'/H5" H5/Me H2 NH
Cl 5.90 2.32 2.65 4.68 4.14 7.93 3.82/3.88 5.98
T2 6.25 2.33 2.68 4.95 4.29 7.70 4.20 1.71 13.70
T3 6.26 2.32 2.70 4.95 4.33 7.56 4.20 1.67 13.70
T4 6.14 2.19 2.66 4.94 4.25 7.51 4.14 1.71 13.85
T5 5.82 2.09 2.47 4.91 7.31 4.14 1.69 14.00
G6 5.78 2.61 2.65 4.97 4.35 7.86 4.09 12.58
C7 5.40 1.82 2.2 4.97 4.76 7.29 4.08 5.36
A8 5.70 2.68 2.79 5.00 4.32 8.17 4.15 7.14
A9 5.72 2.59 2.79 5.01 4.39 8.09 4.19 7.05
AIO 5.83 2.55 2.84 5.01 4.4 8.03 4.22 7.11
All 5.99 2.51 2.85 4.99 4.42 7.94 4.26 7.61
G12 5.97 2.28 2.31 4.98 4.59 7.50 4.18 14.29
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Appendix 1. IH chemical shifts of the d(GAAAAGCTITTC)2 duplex at 298K.
HI' H2' H2" H3' H4' H5'/H5" H6/H8 H5/Me H2 NH
Gl 5.50 2.40 2.60 4.80 4.15 3.65 7.84
A2 5.78 2.70 2.82 5.03 4.38 4.06/4.15 8.19 7.41
A3 5.80 2.59 2.82 5.03 4.41 4.19 8.09 7.17
A4 5.84 2.55 2.82 5.03 4.42 4.22 8.01 7.45
A5 5.94 2.50 2.82 5.01 4.41 4.22 7.91 7.13
G6 5.66 2.42 2.57 4.91 4.37 4.20/4.16 7.48
C7 5.86 2.05 2.49 4.68 4.23 4.1114.17 7.28 5.09
T8 6.01 2.21 2.61 4.88 4.23 4.11 7.46 1.53 12.75
T9 6.15 2.19 2.65 4.90 4.23 4.14 7.50 1.65 13.46
TIO 6.17 2.18 2.55 4.91 4.26 4.14 7.45 1.73 13.46
TIl 6.16 2.24 2.63 4.92 4.31 4.18 7.50 1.70 14.12
C12 6.27 2.28 2.56 4.58 4.21 4.05 7.63 5.80
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Appendix 1.3 IH chemical shifts for the DNA duplex of the 2:1
d(GAAAAGCTITTC)rH332S8 complex at 298K.
HI' H2' H2" H3' H4' HS'/HS" H6/H8 /HS/Me H2 NH
Cl 5.98 2.39 2.74 4.72 4.17 3.86/3.94 8.01 6.04
T2 6.53 2.30 2.71 4.98 4.37 4.13/4.19 7.73 1.80 14.74
T3 5.46 1.90 2.28 4.63 4.02 7.46 1.70 14.74
T4 5.09 1.66 2.13 4.47 3.36 7.14 1.51 13.90
TS 4.57 1.25 1.49 4.45 6.74 1.45 13.65
G6 5.73 2.59 2.56 4.35 4.12 7.80 12.65
C7 5.41 1.43 2.02 4.74 4.04 4.13 7.21
A8 5.44 2.82 2.82 5.05 4.35 3.94/4.07 8.31 7.22
A9 6.11 2.78 2.86 5.13 4.48 4.16/4.23 8.21 7.60
AID 5.45 2.12 2.56 4.67 3.86/4.08 7.91 7.94
All 5.09 1.94 2.31 4.54 3.70 2.80/2.92 7.61 8.28
G12 5.03 1.78 1.89 4.29 3.80 3.33 7.07 15.30
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Appendix 1.4 IH chemical shifts of the d(GTTTTGGCCAAAAC)2 duplex at 298K.
HI' H2' H2" H3' H4' H5'/H5" H6/H8 H5/Me H2 NH
Cl 5.78 2.29 2.59 4.62 4.06 3.78 7.83 5.88
T2 6.22 2.30 2.66 4.92 4.30 4.07 7.68 1.67 13.74
T3 6.24 2.30 2.67 4.92 4.27 4.18 7.54 1.68 13.86
T4 6.12 2.16 2.63 4.92 4.23 4.10 7.49 1.68 13.97
T5 5.75 1.99 2.39 4.88 4.23 4.10 7.27 1.67 13.97
G6 5.59 2.67 2.72 4.98 4.34 4.14 7.85 12.76
G7 5.83 2.54 2.67 4.94 4.36 4.15 7.72 12.80
C8 5.85 1.98 2.38 4.92 4.12 7.29 5.22
C9 5.20 1.87 2.18 4.75 3.98 7.38 5.55
AIO 5.70 2.69 2.79 5.00 4.32 4.05 8.17 7.19
All 5.71 2.58 2.78 5.01 4.38 8.09 7.03
AI2 5.82 2.54 2.83 5.00 4.39 4.19 8.02 7.10
A13 5.98 2.49 2.83 4.98 4.40 4.20 7.92 7.58
G14 5.93 2.24 2.29 4.57 4.23 4.15 7.47 14.27
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Appendix 1.5 IH chemical shifts of the d(GCAAATITGC)2duplex at 298K.
HI' H2' H2" H3' H4' H5'/H5" H6/H8 H5IMe H2
Gl 5.95 2.76 2.58 4.83 4.21 3.68 7.93
C2 5.45 2.31 1.99 4.84 4.41 4.14 7.40 5.43
A3 5.89 2.95 2.78 5.07 4.42 4.14/4.03 8.24 7.25
A4 5.94 2.90 2.67 5.09 4.51 4.26/4.14 8.13 7.44
A5 6.13 2.76 2.49 4.96 4.23 4.1314.13 8.14 7.35
T6 5.13 2.08 1.53 4.46 6.87 1.29
T7 5.04 2.08 1.61 4.47 3.92 7.01 1.42
T8 4.70 1.97 1.63 3.92 3.61 3.44 6.91 1.51
G9 5.93 2.72 2.64 5.02 4.42 4.15 7.90
CI0 6.23 2.21 2.17 4.50 4.25 4.11 7.49 5.50
GIl 5.95 2.75 2.57 4.84 4.22 3.69 7.94
C12 5.40 2.20 1.86 4.83 4.37 4.10 7.35 5.43
Al3 5.88 2.93 2.81 5.08 4.42 4.1214.02 8.25
A14 6.00 2.82 2.72 5.10 4.50 4.27/4.13 8.16 7.48
A15 5.54 2.49 2.20 4.74 4.16 3.6513.50 8.03 7.51
TI6 5.18 1.99 1.57 4.36 6.89 1.19
TI7 5.30 2.21 1.70 4.49 4.36 3.96 7.11 1.42
TI8 5.68 2.33 1.86 4.37 4.18 4.03 7.06 1.56
GI9 5.91 2.72 2.64 5.01 4.42 4.17 7.89
C20 6.22 2.21 2.17 4.51 4.27 4.10 7.50 5.51
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Appendix 1.6 IH chemical shifts of the d(TIAGGGT)4 quadruplex at 298K.
HI' H2' H2" H3' H4' HS'/HS" H6/H8 IHS/Me H2 NH
TI 6.00 2.lO 2.34 4.64 4.00 3.6S 7.41 1.67
T2 6.2S 2.06 2.34 4.74 4.06 3.93 7.33 1.78
A3 6.28 2.86 2.92 S.10 4.44 4.16/4.10 8.43 8.09
G4 6.01 2.67 2.91 S.OS 4.49 4.27 7.9S 11.23
GS 6.03 2.66 2.74 S.04 4.S1 4.30 7.79 II.4S
G6 6.27 2.S7 2.70 4.91 4.S2 4.27 7.70 11.84
T7 6.07 2.17 2.19 4.49 4.23 4.07 7.36 1.63
Appendix 1.7 IH chemical shifts for the DNA quadruplex of the 2: I
d(TIAGGGT)4-RHPS4 complex at 318K.
HI' H2' H2" H3' H4' HS'/HS" H6/H8 HSlMe NH
TI S.98 2.14 2.38 4.71 4.0S 3.70 7.39 1.63
T2 6.11 2.00 2.30 4.79 4.42 4.IS 7.32 1.71
A3 6.22 2.79 2.82 5.10 4.43 4.16 8.29
G4 5.94 2.59 2.86 5.00 4.46 4.21 7.85 lO.11
G5 5.93 2.57 2.70 5.01 4.46 4.29 7.S8 10.80
G6 6.30 2.68 2.71 5.10 4.47 4.27 7.74 11.0S
T7 6.27 2.34 2.36 4.61 4.23 7.70 1.88
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Appendix 1.S 'H chemical shifts for H33258 molecule of the 2:1
d(GAAAAGCTITTC)2-H33258 complex at 298K.
Pip H2/H6 3.33/4.29 bz2 H4 7.46
Pip H3/H5 3.13/3.73 bz2H6 7.98
bz l H6 7.16 bz2H7 8.22
bz l H7 7.76 bz2 H3 11.63
bzl H3 11.42 phH2/H6 7.42
bz l H4 8.27 phH3/H5 8.136
pipNMe 2.94
Appendix 1.9 'H chemical shifts for HIO molecule of the I: I
d(CGCAAATTTGCG)2-H 10 complex at 298K.
OMe 4.37 bz l H6 8.00
pip NMe 3.08 bz l H7 8.13
bz2 H6 7.00 bz l H4 8.37
bz2 H7 7.77 bz l H3 11.40
bz2 H4 8.33 pip H2/H6 3.51/4.39
bz2 H3 12.13 pip H3/H5 3.76/4.29
phH3 8.15 phH2 7.60
Appendix 1.10 'H chemical shifts for RHPS4 of the 2:1 d(TTAGGGT)4-RHPS4
complex at 318K.
H5 7.09 H2 6.87
H7 7.27 HI 7.24
H9 7.30 Me6 2.36
HIO 7.26 Me8 3.58
H12 7.28 Me13 3.88
H4 7.76
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Appendix 2
Appendix 2.1 NOE restraints for the d(CTTTTGCAAAAG)2 duplex structure, for
one strand only.
residue atom residue atom distance residue atom residue atom distance
T2 H7 Cl H6 4.27 Cl H3' Cl H6 4.73
T2 H7 T2 H6 3.44 Cl H3' T2 H6 3.79
T3 H7 T3 H6 3.34 Cl H4' Cl H6 4.4S
T4 H7 T4 H6 3.30 Cl HS'2 Cl H6 4.65
T5 H7 TS H6 3.S2 Cl HS'I Cl H6 4.24
T3 H7 T3 HI' S.49 A8 H2'l A8 H8 2.70
T2 H7 Cl H3' 3.67 C7 H2'l A8 H8 3.88
T2 H2'2 T2 H6 3.73 A8 H2'2 A8 H8 3.48
T3 H2'2 T3 H6 3.27 A9 H2'2 A9 H8 3.67
Cl H2'I Cl H6 3.2S A9 H2'l A9 H8 2.7S
Cl H2'2 Cl H6 4.09 A8 H2'I A9 H8 S.46
T4 H2'2 T4 H6 3.36 C7 H2'2 A8 HS 4.30
T2 H2'I T2 H6 2.S7 AID H2'l AID H8 3.06
T3 H2'I T3 H6 2.S7 All H2'I All HS 3.16
T4 H2'I T4 H6 3.10 G6 H2'2 G6 H8 3.90
TS H2'2 TS H6 4.44 TS H2'2 G6 H8 4.07
C7 H2'l C7 H6 3.14 All H2'2 GI2 H8 3.S7
T5 H2'l TS H6 3.12 All H2'l GI2 HS 4.32
T4 H2'I TS H6 4.6S TS H2'I G6 HS 4.S1
C7 H2'2 C7 H6 4.S8 AIO H2'2 AIO HS 3.71
Cl H4' T2 H6 4.77 G6 H2'I G6 HS 3.14
T4 H2'2 TS H6 3.41 AS HI' A8 H8 4.77
T2 H3' T2 H6 4.73 C7 HI' A8 HS 5.24
T3 H3' T3 H6 4.S9 A8 H3' A8 HS S.63
TS H3' TS H6 4.63 A9 H3' A9 HS 5.30
Cl HI' Cl H6 4.51 AIO H3' AIO HS 4.SS
T2 HI' T2 H6 4.S0 All H3' All HS 4.69
T2 HI' T3 H6 4.74 G6 H3' G6 HS 5.37
T3 HI' T3 H6 4.74 AID HI' AID HS S.42
T3 HI' T4 H6 4.60 A9 HI' AID HS 4.54
T4 HI' T4 H6 4.76 AS HI' A9 H8 5.SS
T4 HI' TS H6 5.33 A9 HI' A9 HS S.25
TS HI' TS H6 4.87 All HI' All H8 5.53
Cl HI' T2 H6 6.00 T5 HI' G6 HS 5.55
TS H6 G6 H8 4.04 G6 HI' G6 H8 5.42
Gl2 H4' Gl2 H8 4.70 T3 H4' T3 HI' 3.10
All H4' All H8 S.70 T4 H4' T4 HI' 2.82
AID H4' AIO H8 5.70 TS H2'1 TS H3' 2.56
G6 H2'2 G6 H8 3.56 T4 H2'l T4 H3' 2.61
Gl2 H2'2 Gl2 H8 3.50 TS H2'2 TS H3' 2.96
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residue atom residue atom distance residue atom residue atom distance
A9 H3' A9 HI' 4.00 All H2'I All H3' 2.73
T2 H3' T2 HI' 4.25 G6 H2'I G6 H3' 3.18
T3 H3' T3 HI' 3.89 A9 H2'l A9 H3' 2.30
A8 H3' A8 HI' 4.41 A8 H2'I AS H3' 2.54
G6 H3' G6 HI' 4.75 All H2'2 All H3' 2.94
T5 H3' T5 HI' 4.62 AIO H2'2 AIO H3' 3.18
T4 H3' T4 HI' 4.29 G6 H2'2 G6 H3' 2.57
C7 H2'I C7 HI' 3.53 G12 H4' G12 HI' 4.S2
T5 H2'I T5 HI' 3.11 All H4' All HI' 3.1S
T4 H2'l T4 HI' 3.53 A10 H4' AIO HI' 3.26
C7 H2'2 C7 HI' 2.54 G6 H4' G6 HI' 3.34
GI2 H2'I GI2 HI' 2.61 A9 H4' A9 HI' 3.32
GI2 H2'2 GI2 HI' 2.52 A8 H4' A8 HI' 3.49
Cl H2'I Cl HI' 3.31 Cl H4' Cl HI' 3.39
Cl H2'2 Cl HI' 2.38 T4 H2'I T4 H4' 4.95
T4 H2'2 T4 HI' 2.42 C7 H2'l C7 H4' 4.29
All H2'2 All HI' 2.58 C7 H2'2 C7 H4' 3.66
All H2'l All HI' 2.98 Cl H2'l Cl H3' 2.75
AIO H2'2 A10 HI' 2.51 A8 H2'l A8 H2'2 2.45
AIO H2'I AIO HI' 3.03 Cl H2'2 Cl H3' 4.70
A9 H2'2 A9 HI' 2.50 Gl2 H2'2 Gl2 H4' 3.62
A9 H2'l A9 HI' 2.72 G12 H2'l Gl2 H4' 2.90
AS H2'2 A8 HI' 2.16 Cl H5'I Cl H3' 4.57
AS H2'l A8 HI' 2.79 Cl H4' Cl H3' 3.25
TS H2'2 TS HI' 2.44 GI2 H2'I G12 H5' 3.61
AS H4' A8 H3' 2.85 Cl H2'l Cl H4' 4.32
All H4' All H3' 2.76 T2 H2'I T3 H4' 4.25
G6 H4' G6 H3' 2.75 Cl H2'2 Cl H4' 2.96
T3 H4' T3 H3' 2.63 Cl HS'2 Cl H4' 5.27
T2 H4' T2 HI' 3.11 T4 H2'2 T4 H4' 4.95
AS H2'2 A8 H4' 5.32 TS H2'l IS H2'2 2.22
All H2'2 All H4' 3.74 C7 H2'I C7 H2'2 2.23
A9 H2'2 A9 H4' 4.87 G6 H2'l G6 HI' 3.55
A9 H2'l A9 H4' 5.47 G6 H2'2 G6 HI' 2.47
AIO H2'l AIO H4' 4.62 T2 H3 A23 H2 4.30
All H2'l All H4' 4.49 T3 H3 A23 H2 4.26
G6 H2'l G6 H4' 5.50 T5 H3 A20 H2 4.10
All H2'I All H2'2 2.05 T3 H3 A22 H2 4.88
I2 H2'l T2 H2'2 2.16 T4 H3 A21 H2 6.25
Cl H2'l Cl H2'2 2.04 T4 H3 A22 H2 6.25
I4 H2'l T4 H2'2 2.17 T5 H3 A21 H2 6.25
G6 HI A20 H2 6.25
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Appendix 2.2 NOE restraints for the d(CAAAAGCTITTG)2 duplex structure, for
one strand only.
residue atom residue atom distance residue atom residue atom distance
GI H8 Gl HI' 4.29 A2 H3' A2 H2'I 2.64
A2 H8 GI HI' 4.13 A2 H4' A2 H2'I 4.19
GI H8 GI H2'l 2.94 A2 H3' A2 H2'2 2.85
A2 H8 GI H2'1 3.83 A2 H4' A2 H2'2 4.84
GI H8 Gl H2'2 3.82 A2 HI' A2 H3' 4.43
A2 H8 Gl H2'2 3.71 A2 HI' A2 H4' 2.83
GI H8 Gl H3' 4.70 A2 H3' A2 H4' 2.79
A2 H8 GI H3' 5.34 GI HI' A2 HS'I 4.20
GI HS'I GI H8 4.34 A2 HI' A2 HS'I 5.08
GI HI' Gl H2'1 3.38 A2 H3' A2 HS'I 3.19
GI H2'2 Gl H2'1 2.89 A2 H3' A2 HS'2 3.43
GI H3' GI H2'1 2.99 A2 H4' A2 HS'2 3.84
Gl HS'I Gl H2'1 3.06 A3 H8 A2 HI' 4.84
GI HI' Gl H2'2 3.63 A3 H8 A2 H2'1 5.24
GI H3' Gl H2'2 2.74 A3 H8 A3 HI' 5.29
GI HS'I GI H2'2 4.16 A4 H8 A3 HI' 3.39
GI HI' Gl H3' 4.88 A3 H8 A3 H2'1 2.78
GI HI' GI HS'I 4.37 A3 H8 A3 H2'2 3.22
Gl H4' Gl HS'I 3.16 A3 H8 A3 H3' 4.21
GI HI' A2 HS'l 3.30 A3 H8 A3 H4' 5.41
A2 H8 GI HI' 4.14 A3 H8 A3 HS'I 5.61
A2 H8 Gl H2'1 3.83 A3 HI' A3 H2'1 3.82
A2 H8 Gl H2'2 3.71 A3 H2'2 A3 H2'1 1.95
A2 H8 Gl H3' 5.34 A3 H3' A3 H2'1 2.78
A2 H8 A2 HI' 4.02 A3 HI' A3 H2'2 2.60
A3 H8 A2 HI' 4.84 A3 HI' A3 H3' 3.75
A2 H8 A2 H2'1 2.61 A3 H3' A3 H4' 3.95
A3 H8 A2 H2'1 3.85 A3 H3' A3 HS'I 3.31
A2 H8 A2 H2'2 3.43 A3 H4' A3 HS'I 2.22
A2 H8 A2 H3' 4.34 A4 H8 A3 HI' 3.39
A2 H8 A2 H4' 4.53 A4 H8 A4 HI' 4.13
A2 H8 A2 H5'1 5.76 AS H8 A4 HI' 3.93
A2 H8 A2 HS'2 5.33 A4 H8 A4 H2'1 2.73
A2 HI' A2 H2'1 2.95 A4 H8 A4 H2'2 3.17
A2 H2'2 A2 H2'1 2.79 A4 H8 A4 H3' 4.08
A4 H8 A4 H4' 6.03 G6 H8 AS H2'2 3.18
A4 HS'I A4 H8 4.78 G6 H8 AS H3' 4.52
A4 H2'2 A4 H2'1 1.95 C7 H6 G6 HI' 3.38
A4 H3' A4 H2'1 2.95 G6 H8 G6 H2'1 2.86
A4 H4' A4 H2'1 3.54 C7 H5 G6 H2'1 4.52
A4 HI' A4 H2'2 2.56 C7 H6 G6 H2'1 3.58
A4 H4' A4 H2'2 5.22 C7 HS G6 H2'2 3.82
A4 HI' A4 H3' 3.78 C7 H6 G6 H2'2 3.17
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residue atom residue atom distance residue atom residue atom distance
A4 HI' A4 H4' 2.40 C7 H6 06 H3' 5.33
A4 H3' A4 H4' 3.2S 06 H8 06 H4' S.87
A4 H3' A4 HS'I 4.13 AS H8 06 H8 S.60
A4 H4' A4 HS'I 2.4S 06 HI' C7 HS S.73
AS H8 A4 HI' 3.93 06 H8 C7 HS 4.24
AS H8 AS HI' 4.46 06 HI' 06 H8 4.24
06 H8 AS HI' 3.83 06 HI' 06 H2'I 2.77
06 H8 AS H2 6.50 06 H2'2 06 H2'1 2.29
AS H8 AS H2'1 2.70 06 H3' 06 H2'1 3.S2
AS H8 AS H2'2 2.97 06 H4' 06 H2'1 4.36
06 H8 AS H2'2 3.18 06 HI' 06 H2'2 2.47
AS H8 AS H3' 4.07 06 H3' 06 H2'2 3.S3
06 H8 AS H3' 4.S2 06 HI' 06 H4' 3.13
AS H8 AS H4' S.37 06 H3' 06 H4' 3.22
AS H8 AS HS'1 6.41 C7 H6 06 HI' 3.38
AS H8 06 H8 S.60 C7 HS 06 H2'I 4.S2
AS HI' AS H2 S.53 C7 H6 06 H2'1 3.S8
AS HI' AS H2'1 3.89 C7 HS 06 H2'2 3.82
AS H2'2 AS H2'1 2.73 C7 H6 06 H2'2 3.17
AS H3' AS H2'1 3.02 C7 H6 06 H3' S.33
AS HI' AS H2'2 2.68 C7 H6 C7 HI' 3.SS
AS H4' AS H2'2 3.77 T8 H6 C7 HI' 4.43
AS HI' AS H3' 4.4S C7 H6 C7 H2'1 3.27
AS HI' AS H4' 3.13 T8 H6 C7 H2'1 3.46
AS H3' AS HS'I 3.13 C7 H6 C7 H2'2 4.40
06 H8 AS HI' 3.83 C7 H6 C7 H3' 4.30
06 H8 AS H2 6.50 T8 H6 C7 H3' 4.12
C7 H6 C7 H4' 4.11 TlO H6 T9 HI' 5.02
06 HI' C7 HS S.73 TlO H6 TlO HI' S.IO
06 HS C7 HS 4.24 Til H6 TlO HI' 5.00
C7 H6 C7 HS 2.94 TlO H6 TlO H2'1 2.81
C7 H6 C7 HS'2 4.3S TlO H6 TlO H4' 3.87
C7 H2'1 C7 H6 S.OS TlO H3' TlO H2'1 2.S0
C7 HI' C7 H2'1 3.14 TlO H3' TlO H4' 3.3S
C7 H2'2 C7 H2'1 2.22 TlO H4' TlO HS'1 3.32
C7 H3' C7 H2'1 2.7S TlO HI' TlO H2'1 3.43
C7 H4' C7 H2'1 3.56 TlO HI' TlO H2'2 2.46
T8 H5'1 C7 H2'1 3.74 TlO HI' TlO H3' 4.72
C7 HI' C7 H2'2 2.6S Til H6 TlO HI' 5.00
C7 H3' C7 H2'2 3.33 CI2 H6 Til H3' 4.92
T8 HS'l C7 H2'2 4.S0 Til H6 Til HI' 5.44
C7 HI' C7 H3' 3.36 Cl2 H6 Til HI' 4.13
C7 H3' C7 H4' 3.45 Til H6 Til H2'1 2.53
C7 H3' C7 HS'2 5.57 Cl2 H6 Til H2'1 3.98
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residue atom residue atom distance residue atom residue atom distance
e7 H3' e7 H4' 3.45 Til H6 Til H2'I 2.53
e7 H3' e7 H5'2 5.57 eI2 H6 TIl H2'l 3.98
e7 H5 e7 H2'l 6.44 Til H3' Til H6 3.98
T8 H6 e7 HI' 4.43 Til HI' TIl H4' 4.88
TS H6 e7 H2'I 3.46 TIl HI' TIl H5'1 6.20
T8 H6 e7 H3' 4.12 Til H5'I Til H3' 3.91
T8 H2'2 T8 H6 2.79 eI2 H6 Til H3' 4.92
T8 H5'1 e7 H2'I 3.74 eI2 H6 Til HI' 4.13
T8 H5'I e7 H2'2 3.78 cu H6 Til H2'I 3.9S
TS HI' TB H2'1 3.25 crz H6 cu HI' 5.05
T8 H2'2 TB H2'I 2.30 eI2 H6 eI2 H2'1 3.61
TS HI' TS H2'2 2.56 e12 H6 en H2'2 4.S3
T9 H6 T9 HI' 5.45 eI2 H6 e12 H5 4.64
TIO H6 T9 HI' 5.02 eI2 H6 cu H5'1 5.41
T9 H6 T9 H2'1 2.79 eI2 HI' e12 H2'l 5.22
T9 H3' T9 H6 2.79 e12 H3' e12 H2'l 2.90
T9 H2'2 T9 H2'I 2.23 eI2 H5 eI2 H2'l 4.51
T9 HI' T9 H2'2 2.S0 crz HS'l e12 H2'I 5.45
T9 HI' T9 H3' 4.72 eI2 HI' e12 H3' 4.30
T9 HS'I T9 H4' 3.05 eI2 H3' eI2 H4' 4.41
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Appendix 2.3 NOE restraints for the 2: 1 d(CTTTTGCAAAAG)2-H33258 complex
structure, for one strand only.
residue atom residue atom distance residue atom residue atom distance
Cl HI' Cl H6 4.92 AIO H2'2 All H8 3.79
T2 HI' T2 H6 5.02 T2 H2'2 T3 H6 3.43
T2 HI' T3 H6 5.24 C7 H2'2 C7 H6 3.41
T3 HI' T3 H6 4.22 C7 H2'1 C7 H6 2.75
T3 HI' T4 H6 6.26 T3 H2'1 T4 H6 4.31
T4 HI' T4 H6 6.13 T4 H2'2 T4 H6 3.93
T4 HI' T5 H6 4.60 T3 H2'2 T4 H6 3.61
T5 HI' T5 H6 4.44 G6 H2'2 C7 H6 4.74
AIO HI' AIO H8 6.24 All H2'2 GI2 H8 3.42
C7 H5 C7 H6 3.52 Gl2 H2'1 Gl2 HS 3.65
A9 HI' A9 H8 5.36 T4 H2'2 T5 H6 3.47
A8 HI' A9 H8 4.79 T4 H2'1 TS H6 3.92
A9 HI' AIO H8 4.4S TS H2'1 TS H6 2.6S
AIO HI' All H8 5.20 TS H2'2 TS H6 3.43
All HI' All H8 6.24 A9 H3' A9 HS 5.03
All HI' GI2 H8 4.S4 AS H3' A8 H8 5.10
Gl2 HI' Gl2 H8 5.88 T2 H3' T2 H6 5.01
A9 H2'2 A9 H8 3.46 T2 H3' T3 H6 4.08
A9 H2'2 AIO H8 3.39 T2 H4' T2 H6 4.52
A9 H2'I AIO H8 4.00 C7 H3' C7 H6 4.29
Cl H2'2 Cl H6 4.93 Cl H3' T2 H6 4.21
Cl H2'1 Cl H6 3.69 Cl H3' Cl H6 3.93
C7 H2'2 AS H8 4.44 Cl H4' Cl H6 5.31
AIO H2'1 AIO H8 3.60 Cl H5'1 Cl H6 4.40
C7 H2'1 AS H8 4.61 Cl H5'2 Cl H6 4.34
AIO H2'2 AIO H8 4.50 AIO H3' AIO HS 4.7S
Cl H2'1 T2 H6 3.S0 T3 H3' T3 H6 4.51
T2 H2'2 T2 H6 3.50 T3 H4' T3 H6 4.S0
TS H2'2 G6 H8 4.90 All H3' Gl2 HS 6.00
TS H2'1 G6 H8 5.50 All H3' All HS 5.05
T3 H2'1 T3 H6 3.33 TS H3' TS H6 4.02
All H2'1 All H8 3.7S T4 H3' T4 H6 4.50
AIO H2'1 All H8 4.04 Gl2 H3' Gl2 H8 4.91
All H2'2 All H8 4.80 Gl2 HS'2 GI2 HS 5.01
T3 H2'2 T3 H6 3.69 T5 H6 T4 H6 6.26
A9 HS AS H8 4.90 All H2'1 All H3' 3.01
Gl2 HS Gl2 H2'2 4.07 All H2'2 All H3' 3.20
Gl2 HS All H2'1 4.4S TS H2'1 T5 HI' 3.65
T4 H6 T3 H3' 6.30 TS H2'2 TS H3' 3.45
C7 H6 G6 HI' 5.56 T5 H2'1 T5 H3' 3.25
Cl H6 Cl H5 3.07 T4 H2'1 T4 H3' 2.90
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residue atom residue atom distance residue atom residue atom distance
AS HS AS HI' 4.S2 GI2 H2'I Gl2 H3' 3.32
Cl H2'2 Cl HI' 2.7S GI2 H2'2 Gl2 H3' 3.24
A9 H2'l A9 HI' 3.60 T4 H2'2 T4 H3' 3.29
A9 H2'2 A9 HI' 2.9S A9 H4' A9 H3' 2.77
AIO H2'l AIO HI' 3.32 A9 H3' A9 HI' 4.7S
AIO H2'2 AIO HI' 3.06 A9 H4' A9 HI' 3.69
T3 H2'2 T3 HI' 4.00 A9 HS'2 A9 H4' 2.4S
Cl H2'I Cl H2'2 2.24 A9 HS'I A9 H4' 3.37
T3 H2'l T3 HI' 3.47 AS H4' AS H3' 2.90
C7 H2'2 C7 HI' 3.11 AS HS'2 AS H3' 2.S7
C7 H2'l C7 HI' 4.03 AS HS'I AS H3' 3.40
T4 H2'l T4 HI' 3.S3 AS HS'I AS HS'2 2.49
All H2'l All HI' 3.63 AS H3' AS HI' S.OI
T4 H2'2 T4 HI' 3.0S AS H4' AS HI' 4.5S
All H2'2 All HI' 2.96 AS H5'I AS H4' 2.36
A9 H2'l A9 H3' 3.00 T3 H4' T3 H3' 2.72
A9 H2'2 A9 H3' 3.21 T2 H4' T2 H3' 2.77
Gl2 H2'2 Gl2 HI' 3.33 T2 H3' T2 HI' 4.S2
Gl2 H2'l Gl2 HI' 2.SS T2 H4' T2 HI' 3.33
T2 H2'2 T2 H3' 2.S4 T2 HS'2 T2 H4' 3.60
Cl H2'l Cl H3' 3.12 T2 H2'2 T2 H4' 3.24
Cl H2'2 Cl H3' 3.69 T2 H2'l T2 H4' 4.96
AIO H2'2 AIO H3' 3.28 C7 H4' C7 HI' 3.65
T3 H2'2 T3 H3' 3.47 C7 H4' C7 H3' 3.00
AIO H2'l AIO H3' 2.93 C7 H2'2 C7 H4' 4.66
C7 H2'2 C7 H3' 4.19 C7 H2'l C7 H4' 5.14
T3 H2'l T3 H3' 3.17 Cl HS'I Cl H3' 3.24
C7 H2'l C7 H3' 3.50 Cl HS'2 Cl H3' 2.96
T5 H2'2 TS HI' 3.10 Cl HS'I Cl H4' 2.76
Cl HS'2 Cl H4' 2.75 T2 H2'2 T2 HI' 2.SS
Cl H4' Cl H3' 3.1S T2 HI' T2 H2'l 3.11
Cl H3' Cl HI' 3.96 Cl H2'I Cl HI' 3.22
Cl HS'I Cl HS'2 2.40 G6 H3' G6 H2'2 3.64
Cl H4' Cl HI' 3.37 C7 HI' C7 H3' 4.20
T2 H2'l T2 H2'2 2.2S All HS'I All HS'2 2.1S
AIO HS'2 AIO H3' 3.60 T4 H7 T3 H6 3.71
AIO H2'l AIO H2'2 2.22 T3 H7 T3 H6 3.03
T3 H3' T3 HI' 3.45 T3 H7 T2 HI' 4.76
T3 H4' T2 HI' 5.25 T2 H7 Cl HS 3.99
All H4' All H3' 3.18 T2 H7 Cl HI' 2.93
All H3' All HI' 4.70 T4 H7 T3 HI' 6.00
T4 H4' T4 H3' 3.15 T3 H7 T2 H3' 5.16
Gl2 H4' Gl2 H3' 2.94 T2 H7 Cl H3' 4.12
G6 H3' G6 HI' 4.44 T4 H7 T3 H3' 3.S1
G6 H4' G6 HI' 4.57 T2 H7 Cl H2'l 4.26
All H2'l All H2'2 2.34 T2 H7 Cl H2'2 4.28
C7 H2'l C7 H2'2 2.55 T3 H7 T2 H2'2 4.41
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residue atom residue atom distance residue atom residue atom distance
GI2 H2'I GI2 H2'2 2.24 T3 H7 T2 H2'1 3.33
T4 H2'1 T4 H2'2 2.13 T4 H7 T3 H2'2 3.61
T3 H2'1 T3 H2'2 2.13 TS H7 T4 H2'2 4.38
TS H2'1 TS H2'2 3.22 T4 H7 T3 H2'1 3.24
A8 H2 A9 H2 3.75 TS H7 T4 H2'I 3.14
A9 H2 AIO H2 3.75 T2 H7 T2 H2'I 3.76
T4 HI' A22 H2 4.28 T2 H7 Cl H6 3.60
All HS'I All H3' 3.25 T3 H7 T2 H6 3.41
All HS'2 All H3' 4.69 T2 H7 T2 H6 3.84
All HS'I All H5'2 2.52 T4 H6 T4 H7 3.49
GI2 HS'2 GI2 HI' 3.53 T4 H6 TS H7 4.35
Tl7 H3 A9 H2 4.79 TIS H3 AIO H2 3.95
TI7 H3 A8 H2 3.93 TIS H3 A9 H2 5.00
Tl6 H3 AIO H2 4.45 T5 H3 T4 H3 4.52
TI6 H3 A9 H2 3.92 G6 HI C7 H4' 3.88
Tl4 H3 All H2 3.90 G6 HI C7 H6 4.77
HOE26 pipH6 A9 H2 4.43 HOE2S pipH6 A21 H2 4.43
Tl4 HI' HOE26 phH6 3.74 T2 HI HOE2S phH6 3.74
TIS HI' HOE26 phH6 4.S9 T3 HI HOE2S phH6 4.S9
GI2 HI' HOE26 phH6 4.64 G24 HI HOE25 phH6 4.64
HOE26 I pip NMe AS H2 4.45 HOE25 "nin Nlvle A20 H2 4.45
HOE26 pipH6 A8 H2 3.70 HOE2S pipH6 A20 H2 3.70
HOE26 ph H5 All H2 3.22 HOE25 phHS A23 H2 3.12
AlO H2 HOE26 bzI H4 2.91 A22 H2 HOE2S bzl H4 2.91
AIO H2 HOE26 phH5 5.1 A22 H2 HOE2S phHS 5.09
HOE26 phH6 All H2 4.67 HOE25 phH6 A23 H2 4.67
HOE26 bz2 H4 A9 H2 4.07 HOE2S bz2 H4 A21 H2 4.07
A9 HI' HOE26 bz2H4 5.96 A21 HI HOE25 bz2 H4 5.96
TIS HI' HOE26 phHS 3.81 T3 HI HOE2S phHS 3.81
TTI6 HI' HOE26 bzI H4 3.73 T4 HI HOE2S bzl H4 3.73
GI2 HI' HOE26 phHS 4.63 G24 HI HOE2S phHS 4.63
HOE26 nio He A9 HI' 3.47 HOE2S pipH6 A21 HI' 3.47
HOE26 pipNMe A9 HI' 4.65 HOE25 l pin Nlvle A21 HI' 4.65
HOE26 pipHS A8 H2 3.91 HOE25 pipH5 A20 H2 3.91
HOE26 pip Hf A9 H2 4.IS HOE2S pipH6 A21 H2 4.18
HOE26 pipH6 A9 HI' 4.13 HOE2S pipH6 A21 HI' 4.13
HOE26 bz2 H3 AIO H2 4.41 HOE2S bz2H2 A22 H2 4.41
HOE26 bz2 H3 A9 H2 4.96 HOE25 bz2H3 A21 H2 4.96
HOE26 bzI H3 All H2 4.19 HOE25 bzl H3 A23 H2 4.19
HOE26 bzI H3 AIO H2 4.62 HOE2S bzI H3 A22 H2 4.62
Tl6 H3 HOE26 bz2H4 5.77 T4 H3 HOE2S bz2H4 5.77
Tl6 H3 HOE26 bzI H4 5.16 T4 H3 HOE2S bzI H4 5.16
TIS H3 HOE26 phHS 4.90 T3 H3 HOE2S phHS 4.90
Tl4 H3 HOE26 phH6 4.92 T2 H3 HOE2S phH6 4.92
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Appendix 2.4 NOE restraints for the 1:1 d(GCAAATTTGCh-HlO complex
structure.
residue atom residue atom distance residue atom residue atom distance
GI HI' C2 H6 4.40 GIl H2'2 C12 H6 4.05
GI H2'2 C2 H6 3.22 C12 HI' CI2 H6 3.35
C2 HI' C2 H6 3.9S CI2 H2'I CI2 H6 2.S1
C2 H2'I C2 H6 2.65 C12 H2'2 C12 H6 3.6S
C2 H2'2 C2 H6 3.25 C12 H3' CI2 H6 4.9S
C2 H3' C2 H6 4.4S CI2 H4' CI2 H6 4.10
C2 H5 C2 H6 2.78 CI2 HS CI2 H6 2.84
C2 H5'I C2 H6 4.94 CI2 H5'I CI2 H6 5.88
AS HI' T6 H6 4.01 AI5 HI' Tl6 H6 5.41
AS H2'I T6 H6 3.70 AI5 H2'1 Tl6 H6 3.97
AS H2'2 T6 H6 3.S2 Tl6 HI' Tl6 H6 5.15
T6 HI' T6 H6 4.8 Tl6 HI' TI7 H6 4.S1
T6 HI' T7 H6 5.86 TI6 H2'I TI7 H6 3.00
T6 H2'2 T6 H6 3.77 Tl6 H2'2 TI7 H6 2.86
T6 H3' T6 H6 5.25 Tl6 H3' TI6 H6 4.S2
T6 H6 AS HS 5.4S Tl6 H6 AIS HS S.S9
T6 H6 T7 H6 5.84 Tl6 H6 Tl7 H6 5.12
T7 HI' T7 H6 5.06 Tl7 HI' TI7 H6 4.90
T7 HI' T8 H6 5.16 Tl7 HI' TlS H6 4.50
T7 H2'I T7 H6 2.72 Tl7 H2'I Tl7 H6 2.S9
T7 H2'2 T7 H6 3.70 Tl7 H2'I TIS H6 2.97
T7 H2'2 T8 H6 3.00 Tl7 H2'2 TI7 H6 3.60
TS HI' TS H6 4.25 TI7 H2'2 TIS H6 2.65
T8 H2'I T8 H6 2.S5 TI7 H3' TI7 H6 4.99
TS H3' TS H6 5.84 Tl7 H4' TI7 H6 4.28
T8 H6 T7 H6 5.18 TI8 HI' TI8 H6 5.14
T8 H6 G9 HS 3.30 TlS H2'I TIS H6 2.70
G9 HI' CIO H6 4.41 TIS H2'2 TI8 H6 3.61
G9 H2'2 ClO H6 4.63 TIS H6 GI9 HS 5.50
G9 H2'l CIO H6 3.45 GI9 HI' C20 H6 4.89
CIO HI' CIO H6 3.SS G19 H2'1 C20 H6 2.80
CIO H3' ClO H6 3.65 GI9 H2'2 C20 H6 3.46
CIO H5 CIO H6 2.S2 C20 HI' C20 H6 4.03
GIl HI' CI2 H6 5.69 C20 H3' C20 H6 3.75
Gil H2'1 CI2 H6 4.25 C20 HS C20 H6 2.82
Gl HI' GI H8 4.65 AI3 H3' Al3 HS 3.96
Gt H2'1 GI H8 2.63 A13 H4' Al3 H8 5.52
Gl H2'2 GI HS 3.25 AI4 HI' AI4 H8 4.77
GI H3' GI H8 4.S6 AI4 HI' AI5 HS 3.64
C2 HI' A3 H8 4.S8 AI4 H2'1 AI5 HS 3.31
C2 H2'1 A3 HS 4.61 At4 H2'2 AI5 HS 2.74
C2 H2'2 A3 H8 3.37 AI4 H3' At4 HS 4.36
C2 H5 Gt HS 2.S5 AI4 H4' At4 H8 4.84
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residue atom residue atom distance residue atom residue atom distance
A3 HI' A3 H8 4.S8 AI5 HI' AIS H8 5.11
A3 HI' A4 H8 4.22 AIS H2'I AIS H8 2.90
A3 H2'2 A3 H8 4.29 AIS H2'2 AIS H8 3.74
A3 H2'I A3 H8 3.39 AIS H3' AIS H8 4.91
A3 H4' A3 H8 S.S2 AIS H4' AI5 H8 5.39
A4 H2'2 A4 H8 3.20 TI6 H6 AIS H8 5.18
A4 H3' A4 H8 5.06 TI8 HI' G19 H8 4.96
A4 H4' A4 H8 4.67 TIS H2'I GI9 H8 3.66
AS HI' AS H8 4.SS TIS H2'2 GI9 H8 3.30
AS H2'1 AS H8 2.59 TI8 H6 GI9 H8 4.19
AS H3' AS H8 4.60 GI9 H3' GI9 H8 5.18
T6 H6 AS H8 4.S7 T8 H2'2 TS H6 4.42
TS HI' G9 HS 5.06 TI6 H2'2 TI6 H6 3.64
TS H2'I G9 HS 3.47 A4 HI' A4 HS 4.S1
T8 H2'2 G9 H8 3.66 GI H2'1 Gl H3' 3.4S
TS H6 G9 HS 4.65 GI H2'1 Gl H4' 4.03
G9 H3' G9 H8 4.03 Gl H2'2 Gl H3' 3.S4
GIl H2'1 GIl H8 2.79 Gl H2'2 C2 HS 4.6S
Gil H2'2 GIl H8 3.2S GI H3' Gl HI' 4.01
CI2 HI' Al3 H8 4.57 Gl H4' GI HI' 3.64
CI2 H2'I AI3 H8 4.30 Gl H4' Gl H3' 2.67
CI2 H2'2 AI3 H8 4.99 GI HS'I GI HI' S.SO
AI3 HI' AI3 H8 4.7S GI HS'I GI H3' 2.S3
AI3 HI' AI4 HS 4.S9 C2 H2'I C2 HI' 4.2S
A13 H2'l AI3 H8 3.02 C2 H2'l C2 H2'2 2.25
AI3 H2'2 AI3 H8 3.3S C2 H2'I C2 H3' 3.SS
A13 H3' A13 HS 3.96 C2 H2'1 C2 HS 6.07
C2 H2'I C2 HS'I S.13 T7 H2'l T7 H2'2 2.37
C2 H2'2 C2 HI' 2.4S T7 H2'2 T7 HI' 2.66
C2 H2'2 C2 H3' 3.SS TS H2'I TS HI' 3.12
C2 H2'2 C2 H4' 5.20 TS H2'2 T8 HI' 2.56
C2 H2'2 C2 HS'I 6.01 TS H3' T8 HI' 3.54
C2 HS Gl HI' 3.39 TS H4' TS HI' 3.73
C2 HS'I C2 HI' 4.60 TS H4' TS H3' 3.76
A3 H2'I A3 HI' 3.13 TS HS'I TS H3' 3.00
A3 H2'1 A3 H2'2 2.33 G9 H4' G9 HI' 3.0S
A3 H3' A3 HI' 3.61 CIO H2'I CIO HI' 4.0S
A3 H4' A3 H3' 2.S9 CIO H2'2 CIO HI' 3.IS
A3 HS'2 A3 H3' 3.18 CIO H3' CIO HI' 3.40
A4 HI' A3 H2 4.39 Gil H2'I GIl H3' 2.70
A4 H2'I A4 H2'2 2.SS GIl H2'I Gil H4' 3.S7
A4 H2'2 A4 HI' 2.73 GIl H2'2 GIl HI' 3.67
A4 H2'2 A4 H4' 4.70 GIl H2'2 GIl H3' 3.42
Appendices 238
residue atom residue atom distance residue atom residue atom distance
A4 H2'2 A4 HS'I 5.00 Gil H2'2 crz H5 5.33
A4 H3' A4 HI' 4.82 Gil H3' Gil HI' 4.01
A4 H4' A4 HI' 4.64 Gil H4' Gil HI' 3.64
A4 H4' A4 H3' 2.92 Gil H4' Gil H3' 2.67
AS H2'I AS HI' 3.79 Gil HS'l Gil HI' 5.50
AS H2'1 AS H2'2 2.40 en H2'I en HI' 4.28
AS H2'I AS H3' 2.81 en H2'1 ciz H2'2 2.47
AS H2'2 AS HI' 2.66 crz H2'I en H3' 3.67
AS H2'2 AS H3' 3.74 eI2 H2'I cu HS'1 5.79
AS H3' AS HI' 4.86 eI2 H2'2 eI2 HI' 2.97
AS H4' AS HI' 5.18 eI2 H2'2 eI2 H3' 4.21
AS H4' AS H3' 3.56 eI2 HS'I CI2 HI' 4.81
AS HS'I AS H3' 4.85 Al3 H2'l Al3 HI' 3.13
T6 H2'l T6 HI' 3.89 Al3 H2'1 AI3 H2'2 2.34
T6 H2'1 T6 H2'2 2.43 Al3 H2'2 Al3 HS'I 5.99
T6 H2'I T6 H3' 2.96 Al3 H3' A13 HI' 3.61
T6 H2'2 T6 HI' 2.89 Al3 H4' AI3 H3' 2.89
T6 H3' T6 HI' 3.68 AI4 H2'I AI4 HI' 3.60
T7 H2'I T7 HI' 3.61 AI4 H2'2 AI4 HI' 2.70
AI4 H2'2 AI4 H4' 4.11 T7 H4' T7 H3' 3.82
AI4 H2'2 AI4 HS'I 5.50 CIO H4' CIO H3' 3.58
AI4 H3' AI4 HI' 4.41 AI4 H2'I AI4 H2'2 2.67
AI4 H4' AI4 HI' 4.24 AI4 H2'I AI4 H4' 5.24
AI4 H4' AI4 H3' 2.92 TI6 H2'I TI6 HI' 3.73
AI4 HS'I AI4 HI' 5.31 TI6 H2'I TI6 H2'2 2.19
AIS H2'1 AIS HI' 3.35 e20 H4' C20 H3' 2.75
AIS H2'I AIS H2'2 2.43 C2 H2'2 C2 HI' 2.79
AIS H2'I AI5 H3' 3.36 AI3 H2'2 AI3 HI' 2.96
AI5 H2'2 AI5 HI' 3.14 T6 H7 AS H2'1 4.43
AIS H2'2 AI5 H3' 3.50 T6 H7 AS H2'2 4.72
AI5 H4' AIS H3' 3.54 T6 H7 AS H3' 5.50
AI5 HS'I AIS H3' 3.25 T6 H7 AS H8 4.47
AIS HS'I AIS H4' 3.48 T6 H7 T6 H6 3.60
TI6 H2'I TI6 H3' 3.02 T7 H7 T6 HI' 5.78
TI6 H2'2 TI6 HI' 2.67 T7 H7 T6 H2'2 4.85
T16 H2'2 T16 H3' 3.73 T7 H7 T6 H3' 3.48
AI4 H2'2 AI4 H4' 4.11 T7 H4' T7 H3' 3.82
AI4 H2'2 AI4 HS'I 5.50 cio H4' CIO H3' 3.58
AI4 H3' AI4 HI' 4.41 AI4 H2'I AI4 H2'2 2.67
AI4 H4' AI4 HI' 4.24 AI4 H2'1 AI4 H4' 5.24
AI4 H4' AI4 H3' 2.92 Tl6 H2'l T16 HI' 3.73
AI4 HS'I AI4 HI' 5.31 T16 H2'I T16 H2'2 2.19
AIS H2'I AIS HI' 3.35 C20 H4' C20 H3' 2.75
AIS H2'1 AIS H2'2 2.43 C2 H2'2 C2 HI' 2.79
AIS H2'1 AIS H3' 3.36 AI3 H2'2 AI3 HI' 2.96
AI5 H2'2 AIS HI' 3.14 T6 H7 AS H2'1 4.43
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residue atom residue atom distance residue atom residue atom distance
AI5 H2'2 AIS H3' 3.50 T6 H7 AS H2'2 4.72
AI5 H4' AI5 H3' 3.54 T6 H7 AS H3' 5.50
AI5 H5'1 AI5 H3' 3.25 T6 H7 AS H8 4.47
AIS HS'I AI5 H4' 3.48 T6 H7 T6 H6 3.60
Tl6 H2'1 Tl6 H3' 3.02 T7 H7 T6 HI' 5.78
TI6 H2'2 Tl6 HI' 2.67 T7 H7 T6 H2'2 4.85
TI6 H2'2 Tl6 H3' 3.73 T7 H7 T6 H3' 3.48
TI6 H3' Tl6 HI' 3.64 T7 H7 T6 H6 3.67
Tl7 H2'1 Tl7 HI' 3.68 T7 H7 T7 H6 3.50
TI7 H2'1 Tl7 H2'2 2.42 T8 H7 T7 HI' 6.14
Tl7 H2'1 Tl7 H3' 2.67 T8 H7 T8 H6 3.58
Tl7 H2'2 Tl7 HI' 3.06 Tl6 H7 AI5 H2'I 4.04
TI7 H3' Tl7 HI' 3.88 Tl6 H7 AI5 H2'2 4.69
TI8 H2'1 TIS HI' 2.53 Tl6 H7 AI5 H3' 5.27
TI8 H2'I TIS H2'2 2.35 Tl6 H7 AI5 H8 4.28
TI8 H2'2 Tl8 HI' 3.55 TI6 H7 Tl6 H6 3.60
TI8 H2'2 Tl8 H3' 3.95 Tl7 H7 Tl6 HI' 5.65
TI8 H4' Tl8 HI' 4.65 Tl7 H7 Tl6 H2'2 5.45
TI8 H5'1 TIS HI' 5.57 Tl7 H7 Tl6 H3' 5.69
GI9 H4' GI9 H3' 2.S8 Tl7 H7 Tl7 H6 3.55
C20 H3' C20 HI' 3.60 Tl8 H7 Tl7 HI' 5.7S
GI H2'I GI H2'2 2.24 TIS H7 Tl7 H2'I 4.67
A3 H2'2 A3 HI' 3.17 TIS H7 Tl7 H2'2 5.70
A4 H2'1 A4 H4' 4.64 Tl8 H7 TIS H6 3.70
T7 H2'I T7 H3' 2.74 Gil HI' GIl HS 4.72
C20 H6 GI9 H8 4.9S C20 H6 GI9 H8 5.1S
AI3 HI t AI4 H8 4.51
A4 H2 HIO bzl H4 5.50 HIO loioH2 AI4 HI' 4.50
Tl7 HI' HIO bzl H4 4.47 HIO IpipH2 AI4 H2 4.50
TI6 HI' HIO bzlH4 4.11 HIO IphH2 AI5 H2 3.32
AS H2 HIO bzl H4 5.00 AI4 HI' HIO ohH6 5.13
Tl7 HI t HIO bzl H7 3.99 AI5 HI' HIO ohH6 3.S7
AS H2 HIO bzI H7 5.20 Tl6 HI' HIO phH6 5.04
AS HI' HIO bzl H7 5.20 AI4 H2 HIO ph H5 4.08
T6 HI' HIO bzl H7 3.99 AI5 HI' HIO ohH5 3.87
A4 H2 HIO bzl H6 4.50 AI5 H2 HIO ohH5 3.45
HIO OMe A3 H2 5.50 Tl6 HI' HIO phH5 5.20
HIO OMe A4 H2 4.45 Tl7 HI' HlO bz2H4 5.50
HIO OMe AS HI' 4.23 Tl6 HI' HIO bz2H4 4.45
HIO OMe Tl7 HI' 5.50 AIS H2 HIO bz2 H4 5.00
HIO OMe A4 HI' 4.20 AI5 H2 HIO bz2 H3 3.40
HIO OMe AS H2 4.10 AI4 H2 HIO bz2 H3 4.23
HIO pipH3 AI4 HI' 4.50 AS H2 HIO bz l H3 4.36
HIO pipH3 AI4 H2 4.50
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Appendix 2.S NOE restraints for the d(ITAGGGT)4 quadruplex structure, for one
strand only.
residue atom residue atom distance residue atom residue atom distance
Tt H6 rt HI' 4.50 04 H8 04 H2'2 3.45
T2 H6 TI HI' 6.33 05 HS 04 H2'2 3.37
Tt H6 Tt H2'1 2.74 04 HS 04 H3' 4.51
Tt H2'2 rt H6 3.46 04 H8 04 H4' 5.68
Tt H6 Tt H3' 4.S4 A3 H8 04 HS 6.33
ri H6 TI H4' 6.33 05 HS 05 HI' 5.43
T2 H6 T2 HI' 5.29 05 HS 05 H2'1 3.24
T2 H6 T2 H2'1 3.32 05 HS 05 H2'2 3.42
T2 H6 T2 H2'2 4.16 05 HS 05 H3' 4.5S
T2 H6 T2 H3' 5.37 06 HS 05 H3' 5.09
T2 H6 T2 H4' 6.33 05 HS 05 H4' 5.88
A3 H8 T2 H6 6.33 04 H8 05 H8 6.33
T7 H6 06 Ht' 6.33 06 H8 06 HI' 4.68
T7 H6 06 H2'I 4.48 06 H8 06 H2'1 2.55
T7 H6 06 H2'2 4.04 06 H8 06 H2'2 3.24
T7 H6 06 H3' 5.28 06 HS 06 H3' 4.53
T7 H6 T7 HI' 4.19 06 H8 06 H4' 6.08
T7 H6 T7 H2'I 3.62 06 H8 T7 H6 6.33
T7 H6 T7 H2'2 4.44 06 HS T7 H7 4.66
T7 H6 T7 H3' 4.23 Tt H7 Tt HI' 5.91
T7 H6 T7 H4' 6.13 ri H6 ri H7 3.77
06 HS T7 H6 6.33 ri HI' T2 H7 6.26
A3 H8 T2 HI' 5.72 rt H3' T2 H7 5.51
A3 H8 T2 H2'1 5.72 T2 H7 T2 H2'I 4.60
A3 H8 T2 H2'2 4.15 T2 H2'2 T2 H7 5.68
A3 H8 T2 H3' 6.33 T2 H3' T2 H7 4.SS
A3 HS A3 HI' 5.32 T2 H6 T2 H7 3.53
04 HS A3 HI' 5.69 06 HI' T7 H7 S.S4
A3 H8 A3 H2'I 3.41 06 H2'} T7 H7 5.23
A3 H8 A3 H2'2 3.S1 06 H2'2 T7 H7 5.27
A3 H8 A3 H3' 5.73 06 H3' T7 H7 5.20
A3 H8 A3 H4' 6.33 06 H4' T7 H7 6.32
04 H8 04 HI' 4.87 06 HS T7 H7 4.66
05 H8 04 HI' 6.22 T7 HI' T7 H7 6.05
04 H8 04 H2'I 3.02 T7 H2'2 T7 H7 5.19
T7 H6 T7 H7 3.57 A3 H3' A3 H4' 3.08
Tt HI' ri H2'1 3.63 A3 H3' A3 HS'I 3.08
Tt H2'2 rt H2'1 2.15 A3 H4' A3 HS'I 2.88
TI H3' TI H2'I 2.85 A3 H2 04 HI' 4.90
rt H2'I ri H3' 2.88 04 HI' 04 H2'} 3.30
Tt H4' rt H2'I 4.26 04 H2'2 04 H2'I 2.12
Tt H2'I ri H4' 4.60 04 H3' 04 H2'1 2.63
Tt HI' ri H2'2 2.90 04 HI' 04 H2'2 2.SS
ri H2'2 rt H4' 4.75 04 H3' 04 H2'2 2.66
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residue atom residue atom distance residue atom residue atom distance
Tl HI' Tl H3' 4.93 G4 H4' G4 H2'2 3.91
Tl HI' Tl H4' 3.84 G4 HI' 04 H3' 4.26
TI H3' Tl H4' 3.40 G4 HI' G4 H4' 3.86
Tl H3' T1 HS'I 3.38 G4 H3' 04 H4' 2.88
T1 H4' T1 HS'I 3.21 G4 H3' G4 HS'I 2.82
T2 HI' T2 H2'I 3.S9 GS HI' GS H2'1 3.03
T2 H2'2 T2 H2'1 2.17 GS H2'2 GS H2'I 2.09
T2 H3' T2 H2'1 2.80 GS H3' GS H2'I 2.44
T2 H4' T2 H2'1 3.94 GS H4' OS H2'1 3.48
T2 H3' T2 H2'2 3.41 GS HI' OS H2'2 2.S7
T2 HI' T2 H2'2 2.92 GS H3' OS H2'2 2.S8
T2 H3' T2 H2'2 3.19 GS H4' GS H2'2 3.88
T2 H4' T2 H2'2 3.87 GS HI' OS H3' 3.83
T2 HI' T2 H4' 3.37 05 HI' 05 H4' 4.38
T2 H3' T2 H4' 3.74 GS H3' G5 H4' 2.83
T2 H3' T2 HS'I 3.2S G5 H3' G5 HS'I 2.70
T2 H4' T2 HS'I 2.7S G6 HI' G6 H2'I 2.98
A3 H2 A3 HI' 4.10 G6 H2'2 G6 H2'I 2.12
A3 HI' A3 H2'1 3.45 G6 H3' 06 H2'I 2.51
A3 H3' A3 H2'1 2.59 G6 H4' G6 H2'I 4.00
A3 H4' A3 H2'I 5.00 G6 HI' 06 H2'2 2.46
AJ HI' A3 H2'2 2.74 G6 H3' 06 H2'2 2.88
AJ H3' AJ H2'2 3.18 G6 H4' G6 H2'2 3.77
AJ H4' A3 H2'2 4.27 G6 HI' G6 H3' 4.11
AJ HI' A3 H3' 4.16 G6 HI' G6 H4' 3.36
AJ HI' A3 H4' 4.S3 G6 H3' G6 H4' 2.88
G6 H3' G6 H5'I 2.65 T7 HI' T7 H3' 4.93
T7 HI' T7 H2'I 3.27 T7 HI' T7 H4' 3.87
T7 H3' T7 H2'I 2.88 T7 H3' T7 H4' 3.4
T7 HI' T7 H2'2 2.45 T7 H5'I T7 H3' 2.74
T7 HJ' T7 H2'2 3.34 T7 H4' T7 H5'I 1.94
T7 H4' T7 H2'2 4.00 A3 H2'2 A3 H2'I 2.14
AJ H62 AIO H2 5.06 GI8 N7 G25 N2 2.95
A24 H61 04 NH 4.71 GI8 06 G25 NI 2.9S
G4 NH A3 H2 5.65 G4 N2 G2S N7 2.9S
G4 NH A24 H8 S.64 G4 NI G25 06 2.95
G4 NH G4 H21 4.S8 GIl N2 G4 N7 2.95
G4 NH G25 H8 5.00 Gil NI 04 06 2.95
GI2 NH GS H8 5.13 Gl9 N2 GI2 N7 2.9S
G4 NH G5 NH 4.19 GI9 NI GI2 06 2.95
GS NH G2S H8 4.54 GI9 N7 G26 N2 2.9S
GS NH G5 H21 4.85 Gl9 06 G26 NI 2.9S
GS NH G26 H8 5.00 GS N2 G26 N7 2.9S
G6 NH G26 H8 S.88 GS NI G26 06 2.95
G6 NH GS NH 4.36 GI2 N2 G5 N7 2.95
G6 NH G27 H8 4.67 GI2 NI GS 06 2.95
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residue atom residue atom distance residue atom residue atom distance
G6 NH G6 H2I 4.63 G20 N2 Gt3 N7 2.95
G6 H22 G6 NH 4.25 G20 NI G13 06 2.95
G5 H22 G26 H8 4.25 G20 N7 G27 N2 2.95
G5 H22 G5 NH 4.25 G20 06 G27 NI 2.95
G4 H22 G25 H8 4.25 G6 N2 G27 N7 2.95
G4 H22 G4 NH 4.25 G6 NI G27 06 2.95
G6 H22 G27 H8 4.25 GI3 N2 G6 N7 2.95
GI8 N2 Gt I N7 2.95 Gt3 NI G6 06 2.95
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Appendix 2.6 NOE restraints for the 1:1 d(TI AGGGT)4 -RHPS4 complex structure,
for one strand only.
residue atom residue atom distance distance
Tt HI' Tt H6 2.50 4.00
Tt H2" Tt HI' 1.80 3.00
Tt H2" Tt H3' 2.50 4.00
Tt H2" Tt H4' 3.50 S.SO
Tt H2" Tt H6 2.50 4.00
TI H2" Tt HS' 3.S0 S.SO
TI H2' Tt HI' 2.50 4.00
Tt H2' Tt H2" 1.80 3.00
TI H2' Tt H3' 2.S0 4.00
TI H2' Tt H4' 3.S0 S.SO
Tt H2' Tt H5' 3.S0 S.50
Tt H2' Tt H6 1.80 3.00
TI H3' Tt HI' 3.50 S.50
Tt H3' Tt H6 2.S0 4.00
TI H4' Tt HI' 3.S0 5.S0
TI H4' Tt H3' 2.S0 4.00
TI H4' Tt H6 3.S0 5.S0
Tt HS' Tt H3' 2.50 4.00
TI HS' Tt H4' 2.50 4.00
Tt H5' Tt H6 2.50 4.00
Tt Me Tt H6 2.S0 4.00
T2 HI' T2 H6 2.50 4.00
T2 H2" T2 HI' 1.80 3.00
T2 H2" T2 H3' 1.80 3.00
T2 H2" T2 HS" 3.S0 5.50
T2 H2" T2 HS' 3.50 5.50
T2 H2" T2 H6 2.50 4.00
T2 H2" A3 H8 2.50 4.00
T2 H2' T2 HI' 2.50 4.00
T2 H2' T2 H2" 1.80 3.00
T2 H2' T2 H3' 1.80 3.00
T2 H2' T2 HS" 3.50 5.50
T2 H2' T2 H5' 3.50 5.50
T2 H2' T2 H6 1.80 3.00
T2 H2' A3 H8 3.50 5.50
T2 H3' T2 HI' 3.50 5.50
T2 H3' T2 H6 2.50 4.00
T2 H3' A3 H8 3.50 S.50
T2 H4' T2 HI' 3.S0 5.50
T2 H4' T2 H3' 2.50 4.00
T2 HS" T2 H3' 2.50 4.00
T2 H5" T2 H5' 1.80 3.00
T2 H5" T2 H6 3.50 S.SO
T2 HS' T2 HI' 3.50 5.50
T2 HS' T2 H4' 1.80 3.00
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T2 H5' T2 H6 3.50 5.50
T2 Me Tl HI' 3.50 5.50
T2 Me Tl H4' 3.50 5.50
T2 Me T2 H6 2.50 4.00
T2 Me A3 H4' 3.50 5.50
A3 HI' A3 H8 2.50 4.00
A3 HI' G4 H8 3.50 5.50
A3 H2' A3 H2" 1.80 3.00
A3 H2" A3 HI' 1.80 3.00
A3 H2" A3 H3' 1.80 3.00
A3 H2" A3 H4' 2.50 4.00
A3 H2" A3 H5' 3.50 5.50
A3 H2" A3 H8 1.80 3.00
A3 H2" G4 H8 2.50 4.00
A3 H2' A3 HI' 1.80 3.00
A3 H2' A3 H4' 3.50 5.50
A3 H2' A3 H5' 3.50 5.50
A3 H2' A3 H8 1.80 3.00
A3 H3' A3 H8 2.50 4.00
A3 H3' G4 H8 3.50 5.50
A3 H4' A3 HI' 1.80 3.00
A3 H4' A3 H3' 1.80 3.00
A3 HS' A3 HI' 3.50 5.50
A3 H5' A3 H3' 2.50 4.00
AJ HS' A3 H4' 2.50 4.00
AJ H5' A3 H8 3.50 5.50
G4 HI' G4 H8 2.50 4.00
G4 HI' GS H8 2.50 4.00
G4 H2" G4 HI' 1.80 3.00
G4 H2" G4 H3' 1.80 3.00
G4 H2" G4 H4' 2.50 4.00
G4 H2" G4 H5' 3.50 5.50
G4 H2" G4 H8 1.80 3.00
G4 H2" G5 H8 2.50 4.00
G4 H2' G4 HI' 1.80 3.00
G4 H2' G4 H2" 1.80 3.00
G4 H2' G4 H3' 1.80 3.00
G4 H2' G4 H4' 3.50 5.50
G4 H2' G4 H5' 3.50 5.50
G4 H2' G4 H8 1.80 3.00
G4 H3' G4 HI' 2.50 4.00
G4 H3' G4 H8 2.50 4.00
G4 H3' G5 H8 3.50 5.50
G4 H4' G4 HI' 2.50 4.00
G4 H4' G4 H3' 1.80 3.00
G4 H4' G4 H8 3.50 5.50
G4 HS' G4 HI' 3.50 5.50
G4 H5' G4 H3' 2.50 4.00
G4 H5' G4 H4' 2.50 4.00
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G4 HS' G4 H8 3.50 5.50
G5 HI' GS H8 2.50 4.00
G5 HI' G6 H8 2.50 4.00
GS H2" GS HI' 1.80 3.00
GS H2" GS H3' 1.80 3.00
GS H2" GS H4' 3.50 5.50
GS H2" GS HS' 3.50 5.50
GS H2" G5 H8 2.50 4.00
GS H2' G5 HI' 2.50 4.00
GS Hr G5 H2" 1.80 3.00
GS H2' GS H3' 1.80 3.00
GS H2' GS HS' 2.50 4.00
GS H2' GS H8 2.50 4.00
GS H2' G6 H8 1.80 3.00
GS H3' GS HI' 2.50 4.00
GS H3' GS H8 2.50 4.00
GS H3' G6 H8 3.50 5.50
GS H4' GS HI' 2.50 4.00
GS H4' GS H3' 1.80 3.00
GS H4' GS H8 3.50 5.50
GS H5' GS HI' 3.50 5.50
GS HS' GS H3' 2.50 4.00
GS HS' GS H4' 2.50 4.00
GS HS' GS H8 2.50 4.00
G6 HI' G6 H8 2.50 4.00
G6 H2" G6 HI' 1.80 3.00
G6 H2" G6 H3' 1.80 3.00
G6 H2" G6 H8 2.50 4.00
G6 H2' G6 HI' 2.50 4.00
G6 H2' G6 H3' 1.80 3.00
G6 H2' 06 H2" 1.80 3.00
G6 H2' G6 H8 1.80 3.00
G6 H3' G6 HI' 2.50 4.00
G6 H3' 06 H8 2.50 4.00
06 H4' G6 H8 3.50 5.50
G6 HS' G6 HI' 3.50 5.50
G6 HS' G6 H3' 2.50 4.00
G6 HS' G6 H4' 2.50 4.00
G6 HS' G6 H8 3.50 5.50
T7 HI' T7 H6 2.50 4.00
T7 H2" T7 HS' 3.50 5.50
T7 H2" T7 HI' 1.80 3.00
T7 H2" T7 H3' 1.80 3.00
T7 H2" T7 H6 2.50 4.00
T7 H2' T7 HI' 2.50 4.00
T7 H2' T7 H3' 1.80 3.00
T7 H2' T7 HS' 3.50 5.S0
T7 H2' T7 H6 1.80 3.00
T7 H3' T7 H6 2.S0 4.00
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T7 H5' T7 HI' 3.50 5.50
T7 Me G6 HI' 3.00 5.50
T7 Me G6 H3' 3.50 5.50
T7 Me T7 H6 2.50 4.00
rr H2' ri H2" 1.80 3.00
T7 H2' T7 H3' 2.50 4.00
T7 H2' T7 H4' 3.50 5.50
T7 H4' T7 HI' 2.50 4.00
T7 H4' T7 H3' 2.50 4.00
G6 NH G27 H8 2.50 5.50
GI3 NH G5 H8 2.50 5.50
G6 NH G5 NH 2.50 5.50
G4 NH G25 H8 2.50 5.50
G4 NH G5 NH 2.50 5.50
GS NH G26 H8 2.50 5.50
G6 H22 G6 NH 2.50 5.50
GS H22 G5 NH 2.50 5.50
G6 H22 G27 H8 2.50 5.50
GS H22 G26 H8 2.50 5.50
residue atom residue atom distance distance
ACR Me6 G4 H8 3.50 5.50
ACR Me6 G6 H3' 3.50 5.50
ACR Me8 A3 HI' 3.50 5.50
ACR Me8 G4 HI' 3.50 5.50
ACR Me8 G4 H8 3.50 5.50
ACR Me8 G6 HI' 3.50 5.50
ACR Me8 G6 H8 3.50 5.50
ACR Mel3 G4 H8 3.50 5.50
ACR Mel3 G6 H8 3.50 5.50
ACR HS G4 H4' 3.50 5.50
ACR HS G6 H2" 3.50 5.50
ACR H7 A3 H2' 3.50 5.50
ACR H7 G4 H5' 3.50 5.50
ACR H9 G4 H4' 3.50 5.50
ACR H9 G4 H5' 3.50 5.50
ACR H7 G6 H2" 3.50 5.50
ACR Me8 G6 NH 3.50 5.50
ACR Meg G4 NH 3.50 5.50
ACR Me8 A3 H8 3.50 5.50
ACR Met3 G4 NH 3.50 5.50
ACR Mel3 G6 NH 3.50 5.50
ACR HtOIH12 G6 NH 3.50 5.50
ACR HI01H12 G4 NH 3.50 5.50
ACR HI01H12 A3 H2" 3.50 5.50
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Appendix 3
Appendix 3.1 Atom charges for H33258 molecule.
atom charge atom charge atom charge
Cl 0.3258 CI0 -0.4226 H13 0.1558
C2 -0.2492 C14 0.4803 H12 0.1391
C3 -0.2016 N3 -0.3821 HIO 0.1787
C4 -0.0398 C15 0.0754 HN3 0.3318
C5 -0.0987 C16 0.3346 H17 0.1592
C6 -0.1812 N4 -0.5909 H19 0.0962
01 -0.5863 C17 -0.2607 H2O 0.1966
H2 0.1553 C18 0.0405 H21 0.1072
H3 0.1478 C19 -0.1378 H21 0.1072
H5 0.1273 C20 -0.2703 H22 0.1746
H6 0.1728 N5 -0.1783 H22 0.1746
HI 0.4434 C21 -0.0726 H23 0.1597
NI
-0.5031 C22 -0.0976 H23 0.1597
C8 0.3216 N6 -0.2781 H24 0.1199
C9 0.1746 C23 -0.1018 H24 0.1199
N2
-0.5354 C24
-0.0867 H25 0.1624
CI3
-0.1310 C7 0.4658 H25 0.1624
CI2
-0.1830 C25
-0.2543 H25 0.1624
CII
-0.0207 HNI 0.3604 HN6 0.3997
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Appendix 3.2 Atom charges for HIO molecule.
atom charge atom charge atom charge
CII 0.4423 NIO -0.3481 H26 0.1765
CI2 -0.0296 C5 -0.2297 H21 0.3316
C33 -0.0901 C4 -0.2997 H5 0.1905
CI4 -0.305 C3 0.3136 H4 0.1764
C15 0.3917 C8 -0.3500 H8 0.1738
CI6 0.0792 02 -0.3417 HI 0.0660
CI7 -0.3485 Cl 0.1249 HI 0.0660
N20 -0.3742 C22 -0.0617 HI 0.0660
CI9 0.4255 C23 -0.0273 H28 0.1174
NI8 -0.5984 N30 -0.1506 H28 0.1174
C21 0.008 C31 -0.0039 H29 0.1155
C22 -0.162 C32 -0.0746 H29 0.1155
C23 -0.1179 C33 -0.3012 H30 0.3598
C24 0.2275 H2O 0.3490 H31 0.1155
C25 -0.116 HI3 0.1380 H31 0.1155
C26 -0.2604 HI4 0.1931 H32 0.1174
N27 -0.4317 H17 0.1843 H32 0.1174
N9 -0.603 H22 0.1462 H33 0.1667
C6 0.3394 H23 0.1443 H33 0.1667
C7 0.0479 H25 0.1443 H33 0.1667
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Appendix 3.3 Atom charges for RHPS4 molecule.
atom charge atom charge atom charge
Cl 0.1404 CI6 0.0274 HI5 0.1760
C2 0.0117 CI7 -0.2376 HI2 0.1755
C3 -0.1987 CI8 0.2567 HI7 0.1949
C4 0.2421 CI9 -0.1117 HI9 0.1849
C5 -0.0831 C20 -0.2763 H2O 0.1984
C6 -0.2689 C21 0.0892 H24 0.1247
F7 0.1877 N23 -0.0456 H24 0.1130
C8 0.1184 C26 -0.2426 H24 0.1050
C9 0.1632 F22 -0.1872 H26 0.0998
CIO -0.0063 C25 -0.1417 H26 0.1025
Nil -0.0482 C24 -0.1629 H26 0.1063
CI3 -0.0011 H3 0.1733 H25 0.1150
CB
-0.2426 H5 0.1924 H25 0.1015
CI4 0.1750 H6 0.1916 H25 0.1196
CI5
-0.2565
